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Staphylococcus aureus nasal persistently colonises the nasal cavity of 20% of the 
human global population and a further proportion is frequently transiently 
colonised. Prevention of S. aureus colonisation reduces transmission and 
minimizes infections caused by this microorganism, which range from minor 
skin infections to life-threatening diseases. In this study, a murine 
nasopharyngeal colonisation model was established and then used for three 
serial passages of seven days with S. aureus. During the evolutionary timescale, 
a pronounced genetic variation was identified among the surviving colonising 
isolates, demonstrating that S. aureus mutations are naturally selected against 
the selective pressures in the nasopharynx niche. DNA Sequence variants were 
mainly found in genes that encode proteins with roles in DNA and RNA activity 
and those involved in carbohydrate and amino acid metabolism and stress 
responses. S. aureus nasopharyngeal evolved clones revealed a trend for 
increased fitness as evidenced by some weak statistical support for increased 
frequency of colonisation in the murine nasopharynx. This observation 
provides some support for the selection of sequence variants resulting in 
adaptive responses to the niche. Over the course of this study, intra-species 
competition for the nasopharynx niche was observed, whereby a S. aureus 
strain already colonising mice (named SA_MOU) prevented invasion by the 
experimental S. aureus strain after its inoculation. Although the competitor 
strains are closely related to USA300 (both belong to ST8), the SA_MOU genome 
sequence did not reveal strong evidence for similar genetic adaptation to the 
nasopharynx as that identified via the SNPs of USA300 LAC JE2 after serial 
passages of the murine nasopharynx. This study has increased our 
understanding of S. aureus adaptive responses to selective pressures in the 
nasopharynx, which could contribute to future novel strategies aimed at 
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Chapter 1 Introduction 
 
1.1 Staphylococcus aureus  
 
S. aureus is one of the 52 species belonging to the Staphylococcaceae family 
(www.bacterio.net/staphylococcus.html, accessed on 18th September 2017) 
that comprises Gram-positive, catalase-positive cocci with a low GC content 
(30-35%). S. aureus is a facultative anaerobe usually distinguished from other 
staphylococci by its ability to produce coagulase, an enzyme that interacts with 
prothrombin resulting in blood clotting by the conversion of fibrinogen to fibrin 
(Murray, 2012).  
 
S. aureus is occasionally found on the skin and mucosa of mammals and birds 
where it mostly establishes an asymptomatic colonisation. As an opportunistic 
pathogen, S. aureus has a vast virulence determinant arsenal that enables 
invasion of host tissues to cause a wide range of infections from superficial, 
uncomplicated skin infections, including impetigo (Liu et al., 2009) and 
abscesses (López et al., 2013), to life-threatening diseases such as pneumonia 
(Ott et al., 2010), meningitis (Pereira et al., 2015), endocarditis (Huang et al., 
2008) and osteomyelitis (Lalikian et al., 2017). Food poisoning (Zhao et al., 
2017) and both scalded skin and toxic shock syndromes (Handler & Schwartz, 
2014; Kulhankova et al., 2014) are examples of toxin-dependent diseases 
caused by S. aureus.  
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Treatment of infections caused by S. aureus has become an increasing challenge 
for healthcare facilities after the emergence of strains with high levels of 
resistance to multiple antibiotics, exemplified by Methicillin-Resistant S. aureus 
(MRSA). Such strains represent a great concern in healthcare units since they 
are a frequent cause of nosocomial infections that are complicated in their 
treatment (Al-Talib, 2010). In recent years MRSA strains have surged in healthy 
humans without previous exposure to healthcare settings, indicating new 
trends in pathogen evolution (Community-Associated MRSA – CA-MRSA) (Otto, 
2013).  
 
S. aureus possess diverse ways to evolve resistance to a vast range of 
antibiotics. In the 1940s, penicillin-resistant strains were observed 
(Rammelkamp & Maxon, 19420 and two decades later they reached pandemic 
levels. These strains produce a penicillinase that interacts with the β-lactam 
ring of penicillin resulting in drug inactivation. In the 1960s, methicillin was 
then introduced to overcome the penicillin resistance. Methicillin has less 
affinity with the β-lactamases produced by S. aureus but two years after it was 
introduced there were reports of methicillin-resistant strains (Peacock & 
Paterson, 2015). MRSA strains express an additional penicillin-binding protein 
(PBP2a) that has less affinity to β-lactams. PBP2a is encoded by the mec gene 
(mecA, mecB and mecC) located in the staphylococcal cassette chromosome mec 
(SCCmec). The incorporation of this genetic mobile element led to the evolution 




SCCmec structure consists of the mec gene and its regulatory elements 
(repressor, signal transducer and insertion sequences), cassette recombinase 
genes (ccrA, ccrB and ccrC) and the J regions that are located beside mec and ccr. 
Different combinations of the mec and ccr complexes define the SCCmec types 
that can be divided in subtypes according to variations in the J regions in the 
same type. To date, 11 types have been described which are divided in several 
subtypes (Lakhundi & Zhang, 2018). 
 
While HA-MRSA is characterised by SCCmec type II, CA-MRSA strains frequently 
carry SCCmec type IV or V. Additionally, CA-MRSA possess the Panton-valentine 
leucocidin (PVL) gene - a cytotoxin that enhances the bacterial virulence. 
However, it has been suggested that the classification of HA-MRSA and CA-
MRSA is no longer valid as infections caused by HA-MSA have been reported in 
patients from community settings and CA-MRSA infections have been observed 
in healthcare settings (Choo, 2017).  
 
Inevitably, the need to control S. aureus infections, especially MRSA, consumes a 
considerable part of the health budget and this economic burden has led to 
hospitals increasing precautions, such as screening for MRSA and isolation of 
patients, to counter the increased length of hospital stay (Ott et al., 2010). It was 
shown that nosocomial MRSA pneumonia results in an overall cost 50% higher 
than a similar infection caused by MSSA (Methicillin-Susceptible S. aureus) (Ott 
et al., 2010). A separate study performed in Germany demonstrated that 
although it is not possible to determine the total economic cost of MRSA 
infections and colonisation, it imposes a high financial impact in the German 
 4 
healthcare system with direct costs ranging from €350 million to €1.5 billion 
(Claus et al., 2014). In the United States, CA-MRSA cases cost up to $13.8 billion 
per year on society (Lee et al., 2013). The economic impact of MRSA on the UK 
in 2005 was between £3 to £11 billion (6-20% of the total NHS expenditure ten 
years earlier), an expense calculated based on changes in productivity, 
healthcare delivery cost and labour supply (Smith et al., 2005). 
 
Thereafter, controlling MRSA infections and its transmission would lead to 
significant economic savings (Gould et al., 2006). The simplest way to avoid S. 
aureus infections is by preventing colonisation. In humans, the most common 
anatomical site colonised by S. aureus are the anterior nares where 20% of the 
global population is persistently colonised and a further 30% is colonised 
transiently (van Belkum et al., 2009). 
 
1.1.1 Typing, phylogeny and epidemiology of MRSA 
 
The epidemiology of MRSA infections depends on phenotypic and genotypic 
typing methods which enable investigations of clonal spreading based on 
characterization of isolates. Multiple criteria are evaluated for the ideal typing 
technique: typeability, reproducibility, discriminatory power, versatility, 
rapidity and simplicity of data interpretation. The most suitable technique 
should possess the majority if not all the characteristics mentioned above (Faria 
et al., 2008). 
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Phage typing was the first typing technique to demonstrate epidemic spread of 
MRSA lineages between hospitals as well as intercontinental spread 
(Mehndiratta & Bhalla, 2012). This method has a great discriminatory power 
which has helped the identification of MRSA strains in epidemiological studies, 
however it possess some disadvantages including the lack of reproducibility, 
the time consumed and a relative high proportion of nontypeable strains 
(Lakhundi & Zhang, 2018). Pulsed-field gel electrophoresis (PFGE) is a 
technique that employs digestion of genomic DNA separated in a gel with 
periodic changes in the orientation of the electric pulse. When carried out with 
the restriction endonuclease SmaI, PFGE is considered the gold standard for 
MRSA typing due its discriminatory power, reproducibility and ease of 
execution and interpretation (Goering, 2010). Although this technique has 
limitations like cost of consumables and labor-intensive protocols, PFGE has 
helped in the understanding of both endemic and epidemic MRSA strains (Blanc 
et al., 2001; Goering, 2010; Weller, 2000). 
 
PCR-based typing systems have been developed for MRSA including Amplified 
fragment polymorphism (AFLP) (Vos et al., 1995), Random amplification of 
polymorphic DNA (RAPD) (Raoul & Fouriner, 2009) and repetitive element 
sequence-based PCR (Rep-PCR) (Sabat et al., 2006) with distinct levels of 
discriminatory power and inter and intra-laboratory reproducibility. Another 
typing technique based on PCR involves the variable region of the agr gene 
(accessory gene regulator), a global regulator of the staphylococcal virulon 
(Francois et al., 2006). Different biotypes of agr (II, III and IV) have been 
 6 
associated with specific clinical conditions and group I is prevalent between 
MRSA isolates (Lakhundi & Zhang, 2018).  
 
Multilocus enzyme electrophoresis (MLEE) is a typing technique that involves 
the extraction of proteins from the cell followed by separation on gels by 
electrophoresis. It has god reproducibility and typeability in general with 
moderate usefulness for outbreak investigations (Lakshmi, 2015). Multilocus 
sequence typing (MLST) is a variation of MLEE which is based on variation of 
multiple loci. This technique analyses seven housekeeping genes and assigns 
alleles to all of them resulting in an allelic profile (sequence type or ST). It has 
provided important insights into the clonal populations of MRSA (Robinson et 
al., 2004). Other techniques involve the characterization of genetic variability. 
While spa typing is based on polymorphism of the X region from the spa gene 
(protein A), SCCmec typing is based on variants of the mobile genetic element 
responsible for β-lactam resistance as mentioned above. They have been used 
for studies of molecular evolution and hospital outbreaks (O’Hara et al., 2016; 
Satta et al., 2013). Ultimately, whole-genome sequencing has the potential to 
resolve a single bp variation between genomes providing a more accurate 
characterization of transmission events and outbreaks (Durand et al., 2018). 
 
Molecular typing methodologies have supported studies of MRSA epidemiology. 
Combination of MLST and SCCmec typing revealed an evolution of MRSA into 
phylogenetically distinct lineages over time and that only a few clones are 
responsible for MRSA diseases (Enright et al., 2002). Findings from both 
techniques also support the theory that SCCmec was introduced multiple times 
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into diverse genetic lineages of S. aureus (Enright et al., 2002). Although MRSA 
populations are naturally dynamic, one or two lineages usually predominate in 
a particular geographical region, where the successful clone reaches a peak 
before it declines and disappears (Willie et al., 2011).  
 
Nowadays, MRSA is pandemic and is represented by a number of strains, 
including HA-MRSA – disseminated in the 1960s – and CA-MRSA – disseminated 
in the mid-1990s (Chambers & Deleo, 2009). Although MRSA has emerged into 
distinct lineages, most of the clones reported belong to five different clonal 
complexes (CCs): CC5, CC8, CC22, CC30 and CC45. These complexes contain 
several STs. While the global population of HA-MRSA is represented mainly by 
CC5 and CC8, CA-MRSA clones are dispersed in several CCs (Chambers & Deleo, 
2009; Feil et al., 2003). In Asia, the most frequently reported subgroups are 
CC5-ST5, CC8-ST239 and CC22-ST22 (Chen et al., 2010; D’Souza et al., 2010). 
The first two are HA-MRSA and studies have demonstrated the spread of these 
clones from hospitals into the community (Song et al., 2011). Even though 
distinct STs from CC5, CC8 and CC30 predominate in Latin America and Africa, 
some STs are common for both regions: ST239, ST8 and ST5 (Breurec et al., 
2011; Rodriguez-Noriega et al., 2010). While multiple CA-MRSA STs have been 
commonly reported in Europe (ST1, ST5, ST8, ST22, ST30, ST80 and ST88), 
ST8-IV (USA300) is almost exclusively the cause of infections caused by CA-
MRSA in the United States, which replaced ST1-IV (USA400) and became 
endemic (Lakhundi & Zhang, 2018). ST22, ST36 and in a small proportion ST80 
isolates are the major cause of MRSA infection in the United Kingdom (Ellington 
et al., 2009)  
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1.2  The anatomy of the human upper respiratory tract 
 
The human respiratory system is responsible not only for air transportation 
from and to the lungs, but also for olfaction, filtering, humidification, together 
with other functions. It is divided into upper and lower airways from which the 
upper respiratory tract (URT) is comprised of the mouth, nose, pharynx 
(segmented into nasopharynx, oropharynx and laryngopharynx) and larynx. 
The URT represents the main air-conducting components of the respiratory 
system and is also the colonisation site for a range of microbes at all levels 
(Isaacs & Sykes, 2002; Pierce & Worsnop, 1999) and is no longer considered 
sterile at lower levels in the lungs (Dickson & Huffnagle, 2015). 
 
Air can enter the respiratory system through the nostrils passing the anterior 
nares, the outermost part of the nose that connects the skin and environment 
with the nasal vestibule and nasal cavity, the latter further segmented in two by 
the nasal septum. Each half of the nasal cavity has horizontal bony projections 
in their lateral walls called turbinates (also known as conchae due to their 
shape) that are divided into inferior, middle and superior. Turbinates are 
important structures that increase surface area within the nasal cavity to 
disrupt the airflow (Dahl & Mygind, 1998).  
 
The nasal vestibule is lined with an epithelium, similar to that of skin (stratified 
squamous, keratinised), which shifts to a ciliated pseudostratified columnar 
epithelium (respiratory epithelium) within the nasal cavity (Uraih & Marompot, 
1990) (Fig 1). Hairs in the nostrils filter foreign particles from the incoming air 
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and mucous secretions (produced by globet cells and subepithelial glands). Cilia 
from the respiratory epithelium aid the filtering mechanism by retaining dust, 
bacteria and other unwanted particles as the air moves from the nasal vestibule 
towards the nasal cavity. The mucus helps with humidifying the inspired air 
that is warmed by capillaries located close to the mucus membrane (Harkema 
et al., 2006). The synchronised beating of cilia on the surface epithelium propels 
the mucous containing filtered trapped materials towards the nasopharynx 
(Morgan et al., 1986). During uncommon situations, such as intense physical 
exercise or nasal obstruction from a cold, the mouth becomes the preferred 
passage for air intake.  
 
Moving through the URT, both left and right nasal cavities open into four 
different paranasal sinuses (frontal, sphenoid, ethmoidal and adenoid) through 
narrow channels called ostia (sinus passages). The biological functions of 
sinuses are still unclear, although they are frequent sites of infections from 
common cold, causing inflammation (Zollikofer & Weissmann, 2008). The 
filtered, moistened and heated air coming from the nose reaches the choanae 
apertures in the posterior part of the nasal cavity that merge into the 
pharyngeal airway, a funnel shaped tube constituted by respiratory epithelium 
similar to the tissue from the nasal cavity that conducts inspired air from the 
URT. Since the nasopharynx houses the pharyngeal ostium of the Eustachian 
tube, an anatomic structure that connects nasopharynx with middle ear, scraps 
of stratified squamous epithelium typical of skin is also present (Uraih & 






Figure 1.1 Epithelia of the anterior nares (A) and nasal cavity (B).  
The anterior nares where the nasal vestibule is located is lined with stratified, keratinised, non-
ciliated squamous epithelium. During differentiation, cells become anucleated and the top layer 
is constituted by corneocytes soaked with a proteinaceous material that contains cytokeratin, 
involucrin, loricrin (coloured rod shapes) among other proteins. The nasal cavity, including the 
nasopharynx is mainly lined by pseudostratified columnar ciliated epithelium. Goblet cells 





The adenoid tonsils located at the top of the nasopharynx (posterior end of the 
nasal cavity) are an aggregate of lymphoid tissue enriched with lymphocytes 
that destroy pathogens during inhalation. Once the air is collected by the 
nasopharynx, it passes through the other segments of the pharyngeal airway 
(oropharynx and laryngopharynx) that also serves as passage for food to be 
further moved downstream towards the larynx. The epiglottis – one of the 
cartilage structures located in the larynx - plays a critical role in controlling air 
entrance into the larynx by blocking breathing during swallowing. The larynx is 
an organ also lined with respiratory mucosa that connects the inferior part of 
the laryngopharynx to the trachea and is known as the voice box as it is 
responsible for vocalisation. The URT terminates at the glottis where vocal 
cords can be found (Isaacs & Sykes, 2002).   
 
 
1.3 Indigenous nasal microbiota and S. aureus carriage 
 
With a main function to process oxygen and carbon dioxide exchange in human 
physiology, adult airways comprise an area ~70m2 (40x larger than the skin 
surface area).  Bacterial species are frequent colonisers of nasal passages based 
on interactions that vary from beneficial to prejudicial and with responses by 
the host ranging from tolerance to damage (Man et al., 2017). Culture-
independent studies have shown high microbiota similarity throughout the 
nasal passages and nasopharynx, although they harbour different patterns of 
bacterial community composition that changes according to host age and health 
status (de Steenhuijen Piters et al., 2015.). 
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A combination of the keratinised squamous epithelium, plus moist, high-oxygen 
availability conditions in the anterior nares and its proximity to the external 
environment favours growth of the dominant skin colonisers such as 
Corynebacterium spp., Propionibacterium spp. and Staphylococcus spp. (Costello 
et al., 2009; de Steenhuijen Piters et al., 2015; Wos-Oxley et al., 2010) Other 
examples of bacteria that are often found in the anterior nares are 
Dolosigranulum spp., Moraxella spp. and Streptococcus spp (Biesbroek et al., 
2014a; Camarinha-Silva et al., 2014) .  
 
The nasopharynx harbours a more diverse bacterial community compared to 
the anterior nares (Yan et al., 2013) possessing high overlap with microbiota 
from proximate niches, like the anterior nares (notably Gram-positive aerobes 
such as Corynebacterium spp., Dolosigranulum spp., Propionibacterium spp. and 
Staphylococcus spp.) and oropharynx and oral cavity (Streptococcus spp. and 
Gram-negative anaerobes Prevotella spp. and Veillonella spp.) (Man et al., 2017; 
de Steenhuijsen Piters et al., 2015). Since the oropharynx is linked to a variety 
of anatomic sites, it generally has a large microbial community constituted by 
pathobionts such as Haemophilus spp., Neisseria spp., Streptococcus spp. and 
commensal Gram-negative anaerobes including Fusobacterium spp., 
Leptotrichia spp., Prevotella spp. and Veillonella spp (Charlson et al., 2011; Gong 
et al., 2014; Segata et al., 2012). 
 
Differences in the nasal microbiota of hosts at different life stages can be 
observed. Children are usually colonised in their nostrils and nasopharynx by 
members of the phyla Actinobacteria (notably Corynebacterium spp.), 
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Firmicutes (notably Streptococcus spp.), Proteobacteria (notably Moraxella 
spp.) and in a lower frequency by Bacteroidetes (Bogaert et al., 2011; Stearns et 
al., 2015). As children reach puberty, a shift occurs and the bacterial community 
in the anterior nares once comprised by those few dominant taxa is replaced by 
a more diverse microbiota where Actinobacteria (notably represented by 
Corynebacterium spp. and Propionibacterium spp.) and Firmicutes (notably 
represented Staphylococcus spp.) become the most frequent major coloniser 
phyla and genera (Oh et al., 2012). In the nasopharynx, predominance of 
bacterial species is proposed to be initially derived from the maternal skin or 
vaginal microbiota in the early stages of life (Moraxella spp., Corynebacterium 
spp., Dolosigranulum spp., Staphylococcus spp. and Streptococcus spp.) 
(Biesbroek et al., 2014b). Although a distinct microbiome profile can be clearly 
described for adults, a broadly similar bacterial nasopharyngeal community 
was reported, except for the absence of Moraxella spp. (Cremers et al., 2014; 
Stearns et al., 2015). 
 
Although S. aureus is found at multiple sites in the respiratory system, it is 
mainly localised to the nasal vestibule (Johannessen et al., 2012) where the 
anterior nares are the primary ecological niche of the URT for S. aureus. Those 
permanently and asymptomatically colonised (~20% of the human population) 
consistently show higher S. aureus abundance than those transiently colonised. 
Due to differences in sampling techniques, it was proposed that those described 
non-carriers could be transient carriers, but with an insufficient S. aureus 
abundance for cultural detection, resulting in the notion that intermittent and 
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non-carriers form a single group with the inability to sustain S. aureus nasal 
colonisation (van Belkum et al., 2009).  
 
Although S. aureus usually acts as an asymptomatic commensal, its colonisation 
represents a high-risk for subsequent infection (von Eiff et al., 2001; van Rijen 
et al., 2008). Success in S. aureus nasal colonisation is governed by a complex set 
of interactions between S. aureus and both the host (e.g. epithelium adherence, 
host immune system evasion) and nasal microbial community (e.g. competition 
for nutrients and host ligands) (Fig 1.2). Therefore, an increased knowledge and 
understanding of S. aureus nasopharyngeal persistence determinants is a focus 
of the study in this thesis.  
 
1.4 Determinant factors of S. aureus carriage 
1.4.1 Host genetic factors 
 
S. aureus carriage patterns support host genetics as an influence on the 
permanent colonisation by the bacteria. Variation in carriage rates is observed 
between different ethnic groups indicating that particular races may be more 
genetically susceptible to S. aureus colonisation (Noble, 1974). Screening of 
random individuals from distinct rural villages in the Netherlands revealed a 
family predisposition to S. aureus carriage, giving indications of influence from 
host genetics in the success of S. aureus colonisation (Noble, 1967). A separate 
study comprising volunteer isolates from Northern China found that individuals 
from the Han ethnic group are less susceptible to S. aureus nasal carriage (Yan 
et al., 2015).    
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Comparisons of carriage patterns in sets of twins, to gain insights of host 
genetic contribution nasal S. aureus colonisation, has provided conflicted 
conclusions. While Hoeksma & Winkler (1963) observed high concordance for 
S. aureus carriage in monozygotic twins, Aly et al. (1974) found no significant 
greater concordance for S. aureus carriage in identical twins compared with 
non-identical twins and non-related children. Besides, no significant heritability 
contribution was found regarding S. aureus carriage in middle-aged and elderly 
Danish twins and the authors suggested a minor influence of host genetic 
determinants in colonisation (Andersen et al., 2012).  Nasal S. aureus carriage 
also seems to be biased by gender, where men show higher colonisation rates 
than woman (Andersen et al., 2012; Andersen et al., 2013; Ruimy et al., 2010). 
 
Multiple host genetic determinants for S. aureus carriage have been associated 
with the immune system. Polymorphisms in diverse genes encoding for 
immune components are linked with high risk for S. aureus nasal carriage: -
defensin 1 (DEFB1) (Nurjadi et al., 2013), interleukin-4 (IL-4) (Emonts et al., 
2008), C-reactive protein (Ruimy et al., 2010), glucocorticoid receptor (van den 
Akker et al., 2006), mannose-binding lectin (Vuononvirta et al., 2011) and Toll-
like receptor 2 (TLR2) (Vuononvirta et al., 2011). For example, the 
glucocorticoid receptor located in the human epithelial cell surface modulates 
the transcription of anti-inflammatory genes and a study described that 
individuals harbouring the 23 lysine allele are more likely to carry S. aureus 
(van den Akker et al., 2006). Polymorphism in the DEFB1 promoter region is 
linked to reduced mRNA expression of -defensin 1 and 3, which is associated 







Figure 1.2 Determinants for S. aureus nasal carriage.  
Schematic representation of the multifactorial nasal colonisation by S. aureus and the major 
components that may affect persistence of S. aureus in the nasal passages. A balanced 
interaction between S. aureus, host factors and the nasal microbiome is critical for colonisation 
by S. aureus. Interference from environmental factors and the host lifestyle (black arrows) 






Although available studies indicate a correlation between host genetics and 
nasal carriage of S. aureus, a definitive answer of genotypic predisposition to 
persistent S. aureus colonisation cannot be established (Mulcahy & McLoughlin, 
2016).  
 
1.4.2 Interaction with the host immune system 
 
Humans have a complex immune system based on diverse mechanisms that 
activate responses to kill bacteria. Therefore, a potential factor that influences 
carriage could alter the ability of S. aureus to evade the host immune responses. 
There is emerging evidence for adaptive immune response as a critical 
determinant of S. aureus nasal carriage and for the ability of certain S. aureus 
strains to manipulate the innate signalling pathways in the nose (Mulcahy & 
McLoughlin, 2016).  
 
The complement cascade is an important feature of the innate immune system 
and it comprises 25 serum proteins enrolled in bacterial killing by altering the 
microbe membrane potential via the membrane attack complex. Complement 
targets microbe cells for phagocytosis via opsonisation and promotes 
inflammation (Stoermer & Morrison, 2011). S. aureus is able to inactivate the 
complement cascade activation through a wide range of secreted proteins.  For 
example, Staphylococcus complement inhibitor protein (SCIN) binds to C3b 
inactivating C3 convertase and thereby obstructs phagocyte recruitment 
(Rooijakkers et al., 2006). S. aureus cell surface anchored protein A (Spa) 
prevents opsonisation by binding the Fc region of IgG resulting in incorrect 
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orientation for phagocytosis receptor-mediated uptake (Deisenhofer, 1981). 
Studies have detected Staphylococcal protein A (Spa) in the exoproteome of a 
nasal carrier S. aureus strain (Muthukrishnan et al., 2011) and also 
demonstrated that Spa-deficient mutants are less virulent in animal models 
(Patel et al., 1987). 
 
Staphylokinase (Sak) activates plasminogen into plasmin enabling bacteria to 
cleave molecules of complement attached to the bacterial cell surface, such as 
C3b and IgG (Rooijakkers et al., 2005). The gene for Sak was shown to be highly 
expressed during nasal colonisation. Sak also possesses alpha-defensin binding 
ability, therefore inhibiting their bactericidal effects (Jin et al., 2004).  
Polysaccharide capsule is present across a range of clinical S. aureus isolates 
and whilst it does not block the attachment of complement molecules to the 
bacterial cell surface, it limits the phagocytosis, suggesting that the capsule 
inhibits the interaction between neutrophils and complement factors adhered 
to the capsule (O’Riordan & Lee, 2004; Thakker et al., 1998).  
 
Fibrinogen-binding proteins play an important role in S. aureus evasion from 
the host immune responses. Extracellular fibrinogen binding protein (Efb) has 
been shown to bind complement factor C3 thereby limiting bacterial 
opsonisation (Lee et al., 2004). The fibrinogen-binding protein, clumping factor 
A (ClfA), has antiphagocytic activity. ClfA expression leads to the bacterial cell 
surface being coated with fibrinogen which consequently blocks the placement 
of opsonins (Bischoff et al., 2004; O’Brien et al., 2002). Studies have shown that 
ClfA is present on the cell surface in post exponential phase and this protein not 
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only inhibits phagocytosis by macrophages (Palmqvist et al., 2004) and aids 
higher virulence of S. aureus in murine model (Josefsson et al., 2001). 
 
S. aureus reduces phagocytosis by inhibiting neutrophil chemotaxis. Chemotaxis 
inhibitory protein of Staphylococcus (CHIPS) binds to C5a and formylated 
peptide neutrophil receptors to avoid recognition of these chemoattractant 
molecules (de Haas et al., 2004). Extracellular adherence protein (Eap) inhibits 
leukocyte recruitment by binding to the adhesive protein receptors like 
intracellular adhesion molecule 1 (ICAM-1) receptor on endothelial cells, 
blocking the adhesion of neutrophils and thereby diapedesis and extravasation 
(Chavakis et al., 2002). 
 
S. aureus expresses potent factors that disable the host immune system, 
including exotoxins. Panton-Valentine leukocidin (PVL) is a S. aureus exotoxin 
associated with high virulent phenotypes such as those of USA300 strains and 
PVL secretion destroys leukocytes (Genestier et al., 2005).  S. aureus that are 
engulfed can escape killing within phagosomes via staphyloxanthin, the orange 
carotenoid pigment in its membrane, which prevents the oxidising effects of 
reactive oxygen species (Liu et al., 2005). S. aureus also possess superoxide 
dismutase enzymes that detoxify reactive oxygen species (Karavolos et al., 
2003).  
 
Innate immune responses from the host include synthesis of antimicrobial 
lipids, peptides or proteins and S. aureus expresses resistance mechanisms. 
Lysozyme is an important enzyme from the host innate immune system, which 
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cleaves the glycosidic bond between N-acetylglucosamine and N-acetyl 
muramic acid residues, consequently disrupting the cell wall. Production of the 
cell wall modifying enzyme, O-acetyl transferase (OatA), leads to N-acetyl 
muramic acid acetylation which combined with the presence of wall teichoic 
acid (WTA) at this site inhibits access of lysozyme to the glycosidic bond with 
N-acetyl glucsamine (Bera et al., 2005).  S. aureus escape from the activity of 
diverse cationic antimicrobial peptides attracted to the anionic bacterial cell 
surface by reducing the negative charge of its membrane.  MprF and Dlt 
enzymes catalyse changes to the charge of the cell membrane and teichoic acid 
to limit integration of antimicrobial peptides into the cell surface. Operon 
mutants for these enzymes have reduced virulence in animal models (Collins et 
al., 2002; Kristian et al., 2003).  Antimicrobial fatty acids (AFAs) are part of skin 
defence and present in the nasal cavity; sapienic acid is active on skin while 
linoleic acid is active in the anterior nasopharynx.  S. aureus has protection 
mechanisms via IsdA (iron-regulated determinant A), WTA and an efflux pump 
for linoleic acid as these components alter cell surface hydrophobicity and limit 
interaction avoiding bacterial killing by the AFAs (Bera et al., 2007; Clarke et al., 
2007; Kenny et al., 2009). Reduced free cis-6-hexadecanoic acid on skin has 
been associated with S. aureus carriage among atopic dermatitis patients 
(Takigawa et al., 2005). 
 
1.4.3 Interaction with the nasal epithelium  
 
Bacterial attachment to surface components of the nasal cavity is a critical step 
in persistence of S. aureus in nasal passages. The anterior nares are lined with 
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keratinised, stratified, squamous epithelium, which undergoes a differentiation 
that changes their appearance to highly keratinised corneocytes (anucleated 
cells). These cells are covered by a matrix composed of proteins such as 
cytokeratin 10 (K10), filaggrin, involucrin and loricrin (Fig 1) (Mulcahy & 
McLoughlin, 2016). The interaction of S. aureus with these proteins is mediated 
primarily by cell wall-anchored adhesins, of which the MSCRAMM (microbial 
surface components recognising adhesive matrix molecules) family is the 
largest group; these enable the bacterial cell to adhere to nasal epithelium 
(Foster et al., 2014). 
 
Clumping factor B (ClfB) is proposed to be a major component in S. aureus 
adherence to the epithelium during colonisation and its role was described in 
rodent models, being linked to promote nasal colonisation of humans. ClfB 
adheres to proteins located in the cornified envelope of desquamated nasal 
epithelial cells such as cytokeratin 10 (K10) and loricrin (Mulcahy et al., 2012; 
Schaffer et al., 2006; Wertheim et al., 2008). The latter is the primary target for 
ClfB and loricrin-deficient mice have reduced levels of S. aureus colonisation; 
recombinant loricrin can inhibit S. aureus adherence to the nasal epithelium 
(Haim et al., 2010; Mulcahy et al., 2012).  The iron-regulated IsdA protein 
promotes adherence to human desquamated epithelial cells through interaction 
with locrinin, involucrin and K10 (Clarke et al., 2009). This protein aids S. 
aureus nasal colonisation in a cotton rat model and IsdA is also expressed 
during colonisation in human and murine models (Burian et al., 2010a; Clarke 
et al., 2006). 
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Inner nasal cavity epithelium is an important niche for S. aureus adherence. The 
cell-wall anchored macromolecule WTA is composed of repeat units covalently 
linked to bacterial peptidoglycan. WTA contributes to the initial S. aureus 
colonisation of the nasal cavity in a cotton rat model, with a WTA-deficient 
mutant strain being unable to persist in the nose after one day, unlike its 
parental strain (Weidenmaier et al., 2004; Wiedenmaier et al., 2008). A 
transcriptomics-based study revealed increased expression of WTA-
biosynthesis genes during the early stages of colonisation, while genes encoding 
ClfB and IsdA showed up-regulation in later growth stages (Burian et al., 
2010a). WTA adheres to epithelial cells in the nasal cavity by binding its ligand 
on the host cell surface: SREC-1 (scavenger receptor expressed by endothelial 
cell-I) (Baur et al., 2014). SREC-1 was first associated with bacterial recognition 
through its mediation of the interaction between Neisseria gonorrhoeae with 
epithelial cells (Rechner et al., 2007) and has an important role in both innate 
immune and inflammatory responses after microbe recognition (Murshid et al., 
2015). Therewith, it was suggested that WTA manipulates host immune 
responses (Mulcahy & McLoughlin, 2016). 
 
Further S. aureus adhesins are associated with promotion of nasal colonisation, 
corroborating the multi-factorial nature of interactions during S. aureus 
attachment to the nasal epithelium, although the range of corresponding 
ligands in the human epithelial cells remain to be characterised (Edwards et al., 
2012). Serine-aspartate repeat containing proteins SdrC and SdrD were shown 
to contribute S. aureus adhesion to desquamated nasal epithelial cells (Corrigan 
et al., 2009) although their specific roles in colonisation are unknown. A recent 
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study identified desmoglein 1 (Dsg1) as the keratinocyte receptor of SdrD 
(Askarian et al., 2016). S. aureus surface protein X (SasX) was linked with 
promoting S. aureus nasal carriage with a SasX-deficient mutant showing 
drastically reduced levels of nasal colonisation compared with the parental 
strain in a mouse model (Liu et al., 2015). Separately, SasG was demonstrated to 
promote S. aureus adhesion to squamous cells and although laboratory strains 
appear not to express SasG at detectable levels, its expression was quantified in 
clinical isolates (Corrigan et al., 2007). Several other S. aureus MSCRAMMs and 
SERAM (secretable expanded repertoire adhesive molecules) adhesins have 
been identified that interact with host factors, including collagen and elastin, 
however, their relative contribution to nasal colonisation is yet to be described 
(Heilmann, 2011).  
 
A further important factor associated with S. aureus nasal colonisation is its 
interaction with nasal mucus. S. aureus cells are usually found trapped in the 
mucus layer in rat and human histological samples (Burian et al., 2010a; 
Peacock et al., 2001) and have the ability to bind mucin from multiple origins 
such as ferret airway mucus, bovine submaxillary gland mucin and purified 
human mucin (Sanford et al., 1989; Shuter et al., 1996). Although the cognate 
ligand for mucin expressed by S. aureus remains uncharacterised, pre-treatment 
with trypsin leads to reduced mucin binding levels, suggesting a cell surface 





1.4.4 S. aureus interactions with nasal microbiota  
 
For a successful colonisation in the nasal passages, S aureus needs to compete 
with other intra and intergenic species together with other S. aureus strains. 
Simultaneous colonisation with two S. aureus strains is considered unusual 
(Weidenmaier et al., 2012) and studies showed it required nasal absence of 
another S. aureus to colonise the niche in a rat model (Margolis et al., 2010) due 
to interference in subsequent colonisation by other coagulase-positive 
staphylococcal strains (Shinefield et al., 1974). S. aureus intra-species 
interference occurs due to polymorphism in agr (accessory gene regulator), 
which leads to a block in virulence gene expression (Ji et al., 1997), although agr 
interference has not yet been associated with strain interference during nasal 
colonisation (Goerke et al., 2003).  
 
Antimicrobial peptides produced by bacteria, known as bacteriocins, are 
usually effective against microbes closely related to the producer strain. 
Bacteriocins produced by S. aureus, also known as aureocins, are active against 
members of nasal flora, including Corynebacterium fimi, Micrococcus luteus and 
Streptococcus spp. (Gamon et al., 1999). Research about S. aureus antimicrobial 
activity against other common nasal isolates is scarce. In a recent study, 
staphylococci were tested for their antimicrobial activity against members from 
the nasal microbiota and S. aureus isolates showed inhibitory activity against 
Dolosigranulum pseudodipthteriticum, Moraxella catarrhalis and M. luteus, but 
no inhibition was detected against other species including Propionibacterium 
acnes, Streptococcus pyogenes and Haemophillus influenza (Janek et al., 2016).     
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S. aureus populations were demonstrated to be more susceptible to toxin-
producing Staphylococcus epidermidis strains than non-producers (Libberton et 
al., 2015). Known bacteriocins produced by S. epidermidis with bactericidal 
activity against S. aureus are: Pep5, epidermin, epicidin 280 and Nukacin ISK-1. 
Both Pep5 and epicidin 280 lantibiotics disrupt the cell membrane and effect 
release of autolytic enzymes from their inhibitors like the teichoic acid. The 
combination of a weakened cell wall and increased osmotic pressure leads to 
cell lysis (McAuliffe et al., 2001). Epidermin is one the most frequent 
staphylococcal lantibiotics, found not only in several S. epidermidis strains but 
also other Staphylococcus species (Bastos et al., 2009). It acts by interacting 
with lipids of the membrane resulting in murein biosynthesis inhibition and the 
formation of a pore. Epidermin also inhibits WTA biosynthesis (Hasper et al., 
2006, Gotz et al., 2014). Nukacin ISK-1 was described in S. warneri (Ceotto et al., 
2009) and, although its mode of action remains unreported, this lantibiotic has 
bacteriostatic activity against S. aureus (Janek et al., 2016). 
 
S. epidermidis negatively interferes in S. aureus nasal colonisation by secreting 
extracellular serine protease (Esp) that inhibits S. aureus biofilm formation, 
including MRSA and VISA isolates (Iwase et al., 2010). This is however 
contentious, since the contribution of biofilm to nasal colonisation is not clear 
and was argued against (Krismer & Peschel, 2011), thereby questioning Esp as 
a mechanism for the negative association with S. aureus.   
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S. aureus is negatively associated with particular Corynebacterium spp. 
colonising the nose. Corynebacterium sp. strain Co304 completely eradicated S. 
aureus carriage from 71% out of 17 carriers in a mechanism proposed to be 
different to bacteriocin-like activity (Uehara et al., 2000). In a separate study, C 
accolens was revealed to convert skin surface triacylglycerides into free fatty 
acids, including oleic and linoleic acid that inhibited the growth of Streptococcus 
pneumoniae grown adjacent (Bomar et al., 2016.). Given the S. aureus 
susceptibility to long chain unsaturated free fatty acid killing (Moran et al., 
2017), the antagonistic mechanism of C. accolens can be extrapolated to S. 
aureus. 
 
Several Streptococcus species, including S. pneumoniae and S. mitis, are 
negatively correlated with S. aureus nasal colonisation (Bessesen et al., 2015). S. 
pneumoniae antagonism with S. aureus was first suggested to be mediated 
through hydrogen peroxide production (Regev-Yochay et al., 2006) and later 
associated with the pilus produced by S. pneumoniae (Regev-Yochay et al., 
2009). H2O2 toxicity for S. aureus was also associated with bacteriophage 
induction, due to induction of the SOS response activating the lytic cycle (Selva 
et al., 2009), but no significant difference in S. aureus nasal colonisation was 
observed when co-colonised with H2O2 producing and non-producing S. 
pneumoniae strains (Margolis, 2009).    
 
Propionibacterium acnes is negatively associated with S. aureus in the nares 
(Frank et al., 2010) and it reduces S. aureus viability both in vitro and in vivo 
(Shu et al., 2013). P. acnes is able to produce, in the presence of glycerol, 
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propionic acid which has S. aureus killing activity at milimolar concentrations 
(Shu et al., 2013). In the absence of glycerol, a natural product on the skin, P. 
acnes inhibits S. epidermidis, presumably via berninamycin A-like thiopeptides 
(Christensen et al., 2016). Given that S. aureus is also affected by these 
antibiotics (Haste et al., 2012), it is possible that these mechanisms target S. 
aureus.  
 
Of the other species with described antagonistic properties, Bacillus subtilis 
synthesises diverse antimicrobials active against S. aureus, including surfactin 
and plipastatin. The combination of these antimicrobials could inhibit S. aureus 
growth in a murine skin model (Gonzalez et al., 2011; Liu et al., 2010). 
Pseudomonas aeruginosa also negatively correlates with S. aureus by affecting 
the agr system expression through signalling peptide 3-oxo-C12-HSL. This 
peptide has been shown to benefit P. aeruginosa rather than S. aureus in co-
colonised sites such as wound infections and the respiratory system of patients 
with cystic fibrosis (Qazi et al., 2006). 
 
1.4.5 S. aureus quorum sensing system and the Agr regulatory mechanism  
 
Quorum sensing is a mechanism by which bacteria sense cell density within a 
population by employing small signal molecules for cell-to-cell communication, 
through which the cells sense and respond to the signal and alter gene 
expression. Changes in gene expression are transduced by means of a two-
component signal transduction system (TCS). The major staphylococcal TCS is 
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agr which regulates virulence determinants such as toxins, exoenzymes and 
adhesins (Le & Otto, 2015).  
 
The agr locus is comprised by two transcriptional units: RNAII and RNAIII, 
regulated by promoters P2 and P3, respectively. While RNAII harbour four 
genes (agrA, agrB, agrC and agrD), RNAIII is an effector molecule that controls 
Agr targets and is also a mRNA that encodes the delta-hemolysin Hdl. An auto-
inducing peptide (AIP) signal is produced from the AgrD precursor, maturated 
by AgrB and exported. AIP detection by AgrC leads to phosphorylation of AgrA 
which activates both promoters P2 and P3, resulting in an auto-feedback 
regulation (Tan et al., 2018) (Figure 1.3).    
 
RNAIII usually acts blocking the translation of a number of surface proteins. It 
also blocks the translation of the repressor of toxin (Rot) protein leading to the 
transcription of many exoproteins and toxins (Boisset et al., 2007) (Figure 1.3).   
 
Quorum sensing inhibition can occur by interference between staphylococcal 
species.  AIP amino acid sequence variation determines different classes of agr. 
While S. aureus has four agr groups (I-IV), S. epidermidis has three (I-III) (Chen 
et al., 2011; Thoendel et al., 2011).  AIP of one strain can inhibt agr activation of 
another strain or staphylococcal species. Quorum sensing antagonism was 
shown between S. aureus and S. epidermidis where AIP class I from the latter is 
able to inhibit all S. aureus agr classes, expect for IV. The opposite happens only 






Figure 1.3. Schematic of the agr autoinduction circuit in S. aureus. 
The AgrD peptide processed by the membrane-anchored AgrB is exported in the form of an 
autoinducing peptide (AIP; tailed thiolactone ring). Ah high extracellular concentrations, AIP 
binds to AgrC receptor and activates the AgrC kinase, resulting in phosphorylation of the AgrA. 
Once phosphorylated, AgrA binds and activates promoters P2 and P3. While P2 drives the 
autoactivation circuit, P3 promotes the transcription of RNAIII, the regulatory effector of the 





       
While antagonism activity results in gene expression alteration, these effects of 
agr in S. aureus nasal colonisation are still unclear (Otto et al., 2009). Burian et 
al. (2010b) showed that agr expression is minimal during nasal colonisation. 
Canovas et al., (2018) identified other staphylococcal coloniser species 
interfering with S. aureus agr with some of them exhibiting broad antagonistic 
activity on S. aureus. A separate study of the role of haemoglobin in S. aureus 
nasal colonisation demonstrated that inhibition of the promoter in each of the 
four classes of agr via haemoglobin reduces nasal colonisation of S. aureus 
(Pynnonen et al., 2011). 
 
1.4.6 Biofilm and its role in S. aureus nasal colonisation 
 
Planktonic cultures of S. aureus show bacteria forming small cell clusters 
(typically with grape-like appearance). Under certain conditions, S. aureus 
communities display the structure of complex dynamic biofilm formations, 
being characteristically composed of several enclosed bacterial layers 
immersed into an extracellular matrix that can adhere to biological and non-
biological surfaces (Otto, 2008). S. aureus biofilm is associated with several 
chronic diseases, such as endocarditis (Parsek et al., 2008), osteomyelitis 
(Brady et al., 2008) and medical device-related infections (Otto, 2008).  
 
S. aureus biofilms are formed upon initial attachment to inert or biotic surfaces 
in which bacterial components such as WTA, lipotheicoic acids, clumping 
factors A and b, fibrinogen/fibronectin-binding proteins (FnBPs) and 
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accumulation-associated protein (Aap) have been reported to play an important 
role in this event (Speziale et al., 2014). After adhesion to a particular tissue, S. 
aureus biofilm undergo a proliferation event leading to the production of an 
extracellular matrix which can be composed of proteins, polysaccharide and/or 
eDNA (figure 1.4). Polysaccharide intracellular adhesion (PIA), also known as 
polymeric N-acetyl-glucosamine (PNAG), is the major constituent of 
polysaccharide biofilms. It is encoded by the icaADBC locus and is a major 
component for the structural integrity of S. aureus biofilms (Lister & Horswill, 
2014). ica-independent biofilms are primarily constituted by proteins (Foster et 
al., 2014) and eDNA (Montanaro et al., 2011), the latter acting as intracellular 
adhesins in the absence of PIA. Protein A (SpA), FnBPs and Biofilm-association 
protein (Bap) have been shown to mediate cell-to-cell aggregation in PIA-
independent biofilm (Foster et al., 2014). Once a mature biofilm is established, 
detachment of micro-colonies may occur as a genetically controlled response to 
environmental cues (figure 1.4). The primary biofilm dispersal mechanism is 
via the production of exo-enzymes that promotes the self-destruction of the 
matrix. In general, proteases (e.g. Proteinase K, SspA and Aureolysin) and 
nucleases (e.g. Nuc and Nuc2) have reduced activity against PIA-dependent 
biofilms (Lister & Horswill, 2014). In contrast, components that target PIA are 
ineffective against polysaccharide-independent biofilms. Non-specific factors 
phenol-soluble modulins (PSMs) are effective against most of the biofilms 
(Peschel & Otto, 2013). Agr system promotes expression of both proteases and 
PSMs. Studies have demonstrated that Agr is essential for biofilm dissemination 
(Beenken et al., 2010; Boles et al., 2008), while its inactivation promotes biofilm 
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formation (Boles et al., 2010). agr mutants were reported in thick biofilm-
associated infections (Yarwood et al., 2004).      
 
S. aureus ability to form biofilm in vitro was proposed to be associated with 
nasal epithelium colonisation (Iwase et al., 2010). As mentioned above, proteins 
associated with staphylococcal biofilms interact with the host to promote S. 
aureus colonisation, such as Spa, Atl, FnBpA, Emp, Eap in addition to further 
adhesive proteins (Sugimoto et al., 2013). These proteins can be degraded by 
Esp protease produced by S. epidermidis, thereby suggesting a mechanism that 
explains antagonistic correlation between S. aureus and S. epidermidis mediated 
by Esp (Iwase et al., 2010). However, Fredheim et al. (2014) found no 
interference between Esp protease and biofilm inhibition of S. aureus. 
Moreover, the authors demonstrated a correlation between biofilm formation 
genes and nasal carriage. Contrastingly, histological studies failed to observe 
biofilm formation during S. aureus nasal colonisation from rat and human 
tissues (Nouwen et al., 2004; ten Broeke-Smits et al., 2010). Since the role of 
biofilm-like S. aureus populations during nasal colonisation therefore remains 
undetermined, inclination for a dispersed life style rather than biofilm 













Figure 1.4. Phases of S. aureus biofilm formation. 
Upon contact with a abiotic or biotic surface, planktonic cells attach via surface-anchored 
proteins. Microcolonies are formed followed by the production of an extracellular polymeric 
substance, as part of the biofilm maturation. The matrix can be composed of Polysaccharide 
Intracellular Adhesin (PIA), extracellular DNA or proteins. Environmental signals trigger 
dispersal mechanisms where cells re-enter a planktonic mode of growth and can seed new sites 








1.5 Models to study S. aureus nasal colonisation  
 
Experimental models are established to address S. aureus colonisation both in 
vitro, ex vivo and in vivo. The role of bacterial adhesion components and their 
respective host ligands during S. aureus nasal colonisation were assessed in 
vitro by differences in adherence to human epithelial cells between mutants and 
their corresponding isogenic parental strains (Baur et al. 2014; Clarke et al., 
2006 Mulcahy et al., 2012). Animal models provide more realistic insights about 
the relevance of such adhesion components, while variations in the 
establishment of nasal colonisation between S. aureus mutant and parental 
strains have given indications about the role of adhesins (Liu et al., 2015; 
Weidenmaier et al., 2008). Similarly, animal models have been used to 
investigate immune system-related factors and their role in S. aureus nasal 
colonisation (Gonzalez-Zorn et al., 2005; Mulcahy et al., 2016). 
 
Metagenome sequencing of 16S rRNA from nasal fluid samples produced 
insights of the nasal microbiome (Choi et al., 2014). Nasal microbial flora has 
been identified with both culture-based methods (Alvarez et al., 2013) and 
multiple culture-independent technologies that include: quantitative 
polymerase chain reaction (qPCR), fluorescence in situ hybridisation (FISH) 
mass spectrometry and DNA microarray (Abreu et al., 2012; Boase et al., 2013; 
Foreman et al., 2009; Frank et al., 2010). These methodologies are used to study 
the population dynamics of the nasal microbiota during S. aureus colonisation 
and interference from other members. Additionally, their combination with 
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murine models was used to study the correlation between S. aureus and 
potential competitors of the nasal niche (Margolis et al., 2010). 
 
Burian et al. (2010b) quantified mRNA levels extracted from nose swabs from 
persistent carriers to investigate the regulatory adaptation of S. aureus to the 
nasal passages and the authors observed a predominant role for the two-
component system WalKR during nasal colonisation. Transcriptomic analysis 
was also used to assess different in vivo expression patterns from distinct S. 
aureus carrier strains. This approach showed as a valuable technique to infer 
essential components for S. aureus carriage requiring further investigation for 
controlling or intervening in colonisation (Chaves-Moreno et al., 2016).  
 
Computational modelling is another tool to be used for assessment of 
interactions during S. aureus nasal colonisation. Recently, temporal and spatial 
predictions of S. aureus and P. aeruginosa metabolism in a biofilm consortium 
could be obtained from a computational model (Phalak et al., 2016). Therefore, 
computational modelling coupled with genomic and metabolic data could be 
important to predict the dynamics of populations in nasal passages during S. 
aureus colonisation.  
 
1.6  Sequencing technologies 
 
More than 50 years ago the first nucleic acid sequence was published where 
Holley et al. (1965) revealed the alanine tRNA sequence from Saccharomyces 
cerevisae. Later, Sanger revolutionised sequencing by presenting a DNA 
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sequencing technology that would be implemented as the standard sequencing 
method for decades. Since inception, many aspects have improved in terms of 
cost, time and effort required to finish a sequencing study, especially after the 
Human Genome Project was implemented in the 1990s resulting in the 
publication of the human genome in 2001 (Lander et al., 2001; McGinn & Gut, 
2013). In terms of bacteria sequencing, the first genome to be published was 
from Haemophilus influenzae in 1995 (Fleischmann et al., 1995) with S. aureus 
following 6 years after with the first two genomes published (Kuroda et al., 
2001). 
Nowadays, there are several, diverse platforms able to perform whole genome 
sequencing that are classified into three generations of DNA sequencers. The 
first generation of DNA sequencing is attributed to the Sanger sequencing 
method as the first most significant sequencing technology developed and for 
decades it was the gold standard for DNA sequencing. Also known as the chain-
termination technique, it latterly consists of the generation of multiple 
fragments of different sizes from a single-stranded DNA template after an 
amplification reaction mixed with deoxyribonucleotides (dNTPs) and 
fluorescent-labelled dideoxynucleotides (ddNTPs). The labelled dNTP 
analogues stop the enzymatic extension due the lack of the group responsible 
for binding with the next dNTP. Because ddNTPs are randomly incorporated in 
the strand under extension, fragments of all possible sizes are generated and 
the fluorescent dye in the terminal ddNTP enables fragments to be separated by 
gel-electrophoresis with detection by fluorescent imaging (Sanger et al., 1977).  
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The somewhat similar but inferior approach that is considered as the birth of 
first generation DNA sequencing was proposed by Maxam & Gilbert (1977). 
Although this technique also uses capillary electrophoresis to separate and 
visualise fragments generated by strand breakage, such fragments are only 
available with radiolabelled DNA (usually P32) using different combinations of 
chemicals to cleave the strand at specific bases, hence explaining why this 
method is also known as the chemical cleavage sequencing technique (Maxam 
and Gilbert, 1977).  
 
The need to lower the cost and time for DNA sequencing volume and also to 
achieve a better accuracy led to the development of second generation 
sequencing platforms, also referred as next generation sequencing. Unlike the 
existing methods at the time of their release, the new semi-automated 
sequencers did not use fluorescent/radio-labelled dNTPs or oligonucleotides 
although mechanistically there was a reliance on DNA polymerase synthesis. 
The new approach enabled massive generation of reads by parallel sequencing 
reactions that resulted in the high efficiency to complete sequencing of a whole 
genome (Heather & Chain, 2016).  
 
Commercially, 454 Life Sciences licensed the first next generation genome 
sequencer in 2005, which was later acquired by Roche in 2007. Also referred as 
DNA pyrosequencing, the library preparation for this technique involves the 
ligation of a DNA fragmented template to adaptor sequences that are later 
attached to beads. An emulsion PCR (emPCR) is then performed to coat the 
beads, resulting in ideally one single DNA amplified fragment immobilised on 
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one bead. After filtration of beads without an attached fragment, the DNA-
coated beads are washed over a picoliter slide that contains millions of wells, 
each supporting one bead. A sequencing reaction occurs as nucleotides are 
incorporated into the DNA fragment on the beads in a reaction that releases 
pyrophosphate. A light signal proportional to the length of the incorporated 
bases is recorded via sensors on the wells (Margulies et al., 2005).  
 
Implementation of 454, parallel-based sequencers became state-of-the-art. 
Illumina sequencers became the second generation sequence platform most 
extensively used after their release. Using Solexa technology that was acquired 
by Illumina in 2007 it is capable of generating millions of highly accurate reads 
quicker and cheaper than most of the other platforms available (Heather & 
Chain, 2016). In this technology, single-stranded fragments of DNA have 
adaptors ligated to their 3’ and 5’ ends. These adapter-linked DNA fragments 
are washed across a flow cell which is loaded with primers complimentary to 
the adaptors. Any DNA fragments that do not attach to the flow cell by one of 
the adapters are washed away and the single-stranded DNA fragment library is 
then used in a PCR to synthesise the complementary DNA strand. After removal 
of the original DNA fragment, a second adapter is annealed to the 
complementary primer on the flow cell and clonal expansion occurs in a 
mechanism called “bridge amplification”. According to this approach, the 
recently generated DNA fragment bends and allows the attachment of the 
second adapter to the primer on the flow cell with subsequent synthesis of 
complementary strand (identical to the original DNA fragment). This double-
strand structure with both ends ligated to the flow cell is then denatured, 
 39 
exposing both forward and reverse copies of the same DNA fragment. This 
process is repeated several times generating dense clusters of DNA populations 
in a confined area (Fedurco et al., 2006).  
 
Sequencing is performed in a sequence-by-synthesis manner where the flow 
cell is coated with fluorescent terminator dNTPs and DNA polymerase to 
initially amplify the forward strands. After a nucleotide is incorporated into the 
strand under extension in the clonal cluster, the polymerisation is blocked and 
the fluorescent dNTPS and polymerase are washed from the flow cell. Repeated 
cycles are performed until the fragment is read and the sequence is deduced by 
monitoring the emission of fluorophore signals from each round. Finally, the 
reverse strand is produced and read according to the same protocol for the 
forward strand (Turcatti et al., 2008). The main platforms from Illumina are 
HiSeq (greater read length and depth) and MiSeq (lower quality, but cheaper 
and faster than HiSeq).  
 
Further second-generation sequencing methodologies emerged in the last 
decade. Applied Biosystems that merged with Invitrogen to form Life 
Technologies developed SOLiD, a sequencing platform that unlike Illumina is 
based not on synthesis but on ligation through DNA ligases (McKernan et al., 
2009). Short read length limits the general use of SOLiD, however the cost per 
base sequenced is a positive factor from this sequencer (Glen, 2011).  
 
Another remarkable sequencing platform based on ligation was implemented 
by Complete Genomics from which the nucleotide sequence is obtained from 
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nanoballs with clonal amplification of a DNA fragment (Drmanac et al., 2010) 
Finally, another notable second-generation sequencing platform is Ion Torrent 
with similarlities to 454, however it involves neither fluorescence nor 
luminescence to detect the nucleotides from the DNA fragment under extension. 
Instead, it measures the pH change during polymerisation and the main 
advantage of this platform relying on the rapidness of the sequencing (Rothberg 
et al., 2011).  
 
Second generation sequencers, with special mention to Illumina sequencers, 
have helped researchers to answer questions about diverse biological 
mechanisms, however for massive projects such as metagenomics and 
comparative higher eukaryote genomics, the final cost for sequencing of 
genomes remained high. Third-generation DNA sequencers were established to 
improve the quality of the finished genome with the challenge to lower the final 
price of sequencing. Although there is not a consensus about the components of 
a platform to be included in the second or third generation of DNA sequencing, 
the most recent methodologies have aimed for longer reads to facilitate the 
genome assembly. Heather & Chain (2016) considered third-generation 
sequencers as those technologies capable of sequencing single DNA molecules 
without the need of a clonal amplification step.  
 
Following these concepts, PacBio from Pacific Biosciences is possibly the most 
notable third-generation platform. It uses zero-mode waveguides (ZMWs) as 
nanostructures where the DNA template is immobilised alongside DNA 
polymerase and phospho-linked nucleotides. As the nucleotides are 
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incorporated in the DNA strand being synthesised, fluorescence signals can be 
monitored in real time. Recent improvements in PacBio technology have taken 
this platform to >99.99% accuracy in the consensus sequence (Flusberg et al., 
2010). 
 
Another third-generation sequencing methodology was implemented by Oxford 
Nanopore when the company released GridION and MinION platforms. Their 
technology is based on the potential of a DNA fragment (or other molecules) to 
pass through nanopore channels under when electronically induced. As the 
DNA travels through the nano holes the ion flow is blocked causing disruptions 
in the current proportional to the fragment size, allowing detection of the acid 
nucleic sequence (Clarke et al., 2009). Nanopore sequencing is at its early stages 
and the technology involved needs much refinement. However, this 
methodology is expected to potentially revolutionise the sequencing field 












1.7 Thesis aims 
 
S. aureus nasal colonisation is a high-risk factor for transmission and infection 
caused by this microorganism. Although studies have aimed to elucidate host-
microbe interactions and bacterial components relevant for S. aureus 
persistence in the nasopharynx, a profound understanding of S. aureus carriage 
determinants are yet to be characterised. This study investigates S. aureus DNA 
sequence variants selected over an experimental nasopharyngeal and their 
potential role in bacterial adaptation to this niche. 
 
Chapter three will aim to develop a long-term nasopharyngeal colonisation 
murine model and its subsequent use to perform serial passages of S. aureus. 
With the model successfully established, the repeated passages are a powerful 
approach to check if there is selection of genetic variants over an evolution 
time-frame in the nasopharynx. Chapter four will aim to capture these 
mutations naturally selected during S. aureus colonisation of the mice 
nasopharynx. It is expected that such DNA sequence variants provide increased 
fitness for colonisation, which will be addressed in Chapter five. Variation in the 
colonisation status amongst nasopharyngeal clones indicates that S. aureus 
adapts to this anatomic site by selecting mutations that lead to improved 





Chapter 2 Materials and methods 
 
2.1 Bacterial strains and growth conditions 
 
The S. aureus strain used in this study was USA300 LAC JE2, a derivative of the 
clinical isolate cured of plasmids p01 and p03. S. aureus USA300 LAC was 
isolated from a skin and soft tissue infection in a detainee from the Los Angeles 
County Jail (LAC) and is well-studied. This strain harbours a SCCmec type IV 
(Fey et al., 2013; McCarthy et al., 2016) and epidemiologically it is confined 
mostly to the Americas, mostly North America, and has gained favour as a strain 
of choice since isogenic variants in the Nebraska Transposon Mutant Library 
allow versatile genetic study. USA300 LAC JE2 was selected for the 
experimental nasopharyngeal evolution work in this study for repeated 
colonisation of the nasopharynx.  
 
All cultures were grown for 18 h at 37°C with shaking unless stated otherwise. 
Brain Heart Infusion (BHI) broth or agar was used as the medium for all work, 








2.2 Establishing a long-term nasopharyngeal colonisation murine model  
 
Animal experiments were carried out in strict accordance with ethical approval 
and recommendations from the University of Liverpool Animal Welfare and 
Ethics Committee. For this study, all experiments with mice were performed in 
the Ronald Ross Building (Department of Clinical Infection, Microbiology and 
Immunology, Institute of Infection and Global Health) under guidance and 
supervision of Dr. Elaine Waters via an ethics licence granted to Prof Aras 
Kadioglu. The animal model proposed in this work was also meant to be used in 
separated immunological studies. Therefore, Dr. Elaine Waters investigated the 
lowest dose capable of colonising the mice nasopharynx so the model could be 
used for both the immune responses from the host upon S. aureus colonisation 
and the bacterial genomic changes after repeated nasopharyngeal long-term 
colonisation by S. aureus. Dr. Elaine Waters concluded that 5 x 104 cfu was the 
lowest bacterial dose (see details of the experimental procedures below) 
suitable for both approaches. 
 
The proposed bacterial load was then used for the standardisation of the long-
term nasopharyngeal colonisation murine model used in this work. The 
inoculum was prepared in Lab H (Biosciences building, University of Liverpool) 
by growing S. aureus USA300 LAC JE2 overnight for 18 h at 37°C in BHI and 
transferring 100 µL of this solution to fresh broth. The culture was allowed to 
grow until OD600 0.4 from which 16 µL was diluted into 984 µL of sterile PBS 
(phosphate-buffered saline) in order to achieve a bacterial load of 5 x 104 
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(inoculum was serially diluted and plated on BHI agar plates to confirm the 
bacterial dose). 
 
The bacterial dose was kept in ice and promptly taken to the Ronald Ross 
building so the mice could be inoculated in less than 30 min after the inoculum 
was prepared. Under guidance of Dr. Elaine, fifteen age-matched, 6-8-week-old, 
outbred BALB/c female mice (Charles River, United Kingdom) divided into 
groups of three were anesthetised and their nose was horizontally inoculated 
with 15 L of the standard bacterial dose prepared as mentioned above. Once 
the mice were inoculated, they were returned to their cages to be further 
evaluated regarding S. aureus nasopharyngeal colonisation at five time points 
over a period of 14 d (1, 3, 5, 7 and 14 d). 
 
Groups of three mice were anesthetised prior to sacrifice at different time 
points. The nasopharynx was then aseptically removed, mixed with PBS and 
mechanically disrupted. Viable counts from the resulting nasal washes of tissue 
were performed by plating 3 x 20 L from the nasopharyngeal material on 
mannitol salt agar prior to incubation for up to 48 h at 37 C until colonies were 








2.3 Experimental evolution 
2.3.1 Nasopharyngeal passages as a selection 
 
The experimental strategy was to perform three serial passages of S. aureus 
USA300 LAC JE2 by repeated colonisation of the nasopharynx of three mice per 
passage (Fig 2.1). Animal handling and inoculum preparation was performed as 
described in section 2.2. After inoculation, the mice were maintained with food 
and water ad libitum for 7 d prior to euthanisation then nasopharynx removal.  
 
An inoculum of USA300 LAC JE2 culture was prepared for the first 
nasopharyngeal passage and instilled in each of three mice. After the 7 d 
incubation period, each nasopharynx was removed and disrupted in the Ronald 
Ross Building and the resulting tissue homogenates were spread on three 
mannitol salt agar plates   bin Lab H. For each agar plate cultured overnight, ten 
clones were randomly selected and subcultured to OD600 4.0. Then, equal 
volumes (1 mL) of the ten cultures were mixed to generate a new inoculum 
followed by dilution in PBS as described in section 2.2 to obtain a bacterial load 
of ~ 5 x 104 cfu. This inoculum was used for a second passage of murine 
nasopharyngeal colonisation. A third and final passage was achieved using this 
approach one more time. Both control and resulting clones from each of the 
three nasopharyngeal passages were stored alongside the nasal homogenates 















































































































































































































































































































2.3.2 Strain confirmation 
 
After each of the three serial nasopharyngeal passages was completed, S. aureus 
isolates recovered from the mice nasopharynx were screened by PCR 
amplification of the staphylococcal protein A (spa) gene to confirm that the 
clones found in the nasal washes after the colonisation period belonged to the 
same spa type as the inoculum strain. DNA extraction (see section 2.4.1) was 
followed by PCR amplification of the Short Sequence Repeat (SSR) region of the 
spa gene. The reactions were undertaken using Mastercycler pro S (Eppendorf) 
and each contained 0.5 M PA 1095F forward PCR primer, 0.5 M PA 1517R 
reverse PCR primer (Shopsin et al., 1999), 80 ng DNA, 25 L of BioMix Red 
(Bioline) and DEPC-treated water up to a total reaction size of 50 L mixed into 
0.2 mL PCR tubes. The run cycle parameters were an initial 10 min at 95C and 
then 30 cycles of 30 s at 95C, 30 s at 60C and 45 s at C with a final 10 min at 
72C. 
 
PCR products were purified by using the Isolate II PCR and gel kit (Bioline), 
analysed by agarose gel electrophoresis (see section 2.4.2) and then sequenced 
by GATC Biotech with samples prepared according to the company 
requirements. The spa sequence was then analysed by using BLASTn (Madden, 
2002) with default settings. Matching PCR fragment sizes and BLASTn output 
data for both controls and passaged clones indicated that they belong to the 




2.4 Genome sequencing 
2.4.1 DNA extraction 
 
For DNA extractions, 1.5 ml of overnight cultures were pelleted at 6000 rpm for 
4 min in sterile Eppendorf tubes. DNeasy Blood and Tissue kit (Qiagen) was 
then used according to the manufacturer’s instructions for Gram-positive 
bacteria, including the addition of lysostaphin (Sigma-aldrich) at a final 
concentration of 15 g/mL and 10 U mutanolysin (Sigma-Aldrich) to the cell 
lysis buffer. A RNase step was also included in the protocol.    
 
2.4.2 Agarose gel electrophoresis 
 
 To analyse gDNA integrity prior to sequencing, 1% (w/v) agarose gels were 
prepared in TAE buffer. When necessary, small PCR products were analysed in 
1.5% (w/v) agarose gels. For visualisation, 2 µL of Midori Green (Nippon 
Genetics) was added into 100 mL of melted agarose. For gDNA integrity 
analysis, loading dye was mixed with the samples before loading onto the gel. 




2.4.3 DNA quantification - Qubit  
 
For DNA quantification, analysis was performed according to the 
manufacturer’s instructions using the Qubit dsDNA BR assay kit (Life 
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Technologies). Briefly, a working solution was used to dilute both the samples 
and standard reagents into Qubit tubes with final volume of 200 L. After 
vortexing, the tubes were incubated for 2 min in room temperature and read in 
Qubit fluorimeter. 
 
2.4.4 DNA purity quantification - Nanodrop analysis 
 
Nanodrop (Thermo Scientific) analysis was performed according to the 
manufacturer’s instructions for DNA samples. Briefly, the equipment was 
cleaned with 70% ethanol and 2 L of the same buffer used to dilute DNA was 




2.4.5 DNA quality control 
 
To meet the requirements for sequencing at the Centre for Genomic Research 
(CGR) at the University of Liverpool, the quality of DNA was assessed using 
agarose gel electrophoresis to detect possible DNA fragmentation, Nanodrop to 
analyse protein and/or solvent contamination and Qubit for quantification. 
Prior to sequencing, DNA was transferred to an Eppendorf with  1000 ng in a 
volume of  55 L as determined by Qubit reads, with none or low DNA 
fragmentation shown in the agarose gels and Nanodrop 260/230 and 260/280 
ratios greater than 1.8.  
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2.4.6 Pooled DNA and control samples 
 
The DNA of ten isolates randomly picked from nasal homogenates for each mice 
amongst the three serial nasopharyngeal passages were pooled prior 
sequencing. To effectively capture frequencies of sequence variance that was 
selected during the experimental nasopharyngeal evolution, DNA was 
individually extracted from each clone and then pooled at equimolar 
concentrations according to the Qubit readings.  
 
Since three serial nasopharyngeal passages were performed and each included 
three colonised mice, the total number of pooled DNA samples was nine. 
Additionally, one sample comprised S. aureus USA300 LAC JE2 as control DNA. 
 
2.4.7 DNA library preparation 
 
DNA libraries with an insert size of 350 bp were prepared using TruSeq PCR-
free sample prep kit (Illumina) according to the manufacturer’s instructions. 
MiSeq (Illumina) was used as sequencing platform for both control and pool of 
isolates. DNA library preparation and samples sequencing was done by the CGR 







2.4.8 Genome assembly 
Reads from both pooled and single isolate samples were mapped against the 
reference S. aureus USA300 genome (NC_007793.1) using two packages of BWA 
software – Burrows-Wheeler Aligner version 0.7.13: aln and mem (Li & Durbin, 
2009). After the alignment, mapped reads were filtered to remove secondary 
alignments, PCR duplicates and reads with poor quality by using Samtools 
software version 1.3.1 (Li et al., 2009).  
 
2.4.9 SNP analysis 
 
SAM files generated after genome assembly and quality check of reads were 
coverted do bcf (binary variant call) with Samtools for SNP (Single Nucleotide 
Polymorphism) calling using the mpileup package. The bcf output file was then 
converted to vcf (variant call format). Variants in the genomes were then called 
by using BCFtools version 1.3 (Li et al., 2009) to generate a VCF file with all the 
polymorphism for each sample. 
 
SNPeff algorithm was then used to annotate the variants called in the VCF files. 
In order to remove SNPs present in both control and pooled clones from serial 
passages, a perl script was used so only the variants that appeared during the 
experimental evolution would be shown. A second perl script was used to the 
pooled isolates so the frequency of reads harbouring variants could be assessed. 
To reduce falsely called variants, SNPs not called from both alignments (BWA 
aln or BWA mem) were removed from the dataset. 
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Chapter 3 Establishment of a murine long term 
nasopharyngeal colonisation model 
 
3.1 Introduction 
3.1.1 Different approaches to study S. aureus nasal colonisation  
 
S. aureus is an opportunistic pathogen commonly found in the anterior nares of 
humans where the bacterium typically colonises the site in an asymptomatic 
manner. However, carriage of S. aureus represents a high-risk factor for the host 
as the bacterium can switch from harmless coloniser to pathogen depending on 
several factors from both bacteria and host and also the environment. Assessing 
the determinants that enable S. aureus to colonise the human nasopharynx is a 
critical step in controlling the spread of this microorganism, since the 
eradication of carriage prevents both infection and transmission of S. aureus 
(von Eiff et al., 2001; Grothe et al., 2014; Liu et al., 2017). Experimental models 
have been developed and tested to assess features of S. aureus colonisation for a 
variety of variable parameters: competition with other bacteria, micronutrients 
acquisition, adhesion to human cells, defence against the host immune weapons 
and etc.  
 
The role of specific S. aureus determinants in nasal colonisation, such as the 
MSCRAMM family of adhesins, was evaluated in vitro by measuring attachment 
ability to human epithelial cells in mutant strains compared with wild type 
(Corrigan et al., 2009; Askarian et al., 2016). Host factors derived mainly from 
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the immune system (innate and adaptive response) were assessed regarding 
their relevance in controlling S. aureus nasal colonisation (Simanski et al., 2013; 
Peres et al., 2015; Burgey et al., 2016). 
 
Further models have been established to check how S. aureus competes with 
other members from the nasal microbiome to persist in this niche. A solid agar 
model was developed to analyse the competition dynamics of different 
communities of S. aureus and S. epidermidis where it was observed that S. 
epidermidis can both prevent and invade S. aureus populations via secreted 
toxins (Libberton et al., 2015). An assay combining in vitro mono and co-culture 
with transcriptomics of S. aureus and Corynebacterium striatum (a common skin 
and nasal commensal) enabled the analysis of changes in gene expression of S. 
aureus that reflects a shift from a virulent to commensal state when in the 
presence of C. striatum (Ramsey et al., 2016). The competition between S. 
aureus and S. pneumoniae was assessed in vitro through plate and liquid 
culture-based assays to propose that the latter kill competing bacteria using 
H2O2 by inducing bacteriophage-mediated lysis, while S. aureus uses catalase as 
a counteracting survival mechanism (Park et al., 2008). However, one year later 
it was reported that, using a rat nasal model, catalase production is not 
significantly relevant for S. aureus nasal colonisation regarding the presence or 
absence of a H2O2-producing S. pneumoniae strain (Margolis, 2009). Such 
findings support the need for the establishment of in vivo models and greater 
study to get a more realistic notion of the important features during nasal 
colonisation by S. aureus.  
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3.1.2 Mice as hosts in S. aureus nasopharyngeal in vivo colonisation 
models 
 
S. aureus has been extensively analysed regarding its virulence factors through 
in vivo models developed for a variety of organisms such as fish (Li & Hu, 2012), 
insect (Prithiviraj et al., 2005) and plant (Miyazaki et al., 2012). Still, mice are 
the most common host used for animal models to evaluate S. aureus 
determinants for both infection and colonisation due to several reasons: 
breeding and maintenance cost, current knowledge about the immune system 
and availability of knock-out strains for numerous genes (Schulz et al., 2017).  
 
Although mice and humans share some expected similarities in their nasal 
passages due to the fact they are both mammals, their anatomical and 
physiological differences may influence the interaction with bacteria. Humans 
can use both nasal and oral cavities to breath while mice breath strictly through 
their nose. A notable anatomic difference is the airflow pattern in rodents, 
which harbour a nasal turbinate shape that favours a better protection of the 
lower respiratory tract and an acute olfaction; the olfactory epithelium in mice 
has a much greater nasal airway area (Harkema et al., 2006). 
Mice used in laboratory experiments can be either germ-free or specific 
pathogen-free. With both populations the fact that the microbiome is known or 
constrained represents an advantage for scientific purposes. In humans, four 
main phyla are the major components of the olfactory microbiota: 
Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria (François et al., 
2016).  
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Particular to S. aureus, in vivo experiments using murine models were reported 
that studied specific components relevant for nasal colonisation. Satorres et al. 
(2009) showed in a murine model that IFN- contributes to S. aureus nasal 
colonisation even though this cytokine is an important element of the mice 
immune defences. Another immune system component, IL-17, was assessed for 
its relevance in the clearance of S. aureus nasal colonisation by analysing the 
production of antimicrobial peptides in a murine model (Archer et al., 2016). 
Adhesins of S. aureus and their role in the nasal colonisation were investigated 
in murine models. The study revealed that the surface proteins, ClfB (Mulcahy et 
al., 2012), IsdA (Burian et al., 2010a), SdrC (Corrigan et al., 2009), SdrD 
(Askarian et al., 2016), and the glycopolymer wall-teichoic acid (Baur et al., 
2014) facilitate nasal colonisation. Responses to oxidative stress are also critical 
for S. aureus nasal colonisation and Cosgrove et al. (2007) described the 
relevance of two genes ahpC and katA, encoding peroxide defence enzymes 
alkylhydroperoxide reductase and catalase, in successful colonisation of rodent 
nasal epithelium.  
 
Despite the fact that mice have been extensively used for infection and 
colonisation models these rodents are not considered a natural host of S. aureus. 
Given that multiple virulence factors expressed by S. aureus are human specific 
means that the physiological conditions from murine models may not be ideal to 
evaluate nasal colonisation and virulence. Infection models are of course critical 
to our understanding of pathogenesis and modern developments accentuate the 
scope of research potential. In this regard, inducing a nasal colonisation in mice 
is useful given the wide range of knock-out mice strains that can be used to 
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assess the contribution of both S. aureus determinants and individual host 
components during colonisation (Holtfreter et al., 2013).  
 
3.1.3 Serial passages as an experimental evolution approach 
 
Exposing microorganisms to different environments induces changes in their 
life-cycle. Depending on the microenvironment pressure encountered, a switch 
in a metabolic pathway might occur, genes can be up or down-regulated, 
mutations that favour bacterial survival for such new conditions might also be 
selected. Experimental evolution experiments that select microorganisms that 
adapt to a specific microenvironment are a useful approach to detect relevant 
mechanisms in the adaptation process. Several studies describe S. aureus 
evolution in vitro by serially passaging isolates over days or even weeks under 
different circumstances to assess adaptation mechanisms. 
 
Most of these reports describe how S. aureus develops resistance to inhibitory 
or sub-inhibitory doses of antimicrobials after serial passages of the bacteria in 
culture media. These laboratory-evolved isolates are a good source of genetic 
information to understand details of the evolution mechanisms specific to a 
certain antimicrobial. Not every relevant bacterial factor can be observed in 
these types of experiments as some of the interactions with the host are not 
reproduced in such in vitro assays. Johnston and co-workers (2016) showed that 
serially-passaged strains in a study of antimicrobial peptide (AMP) resistance 
using experimental evolution presented SNPs in genes related to AMP 
susceptibility. Further studies have performed in vitro serial passages as an 
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experimental method to yield better understanding of resistance to other AMPs 
(Samuelsen et al., 2005; Kubicek-Sutherland et al., 2016).  
 
Mishra and co-workers (2012) tested the reproducibility of serial passages 
performed in vitro. The authors serially passaged a S. aureus strain in media 
containing a sub-lethal dose of the lipopeptide antibiotic daptomycin and after 
20 days they found phenotypic and genotypic changes in the passaged strain 
similar to those identified in a previous study done with the same conditions.  
However, of note some of the metabolic changes and mutations that occurred in 
the evolution process did not match with the first dataset. This discrepancy 
identifies the potential for multiple pathways to resistance and the potential for 
subtle differences in the selection placed on the test bacterium. 
 
Such differences in findings could also relate to the fact that in vitro assays do 
not reflect those conditions found in vivo. Somerville and co-workers (2002) 
showed that serial passages in vitro was a reason for S. aureus having decreased 
aconitase specific activity. By serially passaging a S. aureus clinical isolate they 
observed that after 6 weeks the aconitase activity decreased by 38%. This 
insight reinforces the need to use in vivo models to have a more robust 









S. aureus is an important opportunistic human pathogen and nasal colonisation 
by this microorganism is a risk factor for the host to develop infections. 
Although extensive details of how S. aureus establishes infections have been 
determined, detailed mechanisms of nasal colonisation remain unclear. 
Individual components from both S. aureus and humans have been assessed in 
vitro and in vivo but the effects of colonisation as a global genetic event have not 
been analysed yet using in vivo models. 
 
This chapter aims to describe firstly the development of an in vivo long-term 
asymptomatic nasopharyngeal colonisation model using mice as the host. 
Successful development of the model would enable design and establishment of 
an experimental evolution method using serial passages of S. aureus through 
the nasopharynx of mice. The hypothesis formed is that S. aureus is capable of 
long-term colonisation of the murine nasopharynx. Further, the establishment 
of such a model would enable an experimental evolution approach using serial 
passages of strains.  The output set of isolates generated using this approach 
would then be a good source to investigate genetic changes due to selection that 
would highlight key contributing components in the colonisation event played 








This chapter explores the experimental details and the technical challenges 
associated with establishment of a murine model to identify factors 
contributing to S. aureus nasopharyngeal colonisation.  The robustness of the 
model is a requirement to establish serial passages in subsequent experiments. 
 
3.3.1 Development of a long-term nasopharyngeal colonisation murine 
model 
 
Groups of three mice (6 to 8 week-old, BALB/c) were inoculated in their nose 
by gently pipetting 15 L of the inoculum that was prepared with S. aureus 
USA300 LAC JE2 strain (~ 5 x 104 cfu). The mice were returned to their cages 
and maintained in their previous environment for a period of up to 14 d. All 
animals survived throughout the standardisation of this model until their 
sacrifice day. At each time point chosen (1, 3, 5, 7 and 14 d), the colonisation 
status was determined by sacrificing one mice group from which the 
nasopharyngeal tissue was aseptically removed. The recovered nasopharynx 
parts were smashed and mixed with PBS, resulting in nasal material that was 
cultured and enumerated by plating 60 L of serial dilutions on mannitol salt 
agar that was incubated for 24-48 h at 37 C. The homogenates were then 
stored at -80 C so they could be further analysed at a later date. 
 
After colony counting of the mannitol agar plates, it was evident that S. aureus 
USA300 LAC JE2 successfully colonised the mouse nasopharynx for up to 14 d 
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(Fig 3.1).  S. aureus USA300 LAC JE2 experienced a noticeable cell number drop 
in the first three days of nasopharyngeal colonisation followed by increased 
survival level as per CFU values. From day 5 onwards a slight variation in S. 
aureus population number is observed as the strain seems to reach a steady 
colonising status. The observed colonisation over 14 d represents a time-frame 
suitable for the requirements of this study.  
 
The bacterial load can determine a successful nasal colonisation. A study 
demonstrated association between the inoculum dose (104 to 108 CFU) and 
nasal colonisation status in a mice model using three S. aureus strains 
(Reynolds, Newman and DAK). Lower doses resulted in absence or reduced 
levels of colonisation (Kismer et al., 1999). The current model uses a low dose 
inoculum (5 x 104 CFU) of S. aureus USA300 LAC JE2 relative to inocula used in 
previous mouse colonisation experiments.  This cell number was used because 






















Figure 3.1 Nasopharyngeal colonisation of mice by S. aureus USA300 LAC JE2.  
Inoculation was initiated with a 5 x 104 CFU dose. At each time point the nasopharynx of 3 mice 








3.3.2 Serial passages of S. aureus 
 
Once the model was established, a total of three serial passages of S. aureus 
USA300 LAC JE2 were performed with each one comprising 7 days. 
Nasopharynx removal was performed as described in the procedure performed 
in the model standardisation: the nasopharynx was aseptically homogenised 
with PBS resulting in a nasal wash. For the serial passages no intermediate 
quantitative analysis of the colonisation was determined. The nasopharynx 
homogenate was spread onto mannitol agar plates and bacteria cultured 
overnight.  From the resulting clones on the agar plates, ten from each mouse 
were randomly picked and used for the next passage which was established 
with identical load. DNA from all the isolates was extracted so they could be 
screened by spa gene typing.   
 
In the first attempt to complete all three consecutive colonisation experiments, 
the first two passages were performed without problems. All three mice from 
both passages survived over the incubation period and clones of S. aureus 
USA300 LAC JE2 were recovered. PCR of the spa gene was performed as 
previously described (Shopsin et al., 1999) for all the clones and the wild type 
and electrophoretic separation of the fragments revealed they were of similar 
size (Fig 3.2). The resulting fragments were sequenced and from BLASTn 
output it was determined that the clones were identical and each was matching 
with USA300 LAC JE2 (passaged strains and wild type) spa sequence (Fig 3.3). 
Subsequently, from the third passage a different outcome occurred. Again all 
mice survived from inoculation until the sacrifice day, however the S. aureus 
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isolates recovered from the nasopharynx were sequence identified as being a S. 
aureus strain that was not a match with the inoculum. PCR of the spa gene of 
isolates from all the three mice from the third passage revealed fragments that 
were a different size compared with the inoculated clone pools (Fig 3.2).  Using 
BLASTn once more the sequence of the amplified spa fragments revealed a 
different S. aureus strain was recovered (Fig 3.3). Analysis of the spa gene 
repeat region using the Ridom StaphType software (Harmsen et al., 2003) 
assigned the S. aureus strain to t024 (USA300 belongs to t008). 
 
The source of this strain was not identified and an initial explanation was that it 
could be a laboratory-derived contamination either within the separate 
microbiology or animal facilities.  This unexpected result led to two further 
attempts to repeat the inoculations and third serial passage.  When the same 
outcome occurred twice more over a several month period this led to the most 
likely explanation that the mice were nasally pre-colonised by S. aureus.  
Consequently, the project was put on hold for an extended period of months 
before attempting to complete the third and final passage. After this long break 
the third passage was finally and successfully performed with clones from S. 
aureus USA300 LAC JE2 recovered from the nasopharyngeal tissue concluding 














Figure 3.2 PCR products of S. aureus spa amplified from serial passage clones.  
Agarose gel showing different sizes of spa gene PCR fragments for S. aureus USA300 JE2 LAC 
(Lane 1), an S. aureus isolate from the successful second passage (Lane 2) and isolates from the 





























Figure 3.3 BLAST hit list of spa gene sequence for different S. aureus strains.        
Comparison of the sequence match lists returned by BLASTn for S. aureus USA300 JE2 LAC (A), 
an S. aureus isolate from the successful second passage (B) and isolates from the two failed third 






With the successful completion of a set of serial colonisation passages, the 
outcome was that the experimental evolution was achieved with the following 
set of isolates stored frozen, ready to be accordingly further assessed: 
 
- Control: Wild Type (S. aureus USA300 LAC JE2 – 1 isolate); 
- First Passage: Mouse A1 (10 isolates), Mouse B1 (10 isolates), Mouse C1 (10 
isolates); 
- Second Passage: Mouse A2 (10 isolates), Mouse B2 (10 isolates), Mouse C2 (10 
isolates); 
- Third Passage: Mouse A3 (10 isolates), Mouse B3 (10 isolates), Mouse C3 (10 
isolates). 
 
Schematically the experiment and the clones obtained are shown below (Fig 
3.4).
 
Figure 3.4 Experimental evolution of S. aureus in a murine nasopharyngeal model. 
Representation of three serial passages of S. aureus USA300 LAC JE2 through the nasopharynx 
of mice where each colonisation passage lasted 7 d. For every mouse used in this work, 10 
isolates were recovered from the nasopharynx to be genome sequenced and for passages 1 and 






In this chapter, a long-term S. aureus nasopharyngeal colonisation murine 
model was established and was determined to be sufficiently robust for it to be 
used to perform an experimental evolution using serial passages. The 
colonisation model was successfully standardised for S. aureus USA300 LAC JE2 
strain as judged by the relatively stable maintenance of the bacteria with 
isolates recovered from the nasopharynx up to 14 d post-inoculation.  This 
interval represented sufficient time for the purposes of this study but given the 
difference in numbers between 7 and 14 days, the lesser time was chosen with 
the aim of removing as much potential for variability at the extreme of the 
colonisation timeframe. Kieser et al. (1999) reported one of the first murine 
models to study S. aureus nasal colonisation where carriage was observed for 
more than 20 days depending on the treatment that the mice were exposed to. 
Prior to their investigation only a few studies were performed with animal 
models to assess the features of S. aureus nasal carriage (Sanford & Ramsay, 
1987; Sanford et al., 1989). Later, Kokai-Kun and co-workers (2003) 
established a model for cotton rats where the authors observed S. aureus nasal 
carriage for more than 40 days of study.  
 
The model described here uses a relatively low inoculum of S. aureus: 5 x 104 
CFU. This cell number was selected from prior work looking at 7 days of 
colonisation that evaluated a range of cell numbers in the inoculum to identify 
the minimum threshold that generated reproducibility (Dr. Elaine Waters, 
personal communication). Using this previous data there was a desired attempt 
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to establish the model such that it simulated as much as possible a realistic 
scenario of colonisation.  Studies of the human nasophrynx have identified that 
this tissue is typically colonised with numbers of S. aureus ranging from 101 to 
104 CFU (Xu et al., 2015). In contrast, natural nasopharyngeal colonisation by S. 
aureus in mice was not described at the outset of this study. Most of the nasal 
colonisation models described for S. aureus have used higher doses of bacteria 
in the inoculum (Schulz et al., 2017).  
 
Mulcahy et al. (2012) developed a murine model to assess the relevance of 
adhesins in S. aureus nasal colonisation. The model used a dose of 108 CFU and 
the mice were pre-treated with streptomycin one day before inoculation. Kiser 
and co-workers (1999) in their model also used a 108 CFU inoculum. However, 
the authors observed colonisation with lower levels of bacteria (105 to 107 CFU) 
but only after streptomycin treatment and with S. aureus Reynolds strain. The 
model that is standardised here presents some advantages because it not only 
uses a low level inoculum, but it also does not require pre-treatment with 
antibiotics, which could change the dynamics and relevance of S. aureus nasal 
colonisation and inter-species competition.  
 
Considering the dose size used in the inoculum for the model proposed in this 
work the number of S. aureus consistently decreases until day 3 and after day 5 
it reaches a steady state (Fig 3.1). Margolis et al. (2010) assessed the dynamics 
of different populations (including S. aureus) colonising the nasal passages from 
neonatal rats and the authors concluded that the bacterial density in this niche 
is well controlled, regardless of the cell numbers in the inoculum. Thus the 
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model proposed in this current study can be useful to assess the 
nasopharyngeal colonisation features by S. aureus especially from day 5 until 
day 14. A cotton rat model proposed previously with 7 to 10 days of incubation 
for analysis of nasal colonisation (Kokai-Kun, 2008) supports the model 
standardised here.  
 
With the model established, a series of three consecutive passages were 
performed with each lasting for 7 d. The main challenges for this experiment 
were to make sure that the low dose was enough to colonise the mice and that 
the clones recovered after the incubation period belonged to the same strain 
used in the inoculum. Initially two passages were successfully completed. 
However, a difficulty emerged in completion of the third passage that was a 
repeated issue and initially did not allow the conclusion of the experiment for 
several months.  This problem caused an intermission for the third passage as it 
could not be successfully completed.  
 
With two attempts, even though the mice were colonised by S. aureus, spa gene 
typing revealed that the isolates recovered from the nasopharynx were 
different from that included in the inoculum (Fig 3.2 and 3.3).  The most likely 
conclusion made at the time was that the mice were nasally pre-colonised. This 
hypothesis matched with the later findings from Schulz et al. (2017) where the 
authors reported that laboratory mice supplied by several European and North 
American breeders tested are frequently colonised by S. aureus, with nasal 
carriage rates as high as 20%.  
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Although it is well accepted by some researchers that mice are not a natural 
host for S. aureus (McCarthy et al., 2012; Mulcahy et al., 2012) several studies 
support the use of mouse models as a good representation for S. aureus nasal 
carriage assessment (Gonzales-Zorn, 2005; Mulcahy et al., 2012). Here, it was 
observed that mice can serve as a valuable model system to evaluate S. aureus 
nasopharyngeal asymptomatic colonisation over a course of 1-2 weeks, but in 
this case extra care is needed regarding pre-colonisation by another S. aureus 
strain.  
 
It is possible that higher doses or pre-treatment of the mice with streptomycin 
would solve the pre-colonisation issue found in this work, but as mentioned 
above such actions would not reflect what happens in a typical scenario where 
the established flora will provide a competitive exclusion barrier.  Particularly 
for studies looking at the ecology of S. aureus nasal colonisation with a view to 
determining competitive fitness the removal of the existing flora will alter the 
interpretations.  
 
In this respect, Margolis and colleagues (2010) detailed several interactions 
between competitors in the nasal niche using neonatal rats. The authors 
concluded that pre-colonisation by S. aureus prevents the establishment of an 
invasive S. aureus strain in the nasal passages, supporting the classical 
ecological theory of competition (Hardin, 1960). Whilst for the first two 
passages in the establishment of the current model no problem was observed, 
two sets of mice from different periods used for the third passage were pre-
colonised and such issue seemed to persist over a reasonably long time period 
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as the third passage was only successfully completed almost one year after the 
isolates were recovered from the second passage.   
 
Since the source of the S. aureus strain blocking the colonisation by USA300 LAC 
JE2 was unknown and also the fact that such an event occurred twice in a 
relatively long time frame, a pause in carrying out the third passage was taken. 
The long break in attempting to perform the third passage were due to ethical 
and economic reasons because it was not justifiable from a scientific and ethical 
perspective to perform further attempts with mice likely to be pre-colonised by 
a possibly more adapted S. aureus.  
 
S. aureus animal–adapted strains have been reported as the cause of disease 
with bovine and ovine mastitis (Guinane et al., 2010), as well as disease in 
chickens (Lowder et al., 2009) and pigs (de Neeling et al., 2007). Holfreter et al. 
(2013) characterised for the first time a mouse-adapted S. aureus strain which 
was responsible for an abscess outbreak in male mice at the animal breeding 
facility at the University of Auckland. The authors found that the identified 
outbreak strain was still persistently colonising the mouse colony for 2.5 years 
after the outbreak declined and it showed better fitness to colonise the nasal 
passages of mice in a murine model compared with other strains. 
  
It would be worthwhile to perform characterisation of the strain colonising the 
mice that would be expected to be better adapted to the nasopharynx than S. 
aureus USA300 LAC JE2 that it inhibited from colonisation. Known ecological 
 73 
principles could simply explain the lack of invasion but a comparative study of 
mouse isolates and experimentally-adapted strains would provide insights. 
 
S. aureus USA300 LAC JE2 strain derives from the parental strain S. aureus 
USA300 LAC which was originally isolated from skin and soft tissue infection at 
the Los Angeles County Jail (LAC). The parental strain harbours two plasmids 
(p01 and p03) and JE2 was generated after curing the strain for removal of the 
two plasmids (Fey et al., 2013). JE2 strain was chosen for this model since 
USA300 is one of the main clones responsible for Community-Acquired MRSA 
infections (Diep et al., 2006) and also because there is transposon-based mutant 
library specifically constructed for this strain, Nebraska Transposon Mutant 
Library (Fey et al., 2013). The fact that JE2 is not mouse-adapted may explain 
why the resident strain was possibly more adapted to the mice and resisted 
invasion.  
 
Holfreter et al. (2013) reported remarkable differences in the virulence 
repertoire of mice-adapted and human-related strains. The authors described 
that the sequence type associated to the mouse-adapted strain is uncommon in 
humans and it lacked an hlb phage responsible for encoding human-specific 
immune evasion factors. JE2 was recently assessed in a murine infection model 
and it was found that the major S. aureus autolysin – Atl - is not required for the 
establishment of device-related infections (McCarthy et al., 2016). Such reports 
would suggest a parallel need for murine models with strains adapted to the 
animal. Given that the intention of this study is to mimic the human situation, 
JE2 was selected for the establishment of the model to provide insights into a 
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human disease strain with respect to colonisation.  The methods standardised 
here show that it was successfully passaged through the nasopharynx of the 
mice. 
 
To date there is no report regarding in vivo serial passages of S. aureus as an 
experimental evolution approach to assess nasopharyngeal colonisation 
features. As described in the introduction of this thesis, the murine models 
currently available in the literature are used mainly to assess specific genes and 
their role in the nasal colonisation by comparing carriage rates between wild 
type and mutant strains. Serial passages as a methodology have been 
extensively used for in vitro assays to discover mutations with potential 
relevance in antimicrobial resistance.  
 
Other microorganisms – especially viruses – have been evaluated in terms of 
host-adaptation by serial passages using in vivo models. Qiu et al. (2014) 
passaged a virulent strain of Marburg virus (MARV/Ang) 24 times in a mouse 
model and the authors observed that the evolved clones became adapted and 
capable to cause disease in mice while the wild type remained unable to cause 
infection. Years later, sequencing of the passaged strains revealed several 
mutations in the evolution course relevant for the virus adaptation (Wei et al., 
2017). Similar works for other microorganisms like the H7N9 influenza virus 
(Zhao et al., 2016), Sendai virus (Pena et al., 2016) and Corynebacterium 
pseudotuberculosis (Silva et al., 2017) have been recently reported in murine 
models and a ferret model (Angel et al., 2013).  
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In summary, this study represents an important and relevant approach to 
understand aspects of nasopharyngeal colonisation by S. aureus by using serial 

































Chapter 4 Tracking in vivo evolution of S. aureus during 




4.1.1 Insights regarding S. aureus evolution 
 
S. aureus is an important human pathogen and a commensal commonly found in 
the normal flora of the nasopharynx. How S. aureus colonises the human 
nasopharynx asymptomatically or establishes an infection event is presumed to 
rely on its evolved ability to sense discrete environmental signals that direct 
gene expression appropriate to diverse host sites. In this way, S. aureus is 
versatile in the range of anatomical tissues where it persists, reflecting its high 
genomic and phenotypic diversity. The major events that lead to variability in 
the S. aureus genome are the acquisition of mobile genetic elements (MGEs), 
mutations in the bacterial genome and occasionally homologous recombination 
(Fitzgerald, 2014). 
 
MGEs are fragments of DNA that encode the ability to move between and within 
genomes. MGEs such as bacteriophages, plasmids, transposons and 
staphylococcal cassette chromosomes are known to promote horizontal genetic 
transfer frequently in S. aureus (Lindsay, 2010). For example, the pandemic 
MRSA strain (ST239) was founded after a single chromosomal replacement 
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occurred that accounted for a considerable portion of the bacterial genome 
(Robinson & Enright, 2004). 
 
Besides the relevance of MGE and recombination to S. aureus evolution, the high 
mutation rate of S. aureus is proposed to be an important promoter of 
adaptation under diverse selection pressures. Lopez-Collazo et al. (2015) 
tracked the evolution of a single clinical MRSA clone over a period of 13 years. 
The study of evolution used whole genome sequencing of isolates collected in 
the first and last year of the timeframe to reveal a loss of 66 genes with an 
overall reduction in genome size. The authors also observed several SNPs, of 
which three were proposed to be important for attenuation of virulence in the 
evolved clone, potentially resulting in improved capability of S. aureus to persist 
in host tissue. In a separate study, ten CA-MRSA (USA300) isolates from 
patients of distinct geographic regions were analysed by comparative genomics 
to investigate the evolutionary changes of the strain responsible for a rapid 
emergence of invasive infections. Sequence diversity showed that evolution of 
USA300 was due to clonal expansion followed by diversification and that the 
clinical isolates harboured between 11 to 408 SNPs (Kennedy et al., 2008). 
 
Genetic variation from mutations are mostly due to either SNPs or short INDELs 
(insertion/deletion). SNPs present in coding regions can either result in an 
amino acid change (non-synonymous SNP) or no change (synonymous SNP).  
SNPs present in intergenic regions may affect the promoter and leader of 
operons under its regulation or change the sequence of regulatory small RNAs 
(sRNA). The consequence of indels can be more drastic where these occur in 
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coding regions and lead to a frame shift mutation. Tracking the occurrence of 
such variants is a valuable approach to identify contributory genes involved in 
S. aureus adaptation to specific selective pressures over an evolutionary time-
frame, such as those studies described by Kennedy et al. (2008) and Lopez-
Collazo et al. (2015).  
 
4.1.2 WGS of S. aureus 
 
Advances in WGS enable the rapid genetic discrimination of bacterial strains 
with resolution to a single base pair. The sequencer platforms available are 
under constant improvement, leading to their more frequent usage and greater, 
more accurate coverage. As a research instrument for S. aureus, WGS has 
enabled studies of their population structure, lineage expansion and spread, 
antimicrobial resistance and virulence (Price et al., 2012). Harris et al. (2010) 
used WGS to analyse the evolution of one MRSA lineage over four decades that 
provided insights about mutation rate and intercontinental transmission, as 
well as transmission between hospital patients. Their data revealed insights of 
the expansion and dominance of clones in new geographical regions, and the 
discrimination of isolates recovered from the same healthcare setting.   
 
WGS was also used by Young et al. (2012) to ascribe genetic differences that 
were related to both colonisation and infection events. Their study evaluated 
the transition from nasal carriage to bloodstream infection status by S. aureus 
using WGS, which detected the mutation rate (one mutation per genome every 
seven weeks). The bloodstream isolate differed from the colonising isolate by 
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only 8 mutations that were mainly incorporation of stop codons in regulatory 
proteins, suggesting potential relevant mechanisms relating to S. aureus 
pathogenesis.  
The advent of desktop sequencers has promoted investigations to assess if the 
application of rapid whole genome sequencing can be implemented in routine 
clinical practice. Eyre et al. (2012) used sequencing with the benchtop Illumina 
platform to investigate transmission features during both S. aureus and 
Clostridium difficile outbreaks. The study successfully characterised within 5 
days those isolates related to the outbreak using their similarity at the core 
genome level.  
 
Collectively these studies highlight the resource and capability of the current 
whole genome sequencing platforms to study characteristics of S. aureus 
isolates that pertain to colonisation of its host.  A greater knowledge of the 
features that are important and contribute to nasopharyngeal colonisation will 













S. aureus exhibits genetic variability that is critical in its adaptation to overcome 
diverse selective pressures and persist in a variety of environments such as 
host tissues, whether colonising or infecting them. Interrogation of mutations 
that occur during an evolutionary timeframe of persistence during 
nasopharyngeal colonisation could give indications of contributing components, 
pathways and mechanisms that contribute to S. aureus survival.  
 
This chapter aims to capture the genetic changes occurring during S. aureus 
colonisation of the murine nasopharynx by using experimental evolution 
experiments, based on serial passages of this tissue. The hypothesis is that 
serial passages of S. aureus in this niche will select genetic variants with 
improved fitness for colonisation, which will provide novel insights of 
host/pathogen interactions. The dataset that is generated could also highlight 
relevant features of S. aureus nasopharyngeal colonisation that will aid 











4.3.1 Sequencing QC and alignment statistics  
 
Genome sequencing was performed to determine whether repeated S. aureus 
colonisation selected for SNPs that promote nasopharyngeal colonisation in 
mice. Genetic changes from selection might confer upon S. aureus benefits to 
overcome different challenges for persistence in the nasopharynx, such as 
antimicrobial resistance, nutrient acquisition and surface adherence. 
Sequencing was performed for the control strain (USA300 JE2 LAC) and 90 
isolates randomly picked from the pool of bacteria isolated from the 
nasopharynx of three mice colonised in each of the three passages (see Chapter 
3).  
 
Prior to sequencing, the quality, yield and concentration of the DNA extracts 
were checked to ensure these were suitable for sequencing. According to both 
260/230 and 260/280 ratios analysed using Nanodrop, all the purified samples 
of DNA were of sufficient quality with respect to low levels of salt, solvent and 
protein contaminants (Table 4.1). Measurement using Qubit indicated that the 
yield of DNA was sufficient and gel electrophoresis showed that the integrity of 
each was appropriate. Equivalent amounts of the DNA of ten isolates from each 
mouse was pooled prior sequencing.  This approach of pooled DNA was used to 
maximise capture of sequence diversity across the chosen isolates. DNA 
libraries were prepared using Illumina TruSeq PCR-free kits (350 bp inserts) 
and sequenced on MiSeq platform (Illumina) to an average genomic depth of 62 




Table 4.1: Quality control analysis of S. aureus DNA samples pooled for sequencing. 
 DNA quality data of chosen isolates prior to sequencing.  DNA concentration measurements 
were determined using Qubit and absorbance ratios at 260/280 and 260/230 using Nanodrop. 






S. aureus USA300 LAC JE2 80.1 1.8 2.1 
A1_1 139.3 1.8 1.9 
A1_2 98.8 2.0 2.3 
A1_3 70.0 1.9 2.1 
A1_4 85.9 1.8 2.3 
A1_5 40.7 1.8 2.2 
A1_6 98.9 1.8 2.2 
A1_7 143.3 1.9 2.3 
A1_8 87.4 1.9 2.1 
A1_9 56.7 1.8 2.1 
A1_10 110.8 2.0 2.1 
B1_1 47.4 1.8 2.3 
B1_2 85.5 2.1 2.2 
B1_3 78.8 2.0 2.3 
B1_4 90.1 1.9 2.4 
B1_5 80.3 1.9 2.1 
B1_6 75.5 2.1 2.1 
B1_7 65.0 1.8 2.3 
B1_8 123.8 1.9 2.3 
B1_9 65.9 2.0 2.3 
B1_10 78.8 2.0 2.2 
C1_1 80.3 1.8 2.3 
C1_2 120.3 1.8 2.1 
C1_3 107.8 1.9 2.1 
C1_4 90.7 1.8 1.9 
C1_5 50.3 1.9 2.3 
C1_6 48.9 1.9 2.1 
C1_7 45.4 2.1 2.2 
C1_8 130.4 1.8 2.3 
C1_9 103.4 2.0 2.1 
C1_10 90.4 1.9 2.3 
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Isolate DNA concentration 
(ng/L) 
Absorbance 260/280 Absorbance 
260/230 
A2_1 38.7 1.8 2.2 
A2_2 49.9 1.8 2.3 
A2_3 51.2 1.8 2.1 
A2_4 62.3 2.0 2.2 
A2_5 73.4 2.0 2.3 
A2_6 64.5 1.8 2.3 
A2_7 83.9 2.1 2.3 
A2_8 90.1 1.8 2.2 
A2_9 48.9 1.9 2.3 
A2_10 74.5 1.9 2.1 
B2_1 129.9 1.8 2.1 
B2_2 110.0 1.8 2.2 
B2_3 98.4 2.0 2.3 
B2_4 76.0 1.9 2.2 
B2_5 45.9 2.0 2.1 
B2_6 43.4 2.1 2.2 
B2_7 63.3 1.8 2.3 
B2_8 98.0 1.9 2.3 
B2_9 104.1 2.0 2.1 
B2_10 120.3 1.8 2.1 
C2_1 62.3 1.8 2.1 
C2_2 74.3 1.8 2.2 
C2_3 53.2 1.9 2.3 
C2_4 89.4 1.9 2.2 
C2_5 74.2 1.8 2.1 
C2_6 75.8 1.9 2.2 
C2_7 82.3 2.0 2.3 
C2_8 64.5 1.8 2.3 
C2_9 74.4 1.9 2.1 








Isolate DNA concentration 
(ng/L) 
Absorbance 260/280 Absorbance 
260/230 
A3_1 73.9 1.8 2.3 
A3_2 56.0 1.8 2.2 
A3_3 45.0 2.0 2.1 
A3_4 128.8 2.0 2.1 
A3_5 43.7 1.8 2.3 
A3_6 89.7 1.8 2.2 
A3_7 70.1 1.9 2.1 
A3_8 60.2 1.9 2.3 
A3_9 62.4 2.0 2.3 
A3_10 78.5 1.8 2.3 
B3_1 111.4 1.9 2.2 
B3_2 120.9 1.9 2.2 
B3_3 54.7 2.0 2.1 
B3_4 83.4 1.9 2.3 
B3_5 93.5 2.0 2.3 
B3_6 72.3 1.8 1.9 
B3_7 56.3 2.1 2.1 
B3_8 45.8 1.9 2.4 
B3_9 115.8 1.9 2.3 
B3_10 121.2 2.0 2.3 
C3_1 89.7 1.8 2.2 
C3_2 75.7 1.8 2.1 
C3_3 74.3 1.8 2.3 
C3_4 69.8 1.9 2.2 
C3_5 75.8 1.9 2.1 
C3_6 98.3 2.0 2.1 
C3_7 110.3 1.8 2.3 
C3_8 135.4 1.9 2.2 
C3_9 38.4 1.8 2.1 






A sequence comparison pipeline was established to identify variation across the 
read data that was generated from DNA sequencing using Illumina.  Firstly, the 
sequence reads of both control and pool outputs were aligned to the USA300 
LAC JE2 reference genome (NC_007793.1) using Burrows-Wheeler aligner 
(BWA). To increase the reliability of these alignments and to minimise false-
positive base calls observed in the final dataset, two mapping algorithms were 
used: BWA-aln and BWA-mem. Next, mapped reads from both algorithms were 
filtered for removal of secondary alignments, PCR duplicates and poor quality 
reads according to Samtools. Subsequently, BCFtools was used to call the 





























Figure 4.1 Schematic representation of the pipeline used for sequence variants 
identification.  
Burrows-Wheeler aligner (BWA) was used for alignment IIllumina reads against S. aureus 
USA300 reference genome. Samtools was then undertaken to convert the resulting alignment 
file to SAM format which, after bad quality reads filtering, was converted to a BCF file. BCFtools 
called the SNPs followed by annotation using SNPeff. 
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4.3.2 Sequence variant calling of nasopharyngeal colonisation isolates 
 
The SNPeff algorithm was used to annotate the polymorphisms in the VCF files 
from control sequence of USA300 JE2 LAC and the sequences of pooled clones 
from the nasopharyngeal passages (Fig 4.1). A bespoke perl script was used that 
would filter sequence variation that was present in the reads from the serial 
passage clones and in the control passage relative to the reference USA300 JE2 
LAC genome (NC_007793.1). In this way, identified sequence variants are 
expected to be consequential of selection during the experimental 
nasopharyngeal colonisation.  Since the sequence pools represent the genomes 
of ten isolates, a second bespoke perl script was used to assess the frequency of 
reads containing polymorphisms to quantify the contribution of each 
polymorphism that was present in the total read pool. A polymorphism 
frequency ~20% would indicate selection of the DNA sequence variant was 
present in more than one pool member isolate, while a frequency approaching 
100% would represent genetic variation was uniform across each isolate in the 
pool. For the purposes of this study, a threshold of 9.5% was used to ensure that 
variants present in at least one isolate would be captured from the read data. 
Subsequently, a dataset was curated that described all of the sequence variation 
present in the genomes (intergenic and intragenic variants, synonymous and 





4.3.3 A single nasopharyngeal passage reveals very few intragenic 
sequence variants  
 
After a single passage of seven days within the nasopharynx using three mice, 
bacteria were harvested and 10 isolates of S. aureus USA300 LAC JE2 from each 
mouse were sequenced as three separate pools: mouse A1, B1, C1. Comparison 
of these data revealed that the intragenic sequence variation across the 30 
isolates was low (Table 4.2).  
 
While the genome sequence pool from mouse B1 did not show any intragenic 
SNP, the pool of isolates sequenced from mice A1 and C1 presented the same 
SNP in gene SAUSA300_RS00145 producing protein variant L190F. SAUSA300_ 
RS00145 encodes a transposase from the IS6 family involved in mobilisation of 
the staphylococcal cassette chromosome mec (SCCmec), a genomic island that 
carries determinants for beta-lactam resistance, including mecA gene.  
 
In addition, the sequence pool from mouse A1 revealed an intragenic SNP in 
SAUSA300_RS02185 (A110T) which encodes one of the 11 staphylococcal 
superantigen-like exoproteins (SSL1-11) located in SaPIn2, a pathogenic island 
from S. aureus (Fig 4.2). SSL11 binds glycoproteins of myeloid cells and inhibits 
neutrophil attachment. Polymorphism in SSL11 has been associated with 
complete loss of the binding ability by the exoprotein. A single mutation 
(T168P) introduced into an allele of SSL11 completely abolished carbohydrate 
binding, indicating failure in neutrophil attachment (Chung et al., 2007).  



























































































































neighbouring genomic positions, making it appealing to suggest that RS02185. 
A110T is possibly involved in prevention of internalisation by myeloid cells. 
 
A further non-synonymous intragenic SNP was found in the sequence pool from 
mouse C1. The mutation was observed in valS (K800R) that encodes valyl-
tRNA-synthetase responsible for catalysing the attachment of valine to tRNA. All 
of the non-synonymous intragenic SNPs identified in isolates from the first 
nasopharyngeal passage showed frequency around 20%, suggesting that at 
least two of the ten isolates forming the genomic pool carried the mutation. The 
observation that one sequenced pool did not bear any SNP and that the genic 
mutations observed in the other pools were found in a relatively low 
percentage of reads suggests that there was not a pronounced or uniform 
selection for intragenic change in S. aureus to persist for the seven days of the 
first nasopharyngeal colonisation. 
 
Table 4.2 Nasopharyngeal colonisation isolates have multiple non -synonymous 
intragenic SNPs after 7 days. 
S. aureus SNPs observed in pooled genomic DNA of ten isolates after the first passage of murine 
nasopharyngeal colonisation and sampling. Mouse isolate pools in which the SNPs were 
detected are indicated by A1, B1 and C1. Frequency in pool data shows the percentage of reads 
from each pool that harbours the SNP. 



























































4.3.4 A single nasopharyngeal passage reveals very few intergenic 
sequence variants 
 
The intergenic sequence variation observed in the pools from the first 
nasopharyngeal passage was determined to be minimal, like the intragenic 
polymorphism. One polymorphism was detected in the DNA sequence pool 
recovered from mouse C1. This mutation showed a read frequency (24.92%) 
similar to the intragenic SNPs, with just two of the ten randomly picked isolates 
bearing the altered sequence compared with wild-type (Table 4.3). 
Positionally, both SAUSA300_RS05520 and SAUSA300_RS05515 transcriptional 
start site are 200 bp upstream of this SNP. Therefore, it is possible that the 
mutation affects the expression levels of one or more of these genes as it can 
alter the genes promoter activity. While SAUSA300_RS05520 is involved in cell 
division, the role SAUSA300_RS05515 is possibly implicated in DNA repair due 
the enzyme activity encoded by this locus.   
 
Table 4.3 Nasopharyngeal colonisation isolates have intergenic SNPs after 7 days. 
S. aureus SNPs observed in pooled genomic DNA of ten isolates after the first passage of murine 
nasopharyngeal colonisation and sampling. Mouse isolate pools in which the SNPs were 
detected are indicated by B1 and C1. Frequency in pool data shows the percentage of reads 
from each pool that harbours the SNP. 
Genome 
 change 




-27 bp / SAUSA300_RS05520 (+) 
 

















*Variant annotated by SNPEff as intergenic SNP but located in rRNA gene.  
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A second SNP was annotated as intergenic by the SNPeff algorithm in the DNA 
sequence pool of isolates recovered from mouse B1. Annotation and mapping to 
the S. aureus USA300 LAC JE2 genome revealed that this polymorphism was a 
synonymous intragenic SNP in rrfC (Table. 4.3) that is a gene for 5S rRNA. 
Overall, the number of SNPs (including other synonymous intragenic SNPs; data 
not shown) in each of the three sequence pools ranged from 2 to 5, with a ratio 
of 0.6:1 non-synonymous/synonymous SNPs.  
 
4.3.5 A second nasopharyngeal passage reveals increased intragenic 
sequence variants  
 
The ten isolates that were collectively sequenced as a pool from three mice each 
after the first passage were cultured separately and then pooled in equal 
numbers.  The mixed S. aureus clones were then introduced into mouse 
nasopharynx (A2, B2 and C2) as a second passage, where these isolates were 
left to colonise for seven days, as a repeat of the first passage. After this time 
period for the second passage, bacteria were recovered from the nasopharynx 
of each mouse and 10 isolates were selected randomly.  Genome DNA was 
purified, pooled in equal amounts for each input strain and sequenced as 
before.  
 
Curation and annotation of the DNA sequence data from the second 
nasopharyngeal passage revealed a greater number of intragenic variants in the 
passaged S. aureus clones than for clones sequenced after the first seven days of 
nasopharyngeal colonisation (1st passage). Across the genomic DNA pools from 
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the second passage, polymorphisms ranged from 108 to 112 SNPs, with a rather 
different 1.7:1 non-synonymous/synonymous ratio, compared with the first 
passage.  
 
A higher number of intragenic SNPs was detected in the three sequence pools 
from the second passage with 43 (Table 4.4) and none of these mutations 
matched those intragenic SNPs detected after the first nasopharyngeal passage. 
Notably, a distinct non-synonymous intragenic SNP was found in the gene 
SAUSA300_RS00145 (A194V). Although two distinct SNPs were localised to this 
gene after both the first and second nasopharyngeal passages, this occurred at 
different base pair positions that are adjacent in the genome. The cognate 
amino acid changes for both (L190F, A194V) in the same protein sequence 
region resulted in relatively conservative amino acid changes: all hydrophobic 
amino acids, though leucine is replaced by the hydrophobic, aromatic amino 
acid, phenylalanine.  
 
A notable difference between the variants from the first and second passages is 
the higher frequency of reads for each variant in the latter.  The sequence pools 
from mice B2 and C2 revealed that most of the intragenic SNPs were present in 
at least 90% of the reads, so present in almost all input S. aureus isolates. The 
pool of isolates from mouse A2 had lower frequency of the identified variants, 
where most of the SNPs were detected in at least 60% of the reads, albeit 
substantially higher than the variant frequencies in the first passage (Table 4.4). 
These observations do not explain the greater extent of SNP variants that 
emerged after the first passage compared with the subsequent passage. 
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Further, the high number of mutations found in all three sequence pools was 
not expected, but gives an indication there is a strong selection for allelic 
variants of S. aureus USA300 LAC JE2 due nasopharynx selection pressure. 
 
Mutations were observed in a wide range of cell function categories. Regarding 
loci with DNA replication, recombination and repair activity, non-synonymous 
SNPs were observed in genes encoding GyrA (L84S) and GyrB (I183T), which 
are topoisomerase II DNA-gyrase subunit A and B, respectively, and play an 
important role in DNA replication. A SNP was also detected in the gene 
encoding topoisomerase IV: ParC (T80S). RecF is responsible for nucleotide 
binding during DNA replication and repair and a SNP was present in the gene, 
producing variant RecF (P358A). A SNP was also detected in the gene for the 
DNA translocase relevant cell division event protein FtsK (A180G). A second 
protein from the FtsK/SpoIIIE family also showed polymorphism in its 
sequence: SAUSA300_RS09220 (G1142D). Finally, the gene of subunit C of the 
exonuclease SbcCD, which is enrolled in DNA repair also showed variation in its 
sequence. The relative high number of genes associated with DNA activity 
harbouring SNPs could be related to increased mutability by S. aureus as an 
adaptation mechanism. Weakened DNA replication control including DNA 
repair by S. aureus would promote allelic variability, which would be further 
exposed to selection according to the environmental pressures in the 
nasopharynx, benefiting S. aureus adaptation. The sequential and temporal 
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Mutations in genes associated with RNA pathway activity were present in the 
sequence pools from the second passage (Table 4.4). Three non-synonymous 
SNPs were observed for genes involved in RNA modification: Sun (Y306H; 16S 
rRNA small subunit methyltransferase which is responsible for incorporation of 
modifications into RNAs), SAUSA300_RS04890 (S150F; pseudouridine synthase 
from the RluA family associated to post-transcriptional isomeration of uridine 
to pseudouridine of a variety of cellular RNAs) and SAUSA300_RS09885 (V174I; 
epoxyqueuousine reductase which catalyses the conversion of epoxyqueuosine 
to the hypermodified base queuosine in tRNAs).  Another SNP associated with 
RNA activity was found in SAUSA300_RS06375 (D28E) which encodes an 
endoribonuclease implicated in RNA decay.  
 
With respect to SNPs associated with metabolism, a non-synonymous SNP was 
found within mtlA (E56G), which encodes the PTS system mannitol-specific 
EIICB component for mannitol transport. D-Mannitol is a sugar alcohol and is 
one of the many carbohydrate sources used by S. aureus. Expanding this 
functional category, gutB encodes a dehydrogenase with catalytic activity for 
glucitol/sorbitol (sugar alcohols) and had a SNP in its sequence: T341P. A 
mutation was present in SAUSA300_RS11285, which encodes a TenA/Thi-4 
family protein associated with thyaminase activity. This aminohydrolase is 
involved in thiamine (vitamin B) biosynthesis, an important co-factor for 
several key enzymes in carbohydrate metabolism. A further gene involved in 
carbohydrate metabolism also revealed a SNP in its sequence for all the 
genomic pools of the second passage: SAUSA300_RS09425 (I6V). The protein 
encoded by this gene is a transaldolase of the pentose phosphate pathway 
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(PPP) that has versatile roles for cellular metabolism. A SNP was located within 
the SAUSA300_RS07925 (E196G) gene that encodes an oxidoreductase from the 
short chain dehydrogenase/reductase (SDR) family which have wide specificity 
for sugar, alcohol, and aromatic compounds as substrates. 
 
Further potential contributions to altered S. aureus metabolism were identified 
with a non-synonymous SNPs in gene enrolled in fatty acid metabolism: 
SAUSA300_RS01200 (T601A). This gene encodes the catabolic 3-hydroxyacyl-
CoA dehydrogenase involved in fatty acid oxidation. A non-synonymous SNP 
(K207A) was located within the gene encoding AmpA (Table 4.4), an 
aminopeptidase involved in processing of intracellular proteins via amino acid 
removal. Further SNPs in loci with a role in S. aureus metabolism include 
SAUSA300_RS01715 (Oye family flavin oxidoreductase). 
 
Sequence variants were identified within the genome sequence pools 
associated with oxidative stress resistance (Table 4.4). The gene 
SAUSA300_RS08410 (hemN) that encodes coproporphyrinogen III oxidase 
contained a SNP (Y145A).  The enzyme has a role in haem biosynthesis 
important for catalase and cytochrome biosynthesis. Potential selection for 
altered responses to a variety of stresses were attributed to mutations in genes 
that contribute to S. aureus anaerobic metabolism through nitrite transport 
protein NarK (A241V), peroxidase AhpF (G108D) and general stress tolerance 
protein ClpL (SAUSA300_RS13805.S249A).  
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Genes associated with the bacterial cell envelope appeared to be subject to 
selection during S. aureus adaptation to the nasopharynx. Non-synonymous 
SNPs were found in genes associated with capsular polysaccharide biosynthesis 
protein Cap5I (L253V), peptidoglycan metabolism enzyme undecaprenyl-
diphosphatase DacA, SAUSA300_RS03590 (R69H) and cell membrane lipid 
components biosynthesis/mevalonate pathway/isoprenoid and isopentenyl-PP 
biosynthesis, SAUSA300_RS01310 (G119D).  
 
In addition, SNPs were found in membrane-anchored lipoproteins: 
SAUSA300_RS01070 (N358K) (peptide/nickel transport) and 
SAUSA300_RS02220 (E209D) (tandem lipoprotein from SaPIn2 pathogenic 
island; Fig 4.2) adjacent to the ssl gene which bears a SNP. SNPs were also 
identified in genes encoding hypothetical proteins, with special note to 
SAUSA300_RS09205 which presented 7 allelic variants across the genome 














Table 4.4 Nasopharyngeal colonisation isolates after two passages have non-synonymous 
intragenic SNPs. 
S. aureus SNPs observed in pooled genomic DNA of ten isolates after the second passage of 
murine nasopharyngeal colonisation and sampling. Mouse isolate pools in which the SNPs were 
detected are indicated by A2, B2 and C2, reflecting three independent mice. Frequency in pool 





















































































































































































































































































































































































































































































































































































































































































































































































































4.3.6 A second nasopharyngeal passage reveals increased intergenic 
sequence variants  
 
Intergenic SNPs increased in S. aureus genomic pools after two serial 
nasopharyngeal passages, following the same pattern observed for the non-
synonymous intragenic SNPs. While only one SNP could be detected in the 
intergenic region from the first passage sequence pools, two repeated passages 
of S. aureus in the nasopharynx revealed 26 variants in non-coding regions. 
Similar to the intragenic mutation frequency, the proportion of intergenic 
variants reads were greater than 90% for DNA pools from mice B2 and C2, and 
60% for mouse A2, indicating almost all nasopharynx isolates randomly picked 
possess the SNPs. Similarly, the mouse A2 pool presented a similar frequency of 
variant reads to that of the intragenic SNPs (around 60%). Thirty variants 
mapped in all three genomic pools were annotated as intergenic SNPs by the 
SNPeff algorithm. Further curation of these SNPs relative to the S. aureus 
USA300 LAC JE2 genome revealed that five were synonymous intragenic SNPs 
(Table. 4.5). 
 
Seven intergenic SNPs were located within 200 bp upstream of coding 
sequences, suggesting that such variants could impact on their transcription 
levels. Two of these intergenic SNPs are separated by 8 bp from each other and 
both are within 20 bp upstream of the coding sequences of the pseudogene 
SAUSA300_RS15240 and SAUSA300_RS15245 encoding a hypothetical protein.  
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Two intergenic variants with possible impact on transcription of genes involved 
in arginine utilisation were detected: arcA and argF. Both arcA and argF encode 
enzymes that direct formation of citruline (Fig 4.4), the former as part of the 
arginine deiminase pathway which serves as energy source for S. aureus in 
anaerobic conditions, and the latter within arginine synthesis from glutamate. A 
further copy of arcA is present on the arginine catabolic mobile element that 
increases versatility of USA300 clones and their ability to persist on skin (Diep 
et al., 2006; Pi et al., 2009).  Combined with an intragenic SNP in narK, encoding 
a nitrite respiration transporter in the second passage, it is plausible that these 






















Figure 4.4. Arginine metabolism pathways in S. aureus USA300.   
Enzymes associated with the arginine deiminase pathway are coloured purple and the arginine 




Intergenic SNPs were identified within 200 bp upstream of the genes for 
ribosomal protein S1 (rpsA) and RNA polymerase  subunit (rpoB) concerned 
with transcription and translation. The intergenic base changes close to their 
coding sequence selected over the evolution of S. aureus in the nasopharynx 
might alter their transcription levels.  
 
Whilst most of the SNPs located in non-protein coding regions were dispersed 
around the genome, 13 intergenic SNPs were found in a 151 bp region 
(1929046-1929196) of which five are within 200 bp of the open reading frame 
of transposase SAUSA300_RS09560. This transposase is located in the 
pathogenic island SaPIn3, a variable mobile element that comprises virulence 
genes encoding, most commonly, proteins: serine protease-like; enterotoxins, 
ferrichrome uptake. Eight of the 13 SNPs are located in the regulatory sRNA 
(SprA1) sequence, according to Staphylococcal Regulatory RNAs database 
(Sassi et al., 2015). The frequency of these SNPs was around 50% across the 
three pools from mice A2, B2, C2 indicating that in each case the variants could 
be variably present across the ten members of the pool.  A further SNP within 
this set (genome position: 35817) is within the the sRNA Teg5as. These 
regulatory non-coding, short (50-550 nt) molecules can interact with mRNAs 
and affect the translation or stability of their targets. The remaining intergenic 
SNPs were located outwith coding sequence regions and may not influence 







Table 4.5 Nasopharyngeal colonisation isolates after two passages have intergenic SNPs. 
S. aureus genome sequence variants (SNPs) in non-coding regions observed for isolates after the 
second passage performed in the experimental nasopharyngeal evolution by. Mouse column 
relates to the pool of isolates (A2, B2 and C2) which the SNPs were detected. Frequency shows 






















-1069 bp / SAUSA300_RS00340 (+) 
 
-148 bp (arcA) (-) 












-222 bp / pflB (+) 
 

































































































-9 bp / SAUSA300_RS15240 (+) 
 













-17 bp / SAUSA300_RS15240 (+) 
 














-44 bp / argF (+) 
 
-394 bp / SAUSA300_RS05750 (-) 












-237 / SAUSA300_RS07455 (+) 
 
-165 bp / rpsA (-) 
Hypothetical protein 
 










-289 bp / SAUSA300_RS09565 (+) 
 













-288 bp / SAUSA300_RS09565 (+) 
 













-286 bp / SAUSA300_RS09565 (+) 
 













-280 bp / SAUSA300_RS09565 (+) 
 













-272 bp / SAUSA300_RS09565 (+) 
 
































































































































-100 bp / SAUSA300_RS09690 (+) 
 




























-290 bp / opuD2 (-) 
 


























4.3.7 A third nasopharyngeal passage reveals refinement of intragenic 
sequence variants  
 
A pronounced expansion of S. aureus sequence variants was evident after a 
second nasopharyngeal passage.  Consequently, a third passage was performed 
under the same conditions and this revealed there was no continued large-scale 
expansion of sequence variants. In contrast a lesser extent of sequence 
variation was identified across the genome pools of the three mice, each with 
ten isolate pools. The numbers of intragenic variant SNPs in each of the three 
sequence pools from the third passage ranged from 36-39 mutations, with a 
ratio of 2:1 for non-synonymous/synonymous. Of these, 19 of 20 non-
synonymous intragenic SNPs were present in each of the three sequence pools. 
This increase was mirrored with an increased frequency of variant reads shared 
across the three sequence pools, with at least 90% variant sequence reads, 
compared with the previous passages (apart from SNPs detected in the 
hypothetical transmembrane protein SAUSA300_RS09205). This higher 
percentage of reads harbouring SNPs suggests a clonal selection for certain 
variants from the inoculation pool. 
 
Among the 20 non-synonymous SNPs detected in the sequence pools of the 
third passage, 15 were identified after the second passage. Moreover, a SNP 
found in one sequence pool from the first nasopharyngeal passage (A1), which 
was not subsequently detected in the second passage isolates, reappeared in all 
three genome sequence pools after the third passage. 
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Sequence variants unique to the third nasopharyngeal passage include 
intragenic SNPs in genes for the stress response chaperone DnaJ and the BioA 
biotin co-factor biosynthesis. The former gene adds to those genes with variants 
in the same pathway from the first passage. The remaining non-synonymous 
intragenic SNPs unique to the third passage are located in hypothetical 





Table 4.6 Non-synonymous intragenic SNPs of nasopharyngeal colonisation isolates after 
three passages.  
S. aureus genome sequence variants (SNPs) in non-coding regions observed for isolates after the 
third passage in an experimental nasopharyngeal model. Mouse column relates to the pool of 
isolates (A3, B3 and C3) which the SNPs were detected. Frequency shows the percentage of 
reads from the pools harbouring the SNP. 
Gene 
symbol 










































































































































































































































































































































































1: SNP also observed in the sequence pools from first passage. 











4.3.8 Three serial nasopharyngeal passages reveal refinement of 
intergenic sequence variants 
 
Matching the reduction of the intragenic SNPs detected in the sequence pools 
after the third passage, was a reduction of intergenic SNPs. Specifically, genomic 
pools from the second passage showed 26 intergenic SNPs, while the three 
sequence pools from the third passage presented only 6. Three of these allelic 
variants were identified in the previous nasopharyngeal passage and the 
frequency of reads harbouring these SNPs supports that every isolate of the 
third nasopharyngeal passage contains these sequence variants. 
 
Considering the 3 SNPs uniquely detected in the isolates from the third 
nasopharyngeal passage, one was located in the Teg16 sRNA sequence. The 
other two sequence variants are situated within 200 bp upstream of genes: 
lctP2 encoding a lactate transporter associated with anaerobic respiration and 
pnhD encoding an ABC transporter with phosphate/phosphite/phosphonate 
uptake specificity. A hypothetical phage-associated protein with glycerol 
transport activity involved in acid teichoic acid biosynthesis is possibly affected 
by an intergenic SNP, however, the frequency of reads for this SNP was lower 








Table 4.7: Non-synonymous intergenic SNPs of nasopharyngeal colonisation isolates 
after three passages.  
S. aureus genome sequence variants (SNPs) in non-coding regions observed for isolates after the 
third passage in an experimental nasopharyngeal model. Mouse pool column relates to the pool 
of isolates (A3, B3 and C3) which the SNPs were detected. Frequency shows the percentage of 
reads from the pools harbouring the SNP. 

















-97 bp / SAUSA300_RS00765 (+) 
 
 














-237 / SAUSA300_RS07455 (+) 
 
-165 bp / rpsA (-) 
Hypothetical protein 
 










-100 bp / SAUSA300_RS09690 (+) 
 



























-290 bp / opuD2 (-) 
 










-189 bp / SAUSA300_RS12785 (+) 
 












Table 4.8 Non-synonymous intragenic SNPs of nasopharyngeal colonisation isolates that 
persisted between passages.  
S. aureus genome sequence variants (SNPs) in coding regions observed for isolates from 
repeated passages in an experimental nasopharyngeal model.  
Gene 
symbol 



































































































































































































































































































1: SNP also observed in the sequence pools from first passage. 
2: SNP also observed in the sequence pools from second passage. 
 
 
Table 4.9 Non-synonymous intergenic SNPs of nasopharyngeal colonisation isolates that 
persisted between passages.  
S. aureus genome sequence variants (SNPs) in non-coding regions observed for isolates from 
repeated passages in an experimental nasopharyngeal model.  













-237 / SAUSA300_RS07455 (+) 
 
-165 bp / rpsA (-) 
Hypothetical protein 
 










-100 bp / SAUSA300_RS09690 (+) 
 














-290 bp / opuD2 (-) 
 










In this chapter, whole genome sequencing of S. aureus isolates from consecutive 
passages of a nasopharynx colonisation experimental evolution model was 
performed.  The sequencing experiment was successful overall in the aim to 
detect variants that were possibly selected due to pressures of colonising the 
nasopharynx of the mice in this model that was standardised in Chapter 3. The 
dataset from this chapter reveals a wide range of loci that harbour sequence 
variation and these are involved in multiple pathways and mechanisms with 
potential contributions in the establishment and maintenance of 
nasopharyngeal colonisation by S. aureus. Since a large number of mutations 
was detected in this work, an extended future study to assess the actual 
contribution of each mutation is necessary. First, a few questions arise based on 
the results of this chapter: are the mutations detected here a direct 
consequence of S. aureus adaptation according to the selective pressures during 
nasopharyngeal colonisation? Do these genetic changes provide better fitness 
for S. aureus to persist in the nasopharynx? Why and how does the number of 
SNPs change substantially depending on the passage of S. aureus through the 
nasopharynx? The following chapter is therefore aimed at beginning to 
elucidate some of these questions.  
 
The genetic changes in S. aureus USA300 identified by sequencing make it 
tempting to suggest that S. aureus evolved to become more adapted to the 
nasopharynx through mutations that increase fitness for the anatomic site. 
Several of the intragenic SNPs found in this work associated to diverse cell 
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functions (GyrA.L84S, RS08410.Y145A, RS09425.I6V and, ParC.Y80S,) were also 
identified by a study that assessed the evolution of USA300 clinical isolates in 
the United States (Uhlemann et al., 2012). This overlap might indicate that the 
mutations in this study contribute to adaptation of S. aureus through shared 
drivers of selection, however their relevance to the murine model used here is 
unclear.  
 
Moreover, the mutations observed in the clones might give indications of 
components directly affected in S. aureus by the selective pressure in the 
murine nasopharynx. By introducing S. aureus into the mouse nasopharynx, the 
bacterial cell must defend itself against multiple host stress factors such that 
prolonged successful colonisation could only be achieved if S. aureus overcomes 
these challenges. S. aureus and its weaponry can naturally defeat host and 
environmental factors that impose barriers for S. aureus survival and their 
refinement through selected mutations might be the observed outcome across 
the consecutive passages in this study. Certain components or pathways might 
require a shift in their structure, activity and expression to improve S. aureus 
fitness to the murine nasopharynx with this transition the result of the 
identified mutations.  
 
Foster (2007) states that one of the bacterial responses to stress is to induce 
genetic variability, originating with the promotion of mechanisms that favour 
mutagenesis. Such a response is critical for the adaptive evolution and this 
theory would support the outcomes of this work if S. aureus directly responded 
to the nasopharynx pressure by increasing mutations that could be selected 
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during the evolutionary time-course.  Because the sequence variation captured 
from the clones in this work is represented by pools of isolates randomly 
sampled from the nasal washes, an important feature to be considered is the 
frequency of the reads harbouring the nucleotide variation.  
 
Sequence variation from the pools of isolates after seven days of colonisation 
showed that only a few SNPs appeared in the S. aureus genome. The only locus 
harbouring a SNP after the first nasopharyngeal passage that also revealed a 
SNP in at least one of the second passage genomic DNA sequence pools is 
SAUSA300_RS00145, which encodes a transposase. This enzyme can bind DNA 
and catalyse a “cut and paste” reaction of a DNA fragment (e.g. transposon) 
enabling it to move either between genomes, or for some fragments, within the 
genome. Transposons are one type of mobile genetic element and as part of the 
accessory genome they play an important role in the survival of S. aureus in 
different ecological niches; certain genes of transposons encode proteins for 
antimicrobial resistance and virulence factors (Rouch et al., 1987; Ito et al., 
2003; Olsen et al., 2006). 
 
The staphylococcal cassette chromosome mec (SCCmec) transposase in this 
work is associated with the IS6 family of insertion sequences, which are usually 
found flanking resistance genes (Mahillon and Chandler, 1998). More 
specifically, the transposase is part of the IS431 insertion sequence elements. 
Widely found in S. aureus and other staphylococci like S. epidermidis and S. 
haemolyticus, this transposon has relevance in the mobilisation of genes 
responsible for the resistance to methicillin (Kobayashi et al., 2001). Altered 
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activity by this transposase might impact the mobilisation of the mecA gene, 
which confers resistance to beta-lactams. But since the isolates were not 
screened for excision of the gene, the specific contribution of the SNP cannot be 
concluded; regulation of mobile genetic elements excision by the SOS response 
has been suggested (Simmons et al., 2008; Zgur-Bertok, 2013). Intergenic SNPs 
near to the transcriptional start site of a transposase that belongs to SaPIn3 
pathogenic island were detected from the sequence pools of the second 
passage. This variant might alter the transcription levels of the transposase, 
though it is unclear if this altered its regulation, how mobilisation benefits 
nasopharyngeal colonisation by S. aureus. 
 
A non-synonymous intragenic SNP after the first passage was also detected for 
SAUSA300_RS02185 which encodes an exotoxin, one of the many weapons from 
the S. aureus virulence machinery. This SNP could not be detected in sequence 
pools from the second passage, but was detected again in the third passage. 
Despite the critical relevance of virulence factors in the establishment of an 
infection process by S. aureus, such components are thought not to play a 
critical role for the persistence of S. aureus during nasal colonisation (Chavez-
Moreno et al., 2016). Recent work has evaluated differences in the gene 
expression of virulence determinants during colonisation and disease by S. 
aureus in rat models. It was demonstrated that toxin genes have lower 
expression compared with other virulence components during nasal 
colonisation and that the expression level increased after 1 hour of induced 
bacteremia (Jenkins et al., 2015). Schlievert et al. (2007) demonstrated that 
haemoglobin inhibits the production of of exotoxins. Since it was proposed that 
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haemoglobin in nasal secretions promotes nasal colonisation (Pynnonen et al., 
2011), it is possible that exotoxins are not required for the nasal colonisation of 
S. aureus.  Further studies could examine whether the SNP found in the exotoxin 
gene affects exotoxin production or activity to identify if it promotes S. aureus 
adaptation to the nasopharynx.  
 
With respect to the second passage dataset, mutations were found in diverse 
cell function genes. DNA metabolism-related genes presented non-synonymous 
SNPs within loci encoding DNA topoisomerases: gyrA, gyrB and parC. Mutations 
in these genes of S. aureus and other microorganisms have been extensively 
studied over the last two decades (Heisig, 2009; Redgrave et al., 2014). GyrA 
and GyrB constitute the two subunits of topoisomerase II that acts as a DNA 
gyrase. Topoisomerase IV has two subunits: ParC and ParE. Both enzymes are 
involved in DNA packaging and segregation, with DNA gyrase involved in the 
maintenance of the negative supercoiling of the bacterial chromosome during 
replication, whilst topoisomerase IV decatenates the bacterial chromosomes 
allowing further segregation.  
 
These genes are part of the highly conserved Quinolone Resistance-
Determining Region (QRDR). Both topoisomerases II and IV act by binding to 
DNA and inducing double-strand breaks with posterior ligation of the DNA 
strands. When fluoroquinolone is present, it leads to a drug-enzyme-cleaved 
DNA structure formation that will consequently result in cell death.  
A few bacteria are able to survive with only one gyrase although most of them 
have both enzymes. With S. aureus and other Gram-positive bacteria, 
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topoisomerase IV is more susceptible to quinolones and therefore ParC it is the 
primary target for the antibiotic. Additional mutations in gyrA confers high-
resistance to S. aureus. These mutations are usually found in hotspots identical 
to the SNPs observed in this work for gyrA and parC. An evolution study 
regarding USA300 clinical and colonising strains detected identical SNPs for 
both gyrA (GyrA.L84S) and parC (ParC.Y80S) in two out of eight strains 
(Uhlemann et al., 2012). GyrA.L84S was also detected in 15 out of 21 CA-MRSA 
USA300 clinical samples from the Austrian national reference laboratory 
(Lepuschitz et al., 2018). This supports the potential role of topoisomerases and 
the mutations present in their respective genes for S. aureus nasopharyngeal 
colonisation.  
 
In addition to the genes for topoisomerases II and IV, mutations in DNA repair 
function gene recF was identified.  RecF is involved mainly in DNA damage 
repair that occurs during the replication via homologous recombination, by 
binding single-strand DNA filamentous (Pages, 2016). The recF gene is 
immediately upstream of gyrB and and gyrA, in the same open reading frame 
(Alonso & Fisher, 1995). Although recF has been characterised in S. aureus and 
its role was identified more than 20 years ago, little is known about the protein 
and its relevance for S. aureus colonisation or pathogenesis. The SNP found in 
recF in this work was one of the few identified in both the second to the third 
nasopharyngeal passage, though how this gene might be relevant is unclear. 
The same SNP (RecF.P358F) was found in 9 out of 10 S. aureus USA300 clones 
assessed in an evolution work (Kennedy et al., 2008), reinforcing the potential 
for the recF SNP to increase S. aureus fitness or versatility for nasopharyngeal 
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colonisation. Future experiments could determine whether the mutation rates 
are altered by this SNP and what the colonisation outcomes are with engineered 
recF SNP variant strains, if such a strain could be constructed as an isogenic 
variant. 
 
A further locus with roles in DNA repair that harboured a SNP after the second 
passage was sbcC. This gene encodes the subunit C of the exonuclease SbcCD, 
where SbcC is a protein with ATPase activity and SbcD is responsible for the 
nuclease activity. Exonucleases are important enzymes involved in the 
hydrolysation of phosphodiester bonds from the end of a double-stranded DNA 
by exhibiting 3’5’ activity. Few studies have examined the roles of this gene in 
S. aureus, with most studies performed in E. coli (Lovett, 2011). Chen et al. 
(2007) proposed a role for SbcCD in S. aureus, when they speculated, based on 
homology, that both SbcC and SbcD contribute to DNA repair. They found that 
SbcCD increases survival under exposure to UV irradiation, where sbcCD is part 
of the SOS regulon (set of genes enrolled in response to DNA damage). 
Considering the role of SbcC protein is possible to hypothesise, the identified 
mutation might affect DNA repair.  Reduced activity might promote population 
variation by increasing mutations.  This could be tested in future.  
 
A non-synonymous SNP was identified in ftsK; a locus that encodes a DNA 
translocase. Proteins from this family facilitate chromosome segregation in the 
final stages of cell division by recruiting DNA from the division site before 
cytokinesis is completed (Kaimer & Graumann, 2011). S. aureus encodes two 
DNA translocases: FtsK and SpoIIIE. A recent study of DNA translocases in S. 
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aureus concluded that both enzymes might have similar roles and that at least 
one of the DNA translocases is required for normal chromosome segregation 
(Veiga & Pinho, 2017). Based on their function, the appearance of mutations in 
these loci might increase population fitness. The mutation found in all three 
DNA sequence pools from the second passage (FtsK, K180R) is one of two 
variants detected in genes with DNA repair activity that persisted to the third 
nasopharyngeal passage. A separate study revealed a non-synonymous SNP in a 
FtsK/SpoIIIE family protein in a clinical isolate assessed for evolution during 
asymptomatic carriage (Golubichik et al., 2013), which hints that the SNP found 
in this work contributes for the S. aureus nasopharyngeal colonisation.  
Analysis of sequence variants after nasopharyngeal passage revealed several 
SNPs in RNA-associated pathways. SAUSA300_RS06375 is annotated with 
RNase Y activity. RNaseY is an endoribonuclease involved in RNA decay, a 
critical response mechanism of the bacteria to changes in the 
microenvironment to inhibit the production of unnecessary proteins (Khemici 
et al., 2015). RNaseY also indirectly regulates the expression of virulence genes 
(Marincola et al., 2012). Based on the RNaseY role in S. aureus, a SNP that alters 
enzyme activity might promote adaptation to new environments can be 
expected. Since the SNP is a conservative replacement (D28E), however, it is 
possible that no functional change occurred in protein activity.  
 
A second locus with RNA activity that presented a SNP in all the sequence pools 
from the second nasopharyngeal passage is SAUSA300_RS04890. This locus 
encodes a pseudouridine synthase from the RluA family involved in the site-
specific isomerisation of tRNA uridine into tRNA pseudouridine (Hamma & 
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Ferré-D'Amaré, 2006). Pseudouridine modification is the most abundant post-
transcriptional reaction in cellular RNAs and its biochemical functions are still 
to be clearly elicited. Pseudouridine confers a protective effect for the RNA 
tertiary structure as the pseudouridine form associates with an additional 
hydrogen bond that increases the stability and rigidity of RNAs (Spenkuch et al., 
2014). In E. coli, pseudouridine seems to influence mRNA translation (Kariko et 
al., 2008). Although the biological role of pseudouridine remains unclear, it has 
been suggested that pseudouridine synthase is relevant, not only for the RNA 
isomerisation but as an important component for other cell functions. Whether 
pseudouridine synthase is critical only for uridine modification or plays a 
bigger role in S. aureus metabolism, the activity of this enzyme is relevant for 
the maintenance of the cell viability. The deletion of two pseudouridine genes in 
E. coli results in growth deficiency which can be reverted by a point mutation in 
the enzymatically inert proteins (Gutgsell et al., 2000; Gutgsell et al., 2001).  
 
Similar to SAUSA300_RS04890, another SNP was found in a gene involved in 
RNA maturation. Gene sun encodes a methyltransferase responsible for 
nucleotide modifications in a site-specific manner in the 16S rRNA small 
subunit. Although the relevance of methylation of individual nucleotides is 
unclear, these modifications seem to increase the ribosomal stability and 
consequently affect the synthesis of proteins (Decatur & Fournier, 2002). A link 
between the SNP in sun from this work and post-transcriptional modification of 
RNAs relevant to the success of S. aureus in establishing a nasopharyngeal 
colonisation is not clear.  
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In the context of genes with roles in metabolism, several non-synonymous SNPs 
were found in loci of carbohydrate metabolism pathways after the second 
passage only. Bacteria have the ability to use diverse carbohydrates as sources 
of carbon and energy. Two SNPs associated with sugar metabolism were found 
in loci after the second passage: mtlA and gutB. Mannitol and sorbitol, are 
polyols (sugar alcohols), that are widely abundant hexitols utilised as a carbon 
source. Sorbitol is an isomer of mannitol and is transported by the mannitol 
(Mtl) uptake system in S. aureus, (Kenny et al., 2013). Mannitol fermentation is 
used as a species signature for laboratory identification that discriminates it 
from most other staphylococci. MtlA forms part of the phosphotransferase 
system (PTS) that is the main transport mechanism responsible for acquisition 
of this carbohydrate. Uptake leads to initial phosphorylation of mannitol to 
mannitol-1-P that is further oxidised into fructose-6-P for use in the glycolytic 
pathways for energy production. Mannitol is a relevant carbon source for S. 
aureus, and its use as aa resource by S. aureus could aid survival in deprived-
nutrient microenvironments like the nasopharynx (Krismer et al., 2014). A SNP 
in the gene for an SDR oxidoreductase (Table 4.4) could be linked to sugar 
metabolism based on pathway analysis, potentially associated with polyol 
interconversion.  
 
A SNP in a further carbohydrate metabolism gene that encodes a transaldolase 
was detected in all the three sequence pools in the second passage: 
SAUSA300_RS09425 (I6V). Transaldolase provides a link between the glycolytic 
and pentose-phosphate-pathway (PPP) by catalysing a reversible reaction 
involving fructose-6-P (Richardson et al., 2015). The same SAUSA300_RS09425 
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SNP identified in this work for was observed in a recent study that assessed the 
evolution of clinical S. aureus USA300 isolates across the United States (Jamrozy 
et al., 2016). 
 
Two intragenic SNPs in SAUSA300_RS01715 that encodes a gene ascribed a role 
in carbohydrate metabolism. These were identified after the second passage 
and could be detected after the third passage as the only carbohydrate 
metabolism-related gene. The reason for the lack of maintenance of certain 
SNPs across passages is unclear. Two possibilities exist, either purifying 
selection promotes clones with greater success (fitness) or the mutations are 
reversed, where the former explanation appears most likely.   
 
A SNP identified in the passages was located in SAUSA300_RS11285. This gene 
encodes an enzyme of thiamine (vitamin B1) diphosphate biosynthesis that 
hydrolysis of amino-pyrimidine of thiamine compounds with a potential role in 
hydrolytic cleavage of thiamine. Thiamine pyrophosphate (TPP, active form of 
thiamine) is a critical co-factor of some key enzymes in carbohydrate and amino 
acid biosynthesis (Begum et al., 2013). Thiamine biosynthesis is strongly 
regulated by TPP at transcriptional and enzymatic levels (Muller et al., 2009). If 
the SNP found in this work modifies thiamine levels it might modify utilisation 
of carbohydrate sources in the nasopharyngeal microenvironment, where low 
levels of carbon and amino acid source are reported (Krismer et al., 2014).  
 
A mutation was identified in gene SAUSA300_RS03590 (R69H) that encodes 
enzyme UppP, an undecaprenol diphosphatase.  The SNP might contribute to 
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altered peptidoglycan synthesis since this enzyme is essential for its 
biosynthesis. Peptidoglycan is a linear polymer constituted by repeats of linked 
N-acetylglucosamine and N-acetylmuramic acid that has many roles including 
helping S. aureus resist osmotic pressure and maintain shape (El Ghachi et al., 
2018). 
 
As a facultative anaerobe, S. aureus can grow in low-oxygen environments by 
fermentation or nitrate respiration. NarK is a nitrate/nitrite transporter 
involved in respiration with alternative electron acceptors and a missense SNP 
was found in its gene. Under anaerobic conditions narK is induced in S. aureus 
(Fuchs et al., 2007). In E. coli, Schlag et al. (2008) showed that narK is positively 
regulated by the NreBC system and in response to low oxygen availability with 
very low activity during aerobic growth. Although S. aureus can survive in a 
completely anaerobic environment like abscesses, oxygen availability is not 
known to be reduced in the nasopharynx unless the bacteria grow in a biofilm 
or restricted niche. Still S. aureus has the ability to change its energy 
metabolism pathway which represents an advantage for survival. The SNP 
found in narK might alter S. aureus efficiency in incorporating nitrate, thereby 
increasing fitness in the model. Linked with this respiration, intergenic SNPs 
that might impact the transcription levels of genes involved in arginine 
metabolism e.g. arcA, could help S. aureus survival under anaerobic conditions.  
 
In contrast to this apparent potential anaerobic metabolism link, oxidative 
stress is another environmental factor that S. aureus needs to overcome to 
survive within a host. Reactive oxygen species (ROS) are produced by S. aureus 
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and by the host immune defences. Under aerobic respiration, reduction of 
oxygen by S. aureus eventually leads to the production of superoxide anions and 
hydrogen peroxide. These ROS are also generated by macrophages, monocytes 
and neutrophils due the presence of NADPH oxidase (NOX) in these cells. The 
oxidative damage of ROS is due their potential to oxidise several molecules of 
the bacterial cell including lipids, DNA and proteins and one of the ways that S. 
aureus protects itself from ROS is by producing antioxidants, including 
peroxiredoxins that catalyse the reduction of alkyl hydroperoxides into their 
respective alcohols (Gaupp et al., 2012). AhpC, acting together with AhpF, is one 
of the major peroxireoxins and it was shown in S. aureus to confer resistance to 
ROS (Cosgrove et al., 2007). AhpF enhances the catalytic efficiency of AhpC and 
a SNP found in the sequence pools from the second nasopharyngeal passage for 
ahpF could alter AhpC catalysis, with consequent effects on ROS defence. The 
study of Cosgrove et al., (2007) showed that AhpC is important for nasal 
colonisation in a cotton rat model. 
 
A further SNP in a locus involved in stress resistance was observed in 
SAUSA300_RS13805 encoding ClpL, a protein conserved in most bacterial 
species with a substrate-specific chaperone activity. Clp ATPases can associate 
with ClpP forming a proteolytic system that responds to stress by degrading 
accumulated and misfolded proteins (Frees et al., 2004). Studies have shown 
the relevance of Clp protease activity for S. aureus in the response to nutrient 
limitation (Farand et al., 2013), degradation of S. aureus antitoxins (Donegan et 
al., 2010), oxidative and heat stress (Chatterjee et al., 2005) and biofilm 
formation (Frees et al., 2004). Given the critical role of Clp protease and 
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ATPases in several aspects of the cell survival and maintenance, mutations that 
increase fitness for colonisation are not unexpected. The missense SNP in this 
work needs detailed characterisation since a distinct single mutation was 
reported to result in gain of function by ClpP protease to become nonspecific 
and capable of degrading more than 500 proteins, inhibiting S. aureus growth 
(Ni et al., 2016). 
 
From all the mutations observed in loci from the second passage pools, only one 
is linked to a virulence factor. Cap5I is a protein involved in the biosynthesis of 
S. aureus capsule polysaccharide 5 (CP5), a virulence factor that confers 
resistance for the bacterial cell against clearance by the host immune defences. 
S. aureus clinical strains mainly produces either serotype CP5 or CP8 from all 
the 13 different serotypes already characterised. Both are constituted by 
trisaccharide repeating units (N-acetyl mannosaminuronic acid, N-acetyl-L-
fucosamine and N-acetyl-D-fucosamine) with distinct connections between the 
sugars in the acetylation sites. These CPs act by conferring an escape route to 
the bacterial cells from phagocytic killing (Nanra et al., 2013) and it was shown 
that encapsulated S. aureus strains have more pathogenic potential than 
acapsular strains in models of bacteremia (Thakker et al., 1998), septic arthritis 
(Nilsson et al., 1997) and abscess formation (Portoles et al., 2001). The 
relevance of this SNP in cap5I is unclear since USA300 clones have a CP-
negative phenotype due to multiple mutations (in the cap5 promoter, cap5D nt 
994, and cap5E nt 223; Boyle-Vavra et al., 2015). The lack of CP expression 
makes it difficult to predict the significance of the SNP to colonisation. 
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Other intragenic SNPs worthy of further study include a hypothetical 
transmembrane protein (SAUSA300_RS09205) with multiple non-synonymous 
SNPs. This protein has a conserved domain that indicates membrane-located 
protease activity that is linked to a wide range of protein partner targets. 
Further work is needed to identify the contribution of the protein to cell 
function and colonisation of hosts. 
 
Most of the SNPs from the second nasopharyngeal passage were not identified 
after the third passage. Only 8 loci carried the same SNP in both second and 
third passages comprising genes with DNA or RNA activity (recF, ftsK and 
SAUSA300_RS00265), metabolism (SAUSA300_RS01070, SAUSA300_RS12485, 
gutB and SAUS300_RS01715) and nitrate respiration (SAUSA300_RS09205). 
There are several possibilities to explain the lower number and altered target of 
mutations observed from nasopharyngeal passage two to three.  First, there 
could be a refinement in the genome variability repertoire of S. aureus during 
nasopharyngeal colonisation. This would require that some mutations were 
dominant in their effects or could alternatively overcome the same 
reproduction limitation. Nasopharyngeal colonisation could require that the 
bacterial load reaches a threshold and the selection is distinct each time the 
clones are inoculated into the nasopharynx.  This would account for both 
different mutations emerging, purifying selection and reversion of mutations.  
Such a scenario could be due to different competitor microbiota, variation in 
genetics and differences in the pre-existing mutations present in the inoculum 
on each occasion. There may also be multiple routes through selection of 
mutations to combinatorially achieve the same broad aims. Such answers 
 133 
depend not only on mutation detection through sequencing but an assessment 
of the functional outcome of the mutations. 
 
Regardless, genetic modification of genes involved in certain pathways appears 
to be relevant for S. aureus fitness when colonising the nasopharynx, since each 
passage revealed SNPs unique to that passage. The final passage revealed a 
suite of mutations with some overlaps at the pathway level.  According to the 
findings, mutations in genes for responses to diverse types of stress could 
contribute to survival in the nasopharynx colonisation by S. aureus. Although a 
SNP in clpL observed in the second passage was not detected in the third 
passage, a mutation in dnaJ was revealed in the third passage. DnaJ belongs to 
the heat shock protein (Hsp) family and similarly to Cpl protease contributes to 
stress tolerance by preventing misfolding and aggregation of proteins under 
abnormal conditions. dnaJ is part of an operon consisting of 5 genes, including 
dnaK. DnaK was shown to be critically relevant for S. aureus response to heat, 
oxidative and antibiotic stress (Singh et al., 2007), biofilm formation and 
adherence to eukaryotic cells (Singh et al., 2012). DnaJ presents unfolded 
proteins to DnaK, and it is tempting to speculate that the SNP found in dnaJ 
might increase performance from the DnaJ/DnaK system and the response to 
external stress factors.  
 
A second gene harbouring a SNP unique to the third nasopharyngeal passage 
was present in bioA. This locus encodes an aminotransferase in the biotin 
synthesis pathway. Biotin is a co-factor for carboxylases, which catalyse 
essential reactions in metabolic pathways (da Costa et al., 2012). The 
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identification of a non-synonymous SNP in SAUSA300_RS11285 (thiaminase; 
vitamin B1 metabolism) from the second passage and bioA from the third 
passage supports that these co-factors and the reactions in which they are 
involved are relevant for S. aureus adaptation to the nasopharynx.  
 
In summary, this chapter gives indications of potential components and 
pathways that might contribute to the success of nasopharyngeal colonisation 
by S. aureus. While this fingerprinting approach identifies potential candidates 
during growth and survival, it also raises the requirement for subsequent 
functional genomics approaches to discern individual roles of genes, SNPs, 




























Chapter 5 Assessing in vivo nasopharyngeal adaptation 
of S. aureus  
 
5.1 Introduction 
5.1.1 Understanding S. aureus adaptation  
 
S. aureus’ considerable ability to sense environmental factors and selection 
changes to its genome in a colonisation model were extensively discussed in 
Chapter 4. This chapter focuses on the consequence of mutations due to 
selective pressures in an evolutionary-time frame, specifically adaptation of S. 
aureus resulting in evolved clones exhibiting enhanced fitness to survive and 
persist in a host.  
 
Two-component systems (TCS) are the primary apparatus of S. aureus sensorial 
response mechanisms. These conduits perceive environmental cues and signal a 
response to modulate several cell functions (Villanueva et al., 2018). A study 
that included S. aureus early and late isolates from cystic fibrosis patients 
colonised for at least 5 years described adaptive changes in capsule production, 
biofilm formation, haemolysis, antibiotic susceptibility and cytotoxicity that 
were proposed to contribute for S. aureus persistence in the patients’ airways 
(Hirschhausen et al., 2013). A different study showed that mutations within the 
agr locus, which led to less virulent phenotype, promoted S. aureus adaptation 
during chronic osteomyelitis over a period of 13 months (Suligoy et al., 2018). 
These studies highlight that efficient phenotypic outcomes arise in S. aureus 
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clones adapted to a specific tissue that relieve important environmental 
limitations, including temperature, oxygen tension, cell population density, pH 
and nutrient starvation (Dastgheyb & Otto, 2015; Majerczyk et al., 2010). 
 
Molecular oxygen (O2) is a critical component for S. aureus growth and its 
presence in humans ranges from anaerobic conditions (e.g. intestines) to 
oxygen-enriched organs (e.g. kidneys and liver). The S. aureus response to 
changes in O2 tension is regulated by the SrrAB (Staphylococcal respiration 
response) TCS, which is activated during a shift from aerobic to anaerobic 
conditions and regulates the respiration switch (Yarwood et al., 2001; Kinkel et 
al., 2013). Additionally, S. aureus harbours other O2 regulated TCS (NreBC and 
AirSR/YhcSR) and regulator proteins (Rex and AgrA) that interact to overcome 
low oxygen stress in the host tissue (Pagels et al., 2010; Schlag et al., 2008; Sun 
et al., 2012; Yan et al., 2011).  
 
Moreover, S. aureus is the major pathogen of biofilm-associated infections with 
low oxygen availability, like osteomyelitis (Pendleton & Kocher, 2015), and it 
was shown that S. aureus induces hypoxia in tissues with high levels of oxygen, 
such as the kidneys and liver, in the formation of abscesses (Vitko et al., 2015). 
Fuchs and co-workers (2007) identified that under anaerobic conditions S. 
aureus promotes glycolysis, fermentation and represses the Krebs cycle. 
Therefore, S. aureus clones better adapted for promotion of hypoxia and also for 
an aerobic to anaerobic respiration transition could be more likely to persist in 
the host tissues.  
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In a similar manner to oxygen tension changes, shifts in environmental pH also 
requires appropriate responses from S. aureus. Human tissues provide a wide 
pH range varying from mildly acidic conditions (pH 5.5) on skin to near neutral 
values (pH 7.35-7.45) in the blood. Recently, Flannagan et al. (2018) described 
GraXRS as the major regulatory system associated with S. aureus survival within 
highly acidified macrophage phagolysosomes and that optimal growth in these 
microbicidal organelles is reached after acidic pH exposure. In addition, low pH 
values, as found in the urogenital tract, lung, mouth and abscesses, were 
associated with up-regulation of S. aureus virulence genes by Weinrick et al. 
(2004) and their microarray-based study observed that the main S. aureus acid 
defences are increased urease activity, proton excretion and macromolecule-
repair mechanism after the bacteria were exposed for 10 min to acid conditions 
(Bore et al., 2007). The ability of S aureus to sense, adapt and negate acid stress 
by employing diverse responses was demonstrated in a transcriptomic study in 
which the bacteria were able to increase the medium pH mainly through 
ammonium accumulation and acid groups removal (Rode et al., 2010).   
 
Diverse conditions also induce S. aureus responses to grow according to 
nutritient availability. Carbon sources, including glucose, are the major energy 
source for the majority of organisms and glucose is the most abundant free 
carbohydrate in human serum (Balasubramanian et al., 2017). Studies 
implicated that S. aureus is metabolically adapted to increase its carbohydrate 
uptake capacity and promote glucose fermentation for growth under anaerobic 
conditions (Vitko et al., 2016). When glucose and other primary carbon sources 
are abundant, a signal cascade through the conserved transcription factor CcpA 
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is activated resulting in up-regulation of RNAIII expression which leads to 
virulence gene expression modulation (Seidl et al., 2006). In addition to 
carbohydrate availability, S. aureus responds to scarcity of amino acids by 
increasing the activity of metabolic biosynthesis pathways through 
derepression of target genes regulated by CodY metabolic regulator (Majerczyk 
et al., 2010).  
 
Iron is another vital nutrient across all organisms and it requires adequate 
responses from S. aureus when the bacteria finds itself immersed in 
environments with low concentrations of iron. Host extracellular iron 
concentration is held extremely low and S. aureus is adapted mainly to acquire 
iron via scavenger siderophores called staphyloferrin A and B (Hammer & 
Skaar, 2011). S. aureus possesses multiple extracellular iron acquisition 
mechanisms, which involve haemolysins, cytotoxins and the iron-regulated 
surface determinant (Isd) system (Haley & Skaar, 2012; Torres et al., 2006). 
Both staphyloferrin operons (sfa and sfb) and isd locus are under Fur control 
(Ferric Uptake Regulator) (Dale et al., 2004; Cheung et al., 2009; Torres et al., 
2010).  Adaptive responses from S. aureus were described for other 
environmental stresses, like temperature (Cebrian et al., 2009) and cell density 







5.1.2 S. aureus nasal adaptation mechanisms 
 
The human nose is the main ecological niche for S. aureus in humans and it was 
shown that nasal secretions contain limited nutrients. When grown in a 
synthetic nasal medium (SNM) designed to resemble similar conditions to 
human nasal secretions, global gene analysis revealed high dependence of S. 
aureus on methionine biosynthesis for bacterial growth reinforcing the ability 
of S. aureus to overcome nutrient limitation and adapt to human nasal passages 
(Krismer et al., 2014). In terms of regulatory networks, the WalKR TCS has an 
essential role in maintenance of S. aureus colonisation (Burian et al., 2010b). 
The WalKR regulator, also known as YycGF, is an essential signal transduction 
pathway for cell wall metabolism. Certain SNPs in WalKR are linked with 
increased vancomicin resistance due to wall thickness changes among other 
alterations revealing that variation in this locus can contribute to S. aureus 
adaptation (Howden et al., 2011). With respect to WalKR relevance to S. aureus 
nasal colonisation, an in vivo study involving swabs from asymptomatic S. 
aureus carriers showed by qRT-PCR no activation of prominent regulators such 
as agr, SaeRS, SigB, and GraRS; WalKR being the only exception (Burian et al., 
2010b). A second in vitro study using qRT-PCR showed no increase in transcript 
levels of RNAIII during S. aureus growth in SMN synthetic nasal medium 
(Krismer et al., 2014).    
 
The absence of S. aureus agr system activity during nasal colonisation supports 
the notion of repressed biofilm formation that favours a dispersed mode of 
growth, since the referred mechanism is usually activated by dense biofilm 
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populations (Krismer & Peschel, 2011). Low numbers of bacteria isolated from 
nasal swabs (Nouwen et al., 2004), histological studies (Burian et al., 2010a; ten 
Broeke-Smits et al., 2010) and routine eradication of S. aureus by community 
antibiotics in the nasal niche (Ammerlaan et al., 2009; Van Rijen et al., 2008) 
reinforce S. aureus’ preference for a dispersed mode of growth phenotype in the 
nose. Although S. aureus has been extensively studied, many host-microbe 
determinants of S. aureus carriage are yet to be characterised and their 
understanding will elucidate S. aureus’ adaption ability to colonise the human 




















A key factor that determines versatility of S. aureus to colonise and invade 
diverse host tissues is its ability to sense growth-limiting environmental 
conditions followed by the employment of modulated responses accordingly.  
The extensive repertoire of metabolic pathways tightly controlled by regulator 
systems ensures S. aureus adapts expression after exposure to environmental 
cues thereby improving its fitness.  
 
The current chapter focuses on the contribution of genetic changes selected in 
an experimental nasopharyngeal model for S. aureus nasopharyngeal 
colonisation. The hypothesis is that S. aureus genetic variants selected after 
serial passages in the nasopharynx point a finger at adaptation in this niche, 














5.3.1 Single S. aureus nasopharyngeal isolates posses niche adaptation  
 
In the previous chapter, an experimental evolution model comprising three 
serial passages of S. aureus pools of isolates in the nasopharynx of mice was 
performed and SNPs were curated. To assess whether these genetic changes 
captured in the sequence pools of S. aureus after repeated nasopharyngeal 
passages account for bacterial adaptation in this niche, a single clone was 
randomly selected from each pool of isolates from both second (C2) and third 
passages (C3) (see section 3.3.2), named C12_7 and C14_7 respectively. Since 
few sequence variants were detected in the genomic pools from the first 
nasopharyngeal passage, no clone from this evolutional stage was included in 
subsequent experiments.  
 
5.3.1.1 Variation in the colonisation of single S. aureus isolates from 
distinct nasopharyngeal evolutionary periods  
 
Colonisation ability from nasopharyngeal clones was compared with the control 
isolate (S. aureus USA300 LAC JE2) using the murine model established in 
Chapter 3. Due to technical problems described for the conclusion of the serial 
nasopharyngeal passages (section 3.3.2), in this experiment differences in the 
colonisation level was assessed successfully only between the control isolate 
and the C12_7 clone selected from the second nasopharyngeal passage. Inocula 
of each strain were identically prepared (~ 5 x 104 cfu) and then groups of ten 
mice were inoculated in their nose (one group per bacterial isolate). The 
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success of colonisation was analysed over a period of 14 d where two mice for 
each strain were sacrificed at successive time points (1, 2, 3, 7 and 14 d). The 
nasopharynx was aseptically removed and homogenised followed by colony 
counting on mannitol salt agar (incubated for 24-48 h at 37C ).           
 
As shown in Figure 5.1, the single isolate collected after two serial passages in 
the nasopharynx of mouse showed better colonisation status when compared 
with the control isolate. Whilst after one day of inoculation both isolates were 
present at similar colonisation levels, by day 2 the nasopharyngeal passaged 
clone showed increased colonisation of the nasopharynx compared with the 
control strain that decreased in frequency within this niche. From day 3 
onwards a slight variation in the colonisation patterns is observed, but overall 
both strains reach a steady colonising status with the C12_7 clone showing a 
trend of greater frequency that is not statistically significant.  
 
Similar to the colonisation levels of S. aureus observed during the long-term 
murine model development, cell numbers of both isolates drop markedly in the 
first 24 h. After the next 24 h, C12_7 demonstrates increased survival levels as 
per greater counts in opposition to the control isolate that experienced a 
progressive reduction of its CFU values. Although after 14 d both clones are not 
significantly distinct regarding their colonisation capability, these data indicate 











Figure 5.1 Nasopharyngeal colonisation of mice by S. aureus USA300 LAC JE2 and S. 
aureus C12_7. 
Inoculation was initiated with a 5 x 104 CFU dose of both S. aureus USA300 LAC JE2 
(control; circle) and C12_7 (clone collected after two serial passages; square). At each time 








To gain further insight into fitness of the clones selected from the serial 
passages the experiment was repeated with both clones C12_7 and C14_7.  The 
murine model was used once again to detect variation in S. aureus’ ability to 
colonise the mouse nasopharynx by comparing the colonisation success of the 
three isolates: WT control, C12_7 and C14_7, over a period of 14 d. On this 
occasion, after day one the mean bacterial load in the nasopharynx was 
decreased substantially (Fig 5.2) compared with the previous experiments (c.f. 
with Fig 5.1) considering that the inoculum was ~ 5 x 104 CFU, an outcome that 
was not previously observed when only the control and C12_7 were analysed 
regarding their colonisation status. Amongst the three clones analysed, C14_7 
showed the greatest overall colonisation numbers. Although C12_7 exhibited 
higher population numbers at 24 h, C14_7 showed a trend for increased 
nasopharyngeal colonisation fitness, as judged by numbers, from day 2 
onwards. The control isolate mostly displayed a pattern the lowest numbers of 
bacteria recovered from the nasopharynx over the course of this experiment.  
 
Unexpected outcomes like the apparent clearance of the control isolate from 
day 3 onwards and of C12_7 after 7 d with reappearance after 14 d were 
determined in this experiment. These observations coupled with pronounced 
CFU values reduction after 24 h might suggest various scenarios: that the mice 
were under inoculated, which ultimately led to clearance of some isolates or 
presence of them in the nasopharynx at below detectable levels; there is greater 
batch variation in the mice for these experiments. However, even considering 
such conditions, the clone from the third nasopharyngeal serial passage showed 








Figure 5.2 Nasopharyngeal colonisation of mice by S. aureus USA300 LAC JE2 and clones 
C12_7 and S. aureus C14_7. 
Inoculation was initiated with a 5 x 104 CFU dose for both S. aureus USA300 LAC JE2 
(control; blue circle), C12_7 (clone collected after two serial passages; green square) and 
C14_7 (clone collected after three serial passages; red triangle). At each time point the 







and with use of greater numbers of mice, which were not originally deemed 
justifiable, could have provided better statistical support for any actual 
differences in colonisation ability. 
 
5.3.1.2 Sequence variation of single S. aureus nasopharyngeal colonisation 
isolates  
 
Taking into account the variation in colonisation levels from the three isolates 
(control, C12_7 and C14_7), albeit largely not significant differences, genome 
sequencing was performed followed by SNPs analysis to determine which 
sequence variants from the genomic pools were present in the passaged single 
clones. DNA extraction, quality check and sequencing for both C12_7 and C14_7 
was performed as described in section 4.3.1. Genome sequencing analysis of the 
control (USA300 JE2 LAC) was previously performed (see Chapter 4).   
 
Output from the SNPeff algorithm revealed a strong overlap between the SNPs 
dataset of both clones and their corresponding genomic pools, supporting the 
effectiveness and reproducibility of the methodology used in Chapter 4 to 
capture sequence variation over the nasopharyngeal experimental evolution 
experiment. The isolate from the second nasopharyngeal passage (C12_7) 
showed 92 SNPs overall of which 46 were intragenic non-synonymous 
sequence variants (Table 5.1) and 15 were variants located in intergenic 
regions (Table 5.2).  
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Considering firstly the intragenic non-synonymous SNPs, 97.8% (45/46) of the 
variants detected in the second passage sequence pools were present in clone 
C12_7 (Table 5.1). The single intragenic non-synonymous SNP absent in C12_7 
was V179I located in the hypothetical transmembrane protein 
SAUSA300_RS09205. In the sequence pool, this locus had six further intragenic 
non-synonymous SNPs and all these variants were detected in C12_7. Given that 
SAUSA300_RS09205 (V179I) had the lowest percentage frequency in C2 pool 
(20.28%) makes the absence of this SNP unsurprising. 
 
Regarding intergenic SNPs, the overlap of sequence variants between the pool 
of isolates and clone C12_7 was high with 11 out of 13 intergenic SNPs 
confirmed (Table 5.2).  Two absent from C12_7 were located in a 151 bp region 
and potentially affected either or both SprA1 (regulatory sRNA) and 



























Table 5.1 S. aureus nasopharyngeal clone clone C12_7 non-synonymous intragenic SNPs. 
S. aureus SNPs observed in genomic DNA of a single clone (C12_7) isolated after the second 
passage of murine nasopharyngeal colonisation.  










P/A 358 aa 




I/T 183 aa 
 
gyrA 
































































































































































D/N 71 aa 
















D/E 203 aa 
















































































































































A/D 84 aa 
SAUSA300_ 
RS11285 
Thiaminase II 2214645 
C/T 
G/R 224 aa 


















































Table 5.2 S. aureus nasopharyngeal single isolate after two repeated passages have 
intergenic SNPs. 
S. aureus genome sequence variants (SNPs) in non-coding regions observed for C12_7 isolate 
after two serial passages performed in the experimental nasopharyngeal colonisation model.  
Genome 
change 











-1069 bp / SAUSA300_RS00340 (+) 
 
-148 bp (arcA) (-) 






-222 bp / pflB (+) 
 






















-9 bp / SAUSA300_RS15240 (+) 
 







-17 bp / SAUSA300_RS15240 (+) 
 







-44 bp / argF (+) 
 
-394 bp / SAUSA300_RS05750 (-) 






-237 / SAUSA300_RS07455 (+) 
 
-165 bp / rpsA (-) 
Hypothetical protein 
 




-280 bp / SAUSA300_RS09565 (+) 
 







-272 bp / SAUSA300_RS09565 (+) 
 







-100 bp / SAUSA300_RS09690 (+) 
 

















-290 bp / opuD2 (-) 
 











































The sequenced C14_7 clone from the third nasopharyngeal passage showed 
even overall higher concordance with its genomic pool counterpart. A total of 
19 non-synonymous intragenic SNPs were detected in clone C14_7 matching 
with the same 19 variants in coding regions observed in the C3 sequence pool 
(Table 5.3). Considering intergenic SNPs, clone C14_7 revealed five out of six 
variants observed in the C3 genomic pool (Table 5.4). The sequence variant 
SAUSA300_RS00765 (G164912A) was not detected in C14_7 and it might be 
involved in the regulation of pnhD (encoding a phosphate/phosphite/ 
phosphonate transporter). This SNP was the only intergenic variant detected in 
less than 90% of C3 sequence reads suggesting that other isolates from the C3 
pool, excluding C14_7 possess this particular SNP. 
 
The high level of sequence agreement between single clones and isolate pools 
reinforces the decision to group evolved nasopharynx isolates to maximise the 
SNPs detection. It also validates the use of single clones randomly chosen for 
adaptation studies since most of the C2 and C3 sequence pool variants were 

















Table 5.3 S. aureus nasopharyngeal clone C14_7 non-synonymous intragenic SNPs. 
S. aureus SNPs observed in genomic DNA of the clone C14_7 after three serial passages of 

























































































































































































































































Table 5.4 S. aureus nasopharyngeal clone C14_7 intergenic SNPs. 
S. aureus genome sequence variants (SNPs) in non-coding regions observed for C14_7 isolate 

































-237 / SAUSA300_RS07455 (+) 
 
-165 bp / rpsA (-) 
Hypothetical protein 
 




-100 bp / SAUSA300_RS09690 (+) 
 















-290 bp / opuD2 (-) 
 




-189 bp / SAUSA300_RS12785 (+) 
 





5.3.2 S. aureus intra-species competition in the nasopharynx niche 
 
Although it was previously suggested that S. aureus are not natural colonisers of 
mice (McCarthy et al., 2012; Mulcahy et al., 2012), recent findings demonstrate 
there is frequent colonisation of laboratory mice by S. aureus (Schulz et al., 
2017). Chapter 3 includes description of recurrent failures in performing the 
third nasopharyngeal passage due to prior colonisation of mice by S. aureus. 
Since it was described that colonisation by S. aureus prevents the invasion of S. 
aureus strains (Margolis et al., 2010), a hypothesis that nasopharynx-adapted S. 
aureus strains obstruct the experimental colonisation was proposed. Therewith, 
genome sequencing was performed followed by variant analysis with the aim of 
characterising the presumed mouse-adapted strain (named SA_MOU) to 
provide insights of possible genome sequence variation (alleles) that might 
match with the experimental evolution changes from repeated colonisation of 
the nasopharynx.  
 
Ten S. aureus isolates were randomly picked from mannitol salt agar after 
growth from washed nasopharynx of mice. DNA extraction was performed for 
all isolates and the quality, yield and concentration were checked prior to 
sequencing (Table 5.5). DNA from the isolates was pooled in equivalent 
amounts and both DNA library preparation and sequencing were performed as 
described in section 4.3.1. The resulting raw sequencing reads were quality 
filtered using Cutadapt and Sickle for removal of adapter sequences and reads 
shorter than 10 bp, resulting in four files (two forward and two reverse reads) 
(Table 5.6).    
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Table 5.5: Quality control analysis of DNA samples pooled for sequencing from 
nasopharynx S. aureus SA_MOU isolates.  
DNA quality data of 10 SA_MOU isolates prior to sequencing.  DNA concentration measurements 
were determined using Qubit and absorbance ratios at 260/280 and 260/230 using Nanodrop. 






SA_MOU_1 95.4 1.9 1.9 
SA_MOU_2 90.9 1.8 2.1 
SA_MOU_3 104.8 1.9 2.2 
SA_MOU_4 151.2 1.8 2.2 
SA_MOU_5 72.4 1.8 2.2 
SA_MOU_6 76.6 2.0 2.1 
SA_MOU_7 92.6 1.9 1.9 
SA_MOU_8 97.5 2.0 2.3 
SA_MOU_9 98.2 1.8 2.3 




Table 5.6: Sequencing statistics of Illumina libraries after sequence adapter removal and 
quality filtering.  
Raw data from SA_MOU sequencing reads generated by Illumina TruSeq PCR-free kits and 
sequenced on MiSeq platform.  
 SA_MOU_F1 SA_MOU_F2 SA_MOU_R1 SA_MOU_R2 
Number of reads  2.495.866 2.470.449 2.495.866 2.470.449 
Mean read length (bp) 246.5 242.3 246.6 242.4 
Mean Base Quality Score 39.5 39.4 38.7 38.7 
A content (%) 33.8 33.8 34.3 34.3 
C content (%) 16.2 16.2 15.8 15.8 
G content (%) 15.9 15.9 16.1 16.2 
T content (%) 34.1 34.1 33.8 33.8 





Briefly, the four data files showed Base Quality Score (error rate) above 38, 
GC% content ranging from 31.9% to 32.1% and absence of ambiguous bases (N 
content). At least 2,470,449 reads of 242.3-246.6 bp in size were generated per 
file. These quality filtered paired-end reads were used for the assembly stage. 
 
Due the lack of information about the adapted pre-colonising S. aureus strain, a 
pipeline was established for genome assembly without a reference genome (Fig 
5.3). Therefore, the trimmed data generated by Illumina sequencing was 
constructed with the SPAdes assembler (Bankevich et al., 2012) for de novo 
assembly using K-mer sizes of 21, 33, 55, 77, 99 and 127. Scaffolding and 
alignment of contigs was performed using SSPACE-BASIC (Baseclear). 
Subsequently, Prokka (Seemann, 2014) was used for genome annotation. 
Genome visualisation of the resulting annotated assembly was performed by 
both Geneious (Kearse et al., 2012) and Blast Ring Image Generator (BRIG) 
(Alikhan et al., 2011).  
 
SPAdes was run according to the manufacturer’s instructions for Illumina 
paired-end reads (2x250 bp) including the use of options aimed at minimising 
the number of mismatches in the final contigs. Scaffolding of pre-assembled 











Figure 5.3 Schematic representation of the pipeline used for de novo genome assembly of 
S. aureus SA_MOU nasopharynx strain. 
Raw reads of SA_MOU genome sequencing generated by Illumina sequencer were quality 
filtered using Cutadapt and Sickle. Trimmed reads were assembled into contigs by SPAdes. 
Scaffolding of pre-assembled contigs was performed SSPACE. PROKKA software was used to 






The resulting scaffolds were annotated by Prokka, an annotation software tool 
specialised in bacterial, archeal and viral annotation. Prokka was used so open 
reading frames (ORFs) could be detected in the assembled file for the ultimate 
purpose of strain characterisation based on house-keeping genes analysis. 
Prokka output revealed 2869 CDS, 57 tRNA, 15 rRNA and one tmRNA. 
 
Having the ORFs identified, a multilocus sequence typing technique (MLST) was 
used to gain insights of the S. aureus strain colonising the mouse nasopharynx. 
As required by the MLST server (www.mlst.net), fragments of approximately 
400-520 bp from multiple loci (Table 5.7) were extracted from Prokka 
annotated files prior to allelic profile matching against a sequence type (ST) 
database. The S. aureus MLST database is constituted of 3302 STs including the 
major MRSA clonal lineages circulating in the UK. The search showed that the S. 
aureus strain pre-colonising the mice belongs to ST8, a highly relevant ST since 
it includes CA-MRSA USA300. A recent study demonstrated that the genetic 
variation within ST8 clones is rather substantial considering space and time 
(Strauß et al., 2017). Molecular evolution observations showed that a less 
virulent ST8 ancestor from Central Europe gradually acquired USA300 virulent 
factors after expansion to North America followed by a broad geographic 
spread (Strauß et al., 2017). ST8 possesses clonal heterogeneity in Europe, 
where it co-exists with the dominant ST80 and other clones like ST22 (Otter & 
French, 2010). Natural colonisation and infection of animals by ST8 is rather 
unusual, however it has been demonstrated in horses (Cuny et al., 2008) and 




Table 5.7: MLST profile of S. aureus SA_MOU. 
List of house-keeping genes and their functions used for MLST typing. Internal fragments of 
seven loci were matched against a database constituted by hundreds of unique alleles for each 




Gene function Fragment 
Size (bp) 
Number of unique 





arc Carbamate  
Kinase 
456 357 3 
aroE Shikimate 
Dehydrogenase 













474 380 4 
tpi_ Triosephosphate  
Isomerase 
402 360 4 
yqil Acetyl-CoA 
Acetyltransferase 












The only mouse S. aureus strain characterised to date belongs to ST88 
(Holtfreter et al., 2013). However, the wide genetic variability between ST8 
clones and its vast global presence within microbiology research facilities due 
to its clinical relevance make it tempting to indicate that nasopharyngeal 
colonisation by ST8 occurred in the originating animal handling facility. 
 
Within the described research programme in this thesis, there were multiple 
occasions where S. aureus strains colonising the nasopharynx prevented the 
experimental introduction of the experimental strain, most problematically the 
conclusion of the third serial passage with S. aureus USA300 LAC JE2 (section 
3.2.2). Since isolates from this experimental evolution stage showed a trend for 
better colonisation (Fig 5.2) and since it also belongs to ST8, subsequent 
investigations were performed based on whole genome comparison and non-
synonymous intragenic SNPs captured in the passaged S. aureus isolates to 
determine if there were allelic overlaps between the species.  
 
Prior to SNP analysis, investigations on the genome of the SA_MOU 
nasopharyngeal coloniser strain were made. Firstly, the assembled genome 
from SA_MOU was visualised using Geneious where the resulting assembly was 
aligned by LASTZ to the USA300 reference genome (USA300_FPR3757; NCBI 
Ref Seq: NC_007793.1) and two additional reference genomes representing 
ST22 (HO 5096 0412; NCBI Ref Seq: NC_017763.1) and ST80 (NCTC 8325; NCBI 
Ref Seq: NC_007795.1), dominant STs in Europe. LASTZ is a program designed 
for pairwise alignment and it is a useful tool for finding similar regions between 
genomic sequences millions of nucleotides in length. Alignment showed fewer 
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gaps with the SA_MOU assembled contig matched against the USA300 reference 
genome, supported by a pairwise identify of 99.5% across 94.5% coverage as 
the highest values among the three genome alignments (Fig 5.4). Alignment of 
SA_MOU against ST22 and ST80 genomes revealed high pairwise identify 
(97.9% and 99.4%, respectively) but with considerably lower coverage (88.0% 
and 90.9%, respectively).   
 
Secondly, whole genome comparison from SA_MOU sequenced in this study and 
USA300, ST22 and ST80 publicly available reference sequences was performed 
using Blast Ring Image Generator (BRIG) software. The comparison was done 
with SA_MOU serving as the reference sequence and it clearly shows higher 
similarity with USA_300 (Fig 5.5). Sequence comparison from both ST22 and 
ST80 against SA_MOU identified far more apparent gaps, suggesting sequence 
variation. Of note, SA_MOU also presented gaps in its genome, reflecting that 
scaffolding and alignment of contigs could not be performed in certain regions. 
 
These observations reflect the fact that both SA_MOU and USA300 LAC JE2 are 
closely related strains which belong to the same ST but also present a degree of 
dissimilarity. Slight differences in the genome composition may include 
presence/absence of sequence variants responsible for the differential 









Figure 5.4. LASTZ pairwise alignment of S. aureus genomes. 
S. aureus SA_MOU (ST8 mouse nasopharynx isolate) assembled genome aligned to reference 






Figure 5.5 BRIG analysis of S. aureus genome sequences. 
BRIG comparison of whole genome sequences of four S. aureus strains: S. aureus SA_MOU and 







Subsequent to the genome observations, interrogation of serial passage 
mutations from the C14_7 clone in respective SA_MOU genes was performed. 
Firstly, a search for sequences of 13 loci that harbour non-synonymous 
intragenic SNPs in C14_7 (Table 5.3) was performed for SA_MOU annotated 
genome. The hypothesis was that a certain level of concordance between SNPs 
found in C14_7 and alleles of SA_MOU might be expected if they represent 
adaptation to the mouse nasopharynx.  
 
Sequences for nine of the thirteen genes were identified in SA_MOU genome 
(Table 5.8) with four loci not found in the assembled genome, including gutB 
(sorbitol dehydrogenase), SAUSA300_RS02185 (superantigen-like exoprotein), 
SAUSA300_RS09205 (hypothetical transmembrane protein) and 
SAUSA300_RS15385 (hypothetical protein). The protein sequences detected in 
SA_MOU were then matched against the USA300 reference genome 
(NC_007793.1) using BLASTp to check coverage and identity and also reveal if 
equivalent SNPs identified in C14_7 were present in SA_MOU. Of the nine genes, 
SA_MOU sequences showed 100% identity and coverage, with the exception of 
ftsK and recF. Although FtsK protein sequence showed 100% identity between 
both strains, SA_MOU ftsK is 42 bp longer.  
 
With respect to SNPs correlation outcomes between C14_7 and SA_MOU, only 
two proteins showed matching sequence variation: RecF and FtsK. This 
indicates that there is potential for SA_MOU adaptation to the nasopharynx to 
be mediated through different mechanisms than C14_7, even though the two 
clones are closely related. It also raises the possibility that S. aureus genes ftsK 
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and recF that encode proteins with DNA recombination pathway activity are 
under constant selective pressure and contribute to adaptation during bacterial 
nasopharyngeal colonisation. The allelic variants found in this work for ftsK and 
recF were detected in other S. aureus ST8 strains in previous studies (Kennedy 
et al., 2008). This raises the hypothesis that the SNPs correspondence between 































Table 5.8 Non-synonymous intragenic SNPs comparison between two ST8 S. aureus 
nasopharyngeal single isolates  
Table shows SNPs observed in genomic DNA of C14_7 and their presence/absence in SA_MOU.   
S. aureus C14_7  
      Gene symbol                      Codon change 
S. aureus SA_MOU  
         Gene symbol                      Codon change 
recF 358 aa (P/A)   FNBPBLMC_ 
00036 
358 aa (P/A)   
SAUSA300_ 
RS00265 










601 aa (T/A)  FNBPBLMC_ 
00260 
- 
gutB 341 aa (T/P)   - - 
SAUSA300_ 
RS01715 










110 aa (A/T) - - 
ftsK 180 aa (K/R) FNBPBLMC_ 
01253 
180 aa (K/R) 



































28 aa (Y/C) - - 
SAUSA300_ 
RS10080 
48 aa (R/L) - - 







This chapter has evidenced S. aureus nasopharynx adaptation after serial 
passages in this niche.  In addition, the study revealed the complicating factor of 
S. aureus intra-species competition for nasopharyngeal colonisation.  This study 
presents a potential cornerstone for future studies aimed at elucidating details 
of contributing loci during S. aureus nasal colonisation and adaptation with 
respect to how they contribute to bacterial persistence. S. aureus colonisation 
data from animal models and comparative genomics analyses can give 
indications of components and processes involved in adaptive responses of S. 
aureus in the nasopharynx. This part of the study helped answer several 
questions raised in Chapter 4, however some interrogations like the 
contribution of certain variants for nasopharyngeal adaptation remains 
unknown. Construction of defined allelic variant strains coupled with 
transcriptomics and/or metabolomics studies and phenotypic assays would 
elucidate further particular characteristics of the S. aureus modulated response 
against stress conditions found in the nasopharynx. The discussion that follows 
is aimed at the major mechanisms and pathways that might act to increase S. 
aureus nasopharyngeal fitness. S. aureus genetic variants under selection over a 
nasopharyngeal evolution time-frame were discussed in Chapter 4.   
 
Putting together genetic changes tracked over an evolution time-course with 
evaluation of their contribution for bacterial fitness is a valuable approach to 
identify mechanisms controlled by microorganisms during adaptation. Lopez-
Collazo et al. (2015) investigated microbial variation of a single MRSA clone 
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over a 13-year timeframe of bronchopulmonary colonisation in a patient with 
cystic fibrosis and the authors suggested a correlation between the genetic 
differences observed in the in the S. aureus long-term evolution and the 
bacterial adapted response against the host innate immune components. In this 
context, considering the genetic differences and colonisation rate variation 
between isolates from distinct nasopharyngeal serial passages, it was shown 
here that S. aureus adapts to the nasopharynx niche by regulating a number of 
factors involved in multiple cell pathways and mechanisms resulting in 
improved colonisation status. Similarly, extended bacterial persistence within 
the host tissue has been linked to adaptive changes (Hirschhausen et al., 2013; 
Hoboth et al., 2009; Kennedy et al., 2008). Conversely, a study demonstrated 
limited bacterial diversity in the transition from nasal carriage to fatal 
bloodstream infection caused by a MSSA strain (Young et al., 2012), a finding 
that reflects and reinforces the need to address the real contribution of genetic 
variants for adaptation in general.  
 
The data from this chapter showed the potential connection between S. aureus 
nasopharyngeal adaptation and fluctuation of selective genetic changes. A 
substantial increase in the number of SNPs across the passages may explain the 
trend for better colonisation numbers observed for the S. aureus isolate from 
the second nasopharyngeal passage compared with the control, while the 
refinement of such variants would further improve S. aureus fitness for the 
nasopharynx. However, it is pertinent to mention that adaptive responses by S. 
aureus in this work were due to designed experimental evolution, in contrast to 
natural adaptation during a lifecycle to distinct niches during invasion and 
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colonisation/infection. Additionally, it is plausible to suggest that the S. aureus 
nasopharyngeal adaptation demonstrated here over three serial passages of 7 
days each might possesses different aspects than clinical adapted strains 
isolated from patients colonised for years as previously discussed. Still, the 
finding that S. aureus potentially improved its fitness to persist in the murine 
nasopharynx and that this phenomenon was accompanied by genetic variation 
similar to other evolutionary studies endorses the methodology used in this 
study (serial nasopharyngeal passages of pooled S. aureus isolates) producing 
the outcomes from this work. 
 
Although a definitive statement cannot be reached in this study regarding the 
actual contribution of each mutation detected in the evolved isolate genome 
sequences towards S. aureus adaptation in the nasopharynx, indications of 
pathways modulating S. aureus fitness for nasopharyngeal colonisation can be 
made. The majority of the genetic changes detected here relate to metabolism 
rather than virulence factors. In a separate study, gene expression profiles 
demonstrated up-regulation of S. aureus virulence components upon transition 
from nasal colonisation to bacteraemia (Jenkins et al., 2015). Additionally, 
evolved clones of S. aureus isolated from cystic fibrosis patients provoked 
attenuated immune response by human monocytes (Lopez-Collazo et al., 2015). 
These studies reflect a bacterial colonisation strategy focused primarily in 
regulation of persistence components instead of virulence factor expression, 
which contributes to the long-term colonisation. This is in accordance with the 
minimal number of virulence factors and their regulators with mutations during 
nasopharyngeal adaptation found in this study. In a similar fashion, metal 
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cation acquisition might be largely unaffected by the adaptive changes in S. 
aureus during nasopharynx colonisation as no cytotoxins, haemolysins or other 
acquisition determinants involved in iron transport, for example, showed 
mutations in their sequences.  
 
Data from the nasopharyngeal passaged single isolates suggests a contribution 
of co-factors in S. aureus nasopharyngeal adaptation. Chaffin et al. (2012) 
assessed adaptation features of S. aureus to the lung using transcriptomics 
assays and the authors reported increased in vivo transcription of co-factors 
genes associated with changes in the energy source and higher growth rate. 
This study detected genetic variation in genes for co-factors (biotin and 
thiamine) linked to amino acid and carbohydrate metabolism. The improved 
fitness suggested here for nasopharyngeal passaged clones might reflect a high 
level of involvement between the co-factors and the adaptive response of S. 
aureus to the nasopharyngeal growth limiting conditions.  
 
Aligned with S. aureus metabolism, data from evolved clones also suggests that 
carbohydrate metabolism could be implicated in S. aureus adaptation to the 
nasopharynx. Several mutations located in genes related to carbohydrate 
biosynthesis and transport (mannitol, sorbitol and fructose-6-P metabolism) 
shown in this chapter might contribute for persistence of S. aureus in the nasal 
passages. Human nasal secretions contain low concentration of glucose 
(Krismer et al., 2014) which ultimately leads S. aureus to find alternative ways 
to acquire and utilise other molecules as carbon sources. In terms of 
carbohydrate catabolism, S. aureus possesses three major central carbon 
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metabolism pathways: glycolytic, PPP and tricarboxylic acid (TCA) cycle (Fuchs 
et al., 2012).  
 
The ability of S. aureus to sense environmental changes with subsequent 
regulation of its multiple carbon pathways reflects its potential to grow under 
aerobic and anaerobic conditions and also to use oxygen, nitrite or nitrate as 
the final electron acceptor during respiration. For instance, oxygen deprivation 
and glucose-enriched conditions drive TCA repression by S. aureus while 
bacterial up-regulation of genes involved in glycolysis can be observed (Fuchs 
et al., 2007). A study using gene expression analysis showed adaptive responses 
of S. aureus in a mouse model of pneumonia where the bacteria down-regulates 
both glycolytic and TCA central metabolic pathways (Chaffin et al., 2012). 
Additionally, Ferreira et al. (2013) showed that in environmental conditions 
similar to the nasal cavities niche (low concentration of free monosaccharides 
and high oxygen availability), S. aureus can use glucose and lactose 
simultaneously for growth. The lactate oxidation therefore confers S. aureus 
competitive advantage and better fitness for nasopharyngeal colonisation since 
lactate is the end product of many fermentative commensal bacteria. These 
findings support the capability of S. aureus to modulate an appropriate 
response against environmental limiting condition, albeit if that is also selected 
by the niche in addition to conserved encoded regulatory control. 
 
While it remains unclear which specific aspects of carbohydrate metabolism 
were affected during the S. aureus adaptation to the nasopharynx observed in 
this study, potential components can be highlighted based on selected genetic 
 176 
changes and it is tempting to suggest that they provide increased fitness based 
on improved carbohydrate metabolism of alternative sugar sources which could 
also be combined with an adaptive response to oxygen tension variation as the 
nasal cavities displays high O2 concentration (Ferreira et al., 2013). Future 
studies should clarify the influence of adapted responses by S. aureus.    
 
As well as carbohydrate central metabolism, another S. aureus factor that seems 
to come under selective pressure within the nasopharynx is stress resistance. 
The ability of S. aureus to cope with diverse types of stress was mostly 
addressed by the bacterial response via signal transduction and regulation of 
gene expression (Morikawa et al., 2012). The classical S. aureus stress response 
comprises multiple components such as sigma factors (e.g. SigB, enrolled in 
general response to stress) (van Schaik & Abbe, 2005), two-component systems 
(e.g. agrAC, involved in the regulation of virulence gene expression) (Bronner et 
al., 2004), SarA (staphylococcal accessory regulator) (Cheung et al., 2008) and 
specific regulatory systems (e.g. HrcA and CtsR, implicated in response to heat 
shock responses) (Frees et al, 2004). These global regulators/transcription 
factors act to provide S. aureus with a modulated and adapted response 
according to changing environmental conditions. In this study, some genes 
under control of regulatory components mentioned above showed genetic 
variation during the nasopharyngeal experimental evolution, which might 
explain the trend for better fitness observed with evolved clones for this niche.  
 
In consonance with stress resistance, the response to oxidative stress could be 
of particular relevance in the adaptation of S. aureus to the nasopharynx. There 
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are many relevant stressors with reactive oxygen species (ROS), including free 
radicals (superoxide anion, hydroxyl radical and hydrogen peroxide) and 
reactive nitrogen species (nitric oxide, peroxynitrite anion). These oxidants are 
formed via diverse reactions from both bacterial aerobic growth and host 
oxidative killing mechanisms and the imbalance between their presence in the 
cell and ROS detoxification results in oxidative damage to a range of 
macromolecules such as proteins, DNA and lipids (Groves & Lucana, 2010). S. 
aureus displays multiple defensive molecules that act in the battle against ROS 
(Painter et al., 2015) and adaptive bacterial responses in the nasopharynx 
leading to quicker and more efficient actions against oxidative stress provides S. 
aureus improved fitness for the referred niche.  
 
Characterization of S. aureus adaptation to the airways of a CF patient (Treffon 
et al., 2018), the intracellular niche of human bronchial epithelial cells (Michalik 
et al., 2017) and to the lung (Chaffin et al., 2012) showed increased abundance 
of proteins associated with oxidative stress response. Chavez-Moreno et al. 
(2016) showed high levels of in vivo expression for S. aureus components 
involved in protection from oxidative stress in the anterior nares, indicating 
that S. aureus experiences oxidative stress in its natural niche. These data 
indicate that the differential colonisation potential observed for 
nasopharyngeal passaged clones is partially correlated with adaptive oxidative 
stress response due genetic variation in stress resistance genes (hemN, ahpF 
and clpL) found among these isolates. 
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Adaptive responses against oxidative stress are not only mediate by defensive 
molecules. Exposure to ROS leads to increased mutation rates via activation of 
the SOS response (Painter et al., 2015). Higher mutation rates increase the 
probability of selection for adapted variants, which ultimately enhance the 
bacterial survival from a survival bottleneck. This study detected S. aureus 
variants that were potentially selected due to the stress conditions of the 
nasopharynx related to both oxidative stress and DNA repair machinery. 
Therefore, it is feasible to suggest that exposure to ROS in the nasopharynx was 
a driver of selection of adaptive responses from both oxidative stress and SOS 
responses in S. aureus, which act in a coordinated manner to improve the 
bacterial fitness for the nasopharynx, a phenotypic trend proposed in this 
chapter.  
 
 Additionally, the data presented here showed intra-species competition for the 
nasopharynx niche colonisation. Pre-colonised mice prevented the third serial 
nasopharyngeal passage by S. aureus USA300 LAC JE2 for almost one year, a 
phenomenon observed in distinct sets of mice. Clones from the naturally 
colonising strain were named S. aureus SA_MOU and further analysis showed 
that they belong to the same USA300 LAC JE2 sequence type - ST8 – even 
though they do not share the same spa type (USA300 and SAU_MOU belong to 
t008 and t024 respectively). ST8 is a highly important clonal group as it 
includes the American epidemic CA-MRSA USA300 clone, a genotype 
characterised by high virulence expression and the unique linkage between 
SCCmecIVa and arginine catabolic mobile element (ACME), which provides the 
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bacteria both drug resistance and pronounced virulence factor expression 
during colonisation/infection (Diep et al., 2008).  
 
Genetic diversity within ST8 is reasonably high and according to the MLST 
server used for typing SA_MOU, at least 16 spa types are associated with ST8, 
including t008 (CA-MRSA USA300 spa type) and t024 (SA_MOU spa type). Iwao 
et al. (2012) showed that a ST8-derived CA-MRSA genotype has become the 
major clone associated with skin, soft tissue and invasive infections. The 
authors revealed variation regarding the spa types and although it possesses 
high genomic similarity to USA300, a reasonable level of variation with the 
accessory genes was detected, including a novel pathogenic island (SaPIj50). 
Genetic diversity within ST8 MRSA clone collections has also been 
demonstrated in other studies (Glaser et al., 2016; Kawaguchiya et al., 2013; 
Von Dach et al., 2016). 
 
These observations answer several questions regarding the intra-species 
competition observed in this chapter. Although USA300 LAC JE2 and SA_MOU 
are closely related (both share identical ST), genetic differences between both 
strains might account for SA_MOU ability to naturally colonise the mouse 
nasopharynx and persist in this niche or for SAU300 LAC JE2 inability to invade 
a pre-colonised nasopharyngeal tissue and establish a colonisation. It was 
suggested that ST8 isolates in Europe are formed by a genetically diverse 
population comprised of both ancestral representatives and strains with 
multiple introductions (Strauß et al., 2017). In this study, SA_MOU assembled 
contigs covered 94.5% of USA300 LAC JE2 genome with 99.5% of identity 
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which clearly reflects a degree of genetic dissimilarity between the two 
genomes. 
 
Extended assessment of variation between USA300 LAC JE2 and SA_MOU in 
terms of genetic characters such as PVL, ACME, SCCmec and core/accessory 
genome was not investigated in detail due to time limitation, but it unclear what 
would indicate determinants for successful colonisation by SA_MOU or 
competition and colonisation determinants of murine nasopharyngeal tissue 
with SAU300 LAC JE2 best studied for its assets that contribute to human 
pathogenesis and particularly skin and soft tissue infections. A study compared 
an emerging ST8 MRSA lineage which became the major clone in Japan with 
USA300 and it was demonstrated that the genome from both strains were 
97.4% homologous (Iwao et al., 2012). This finding is in line with the data from 
this study: genetic variation, even at limited levels, between closely related S. 
aureus ST8 strains could be responsible for distinct adaptive responses that 
play a major role in intra-species competition in the context of nasopharyngeal 
colonisation.   
 
Bacterial competition in the nasal cavities is a consequence of diverse 
mechanisms including a dispute for adhesion site and nutrients and direct 
(bacteriocins release) or indirect (host defence stimulation) interference 
(Krismer et al., 2017). Whilst most of the competition studies to date address 
the relationship between S. aureus and other nasal commensals, including 
coagulase-negative Staphylococcus species, it is likely that the intra-species 
competition observed in this study is due to an antagonistic battle for host 
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ligands and nutrients, since the production of antimicrobials would be likely to 
be ineffective against other S. aureus strains and the stimulation of the host 
immune system would probably affect any genetically similar S. aureus lineages.  
 
In respect of bacterial adhesion, S. aureus expresses a vast range of adhesins 
enrolled in microbial adherence such as WTA, ClfB, IsdA, and SdrD and their 
host binding partners have been identified: SREC1 receptor, loricrin and 
cytokeratin matrix proteins and epithelial desmoglein 1 (Askarian et al., 2016; 
Baur et al., 2014; Clarke et al., 2009; Mulcahy et al., 2012). Because attachment 
site availability in the nasal epithelia is limited and bacterium-host adhesion 
occurs via specific and strong mechanisms (Schade & Weidenmaier, 2016), the 
experimental colonisation of mouse nasopharynx by USA300 LAC JE2 was 
potentially limited due to the lack of host ligands. SA_MOU however, 
successfully established a colonisation using attachment sites for S. aureus prior 
to inoculation with USA300 LAC JE2.  
 
Similarly, the ability of SA_MOU to colonise the nasopharynx with subsequent 
prevention of USA300_LAC_JE2 establishment could be accounted for by its 
competence in acquiring nutrients within the nasal epithelia. Nasal secretions 
display scarce nutritional conditions (Krismer et al., 2014; Vanthanouvong & 
Roomans, 2004), and bacteria from the nasal microbiota need to overcome such 
growth factor limitation to grow in this niche. The strain SA_MOU may be 
adapted to coexist with other member of the murine nasal flora to obtain 
certain nutrients (Yan et al., 2013). Colonisation of the mouse nasopharynx by 
SA_MOU could be highly favoured for persistence in contrast to the naïve 
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experimental USA300 LAC JE2 colonisation, since SA_MOU presumably has had 
more time to modulate adaptive responses for survival and to obtain nutrients 
from the host. Therefore, SA_MOU persisted in the nasopharynx even when 
challenged by the serially passaged evolved clone C12_7.  
 
In the light of intra-species competition, it is possible that SA_MOU was adapted 
for the stress conditions in the mouse nasopharynx, which differs to USA300 
LAC JE2. SA_MOU revealed only two variants that matched with the non-
synonymous intragenic SNPs from USA300 LAC JE2 C14_7 (nasopharyngeal 
clone evolved after three serial passages), the isolate better adapted to the 
nasopharynx from the experimental evolution performed here. The SNPs found 
in both strains are located in genes with DNA metabolism (recF and ftsK). RecF 
and FtsK have been associated with the SOS response, a defensive mechanism 
activated upon DNA damage (Simmons et al., 2008) which increases the 
mutation rate in the bacterial cell (Vestergaard et al., 2015). Therefore, 
increased mutagenesis could be an important event during S. aureus 
nasopharyngeal adaptation that leads to distinct adaptive responses from 









Chapter 6 General discussion 
 
The multifactorial drivers of S. aureus nasal colonisation makes its 
establishment and persistence difficult to be elucidated (Mulcahy & 
McLoughlin, 2016). There are suggestions of adaptive responses modulated by 
S. aureus in the nasal cavities (Burian et al., 2010b; Krismer et al., 2014), which 
reflects the bacterium’s ability to interact bidirectionally with the host and this 
will indubitably select variants under these pressures. It was hypothesised in 
this research project that an experimental nasopharyngeal evolution of S. 
aureus would enable the detection of genetic sequence variants to be naturally 
selected through this host-pathogen interaction, providing the bacteria with 
improved fitness to colonise and persist in the nasopharynx. In this study, a 
robust genetic variation within S. aureus nasopharyngeal isolates was found 
after serial passage to impose selection and the identity of the variants may 
explain the trend for adaptation and increased frequency that was observed in 
experimentally evolved clones, using the long-term colonisation murine model 
established here. 
 
The established murine model that was developed in Chapter 3 was effective 
for two different colonisation approaches of S. aureus: serial passages of 7 d 
each and long-term colonisation of 14 d. While the model is animal based and 
human isolates of S. aureus were used, the methodology addressed one concern 
that plagues the reliability of interpreting in vitro studies. Lijek et al. (2012) 
used a murine model to demonstrate that antibodies produced after 
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pneumococcal colonisation cross-react with S. aureus and inhibits nasal 
colonisation of the latter demonstrating the complex interplay between 
colonising species and host immunity.  Meanwhile, in vitro assays were 
interpreted to suggest inhibition of S. aureus colonisation due to hydrogen 
peroxide produced by S. pneumoniae (Park et al., 2008; Regev-Yochay et al., 
2006). Subsequent findings from in vivo studies did not support this in vitro 
data (Margolis, 2009, Lijek, et al., 2012).  Murine models have successfully 
demonstrated the association between various host immune system 
components and both S. aureus infection (Planet et al., 2016) and colonisation 
(Xu et al., 2015). The model developed here made it possible in this study to 
gain insights about S. aureus evolution and adaptation in the nasopharynx to 
add to previous studies.   
 
While in vivo models are clearly superior to in vitro studies, they are not 
without complications. Over the course of the murine model establishment, two 
main factors challenged its standardisation and robustness: inoculum size (~ 5 
x 104 cfu) and issues of prior nasopharyngeal colonisation of the mice. The 
inoculum size chosen was lower than other studies with murine models of S. 
aureus colonisation and infection (Archer et al., 2016; Satorres et al., 2009) and 
this size aimed to not only mimic low bacterial density found during natural 
nasal colonisation by S. aureus (Krismer & Peschel, 2011) but also to avoid a 
strong immune response from the host. The model was successfully established 
with this inoculum size although one event of bacterial clearance could be 
observed in the subsequent experiments (Section 5.3.1.1), which could be due 
to problems with instilling the inoculum or animal behaviour. 
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Initially, no preexisting colonisation of the nasopharynx by S. aureus was 
detected during the murine model establishment, making it possible to 
inoculate and recover the USA300 LAC JE2 strain used in this study. However, 
over time subsequent use of the model for serial passages of S. aureus (Section 
3.3.2) showed that another S. aureus strain was colonising the nasopharynx and 
this apparently blocked further colonisation by the strain used in this work. 
Although mice are not considered natural hosts of S. aureus, high rates of 
colonisation were reported in these rodents from commercial vendors (Schulz 
et al., 2017), which supports interpretation of the problem encountered in this 
study. Despite the frustrating change in usefulness of the purchased mice for 
primary colonisation, the model developed here demonstrated it to be an 
effective experimental tool for future investigations of S. aureus in the 
nasopharynx.  With careful adherence to the inoculum preparation and 
instillation protocols developed in this study together with surveillance of the 
nasal microbiota, the in vivo model can be used to interrogate various aspects of 
S. aureus nasopharyngeal colonisation including invasion, establishment, 
persistence and host immunity. 
 
Further improvement of the mouse model developed here could be achieved 
using humanised mice, which with characteristics of the human immune 
system, and this may enable better interpretation relative to the various human 
specific immune evasion components, for example. Rodents and humans 
possess different nasal anatomic structures, distinct metabolic features, altered 
cell lipid composition, potentially microbiome ROS generation and 
inflammatory responses (Seok et al., 2013; Xiao et al., 2015; Warren et al., 
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2015). These substantial differences were associated with failures in the 
development of anti-staphylococcal vaccines, since antibodies designed from 
mice studies proved to be ineffective against S. aureus infections in humans 
(Parker et al., 2017). By utilising the model developed in this study with 
humanised mice our understanding of host-pathogen interactions during S. 
aureus nasopharyngeal colonisation could be maximised. Humanised mice 
models were used in several S. aureus infection studies where they showed 
remarkably increased susceptibility to infection compared with non-humanised 
control mice (Knop et al., 2015; Prince et al., 2016; Tseng et al., 2015). 
 
Repeated passages of S. aureus in the nasopharynx of mice revealed DNA 
sequence variation as the passages were performed (Section 4.3.3 – 4.3.8). This 
approach exposed clear evidence of natural selection of mutants in the S. aureus 
population during nasopharyngeal colonisation over the experimental 
evolutionary timescale. Published studies identified genomic mutations in S. 
aureus evolved clinical isolates primarily associated with infections (Kennedy et 
al., 2008; Lopez-Collazo et al., 2015). The identification of several non-
synonymous intragenic SNPs in this study shared with those identified in 
previous S. aureus evolutionary studies (Section 4.4) emphasizes the strength of 
the methodology used here to investigate relevant features of S. aureus 
nasopharyngeal colonisation. Furthermore, collation and curation of such 
studies could lead to subsequent investigation of common alleles that are 




Future studies using the murine model developed here coupled with additional 
S. aureus strains will help to clarify the major bacterial components and 
pathways involved in S. aureus nasal carriage. Repeated passages using closely 
and distantly related strains to USA300 would provide more consistent insight 
of genetic variation outcomes, which will reveal both strain-specific and general 
components under selective pressure in the genome during S. aureus 
nasopharyngeal colonisation. Additionally, the replication of three serial 
passages of S. aureus USA300 LAC JE2 using a distinct batch or strains of mice 
would answer the question whether the S. aureus evolution captured here was a 
unique event or a typical consequence of variants that can be selected under 
environmental pressure in the nasopharynx. Attempts were made to reinforce 
the data presented here by repeating the 1st and 2nd passages, however the 
experiments were frustrated due to pre-colonisation of the mice (data not 
shown). Finally, performing additional serial passages and using different S. 
aureus strains could help to identify novel S. aureus components under selective 
pressure in the nasopharynx and potentially indicate sequence variants 
relevant throughout more persistent nasal colonisation. Here, an expansion in 
the number of SNPs found in pooled genomic DNA from the second passage was 
followed by refinement of these mutations after the third passage. Therefore, 
carrying out a fourth or even a fifth repeated passage would reveal the pattern 
of S. aureus genome modulation for longer colonisation periods (e.g. 
stabilisation, re-expansion or further refinement of genomic sequence variants).    
However, such an experiment could also produce evolutionary bottlenecks 
determined by early mutations, so a more broad study would also be required 
to reduce this possibility. 
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The genetic changes captured during S. aureus murine nasopharyngeal 
colonisation in this study was accompanied by a trend of bacterial adaptation to 
this anatomic site with some weak statistical support (Section 5.3.1). Adaptive 
responses of S. aureus evolved clones after exposure to stress conditions have 
been described many times and some responses are well understood (Chaffin et 
al., 2012; Ferreira et al., 2013; Chavez-Moreno et al., 2016). When S. aureus is 
introduced into the mouse nasopharynx, the bacteria must overcome diverse 
growth-limiting conditions, such as low nutrients availability, competition for 
host ligands, modulated epithelial inflammation and competing microbiota that 
can secrete antimicrobials, making it logical to hypothesise that genetic changes 
that promote improved bacterial fitness will be selected over the evolutionary 
timescale and are likely to represent the sum total of the pressures. The 
individual contribution of the numerous intragenic and intergenic SNPs to S. 
aureus nasopharyngeal adaption captured in this study are yet to be addressed 
raising the need for future studies. Several methodologies could be used to 
investigate and elucidate the involvement of an individual SNP in S. aureus nasal 
carriage.  However, with many SNPs identified in this study and only partial, 
weak statistical support for improved fitness the study of single alleles could be 
challenging without more in silico study. 
 
In addition, work should be undertaken to endorse the contribution of DNA 
sequence variants by confirmation of the SNPs identified in the sequence pools 
and single isolates found in this study through PCR amplification and Sanger 
DNA sequencing. Once the variants are attested, differences in the 
nasopharyngeal colonisation status from sets of strains for each SNP (control 
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and mutants: a strain containing a single SNP, mutant strain lacking the gene 
with the SNP and a complemented or knock-in strain) could be investigated. 
Distinct survival rates among these different strains relative to a single SNP 
would indicate that the sequence variant contributes to S. aureus persistence in 
the nasopharynx.  
 
Future analyses should also include global gene expression analysis of evolved 
nasopharyngeal isolates from this study. Comparisons with the control strain 
could reveal the consequences of genetic variation in up/down-regulation of S. 
aureus genes during growth and identify pathways or individual components 
contributing to nasopharyngeal colonisation. Trancriptomics approaches were 
performed to investigate S. aureus adaptation using a mouse pneumonia model 
(Chaffin et al., 2012) and separately a synthetic nasal medium – SNM - that 
simulates the nutritional conditions of the human nose (Krismer et al., 2014). 
Both studies indicated metabolic pathways strongly regulated during S. aureus 
adaptation. Therewith, analysing gene expression profiles of adapted 
nasopharyngeal isolates from either early/late colonisation stages using the 
murine model established here together with different time-points after growth 
in SNM could collectively help to understand S. aureus niche adaptation.   
 
Intra-species competition in the nasopharynx was also addressed in this study. 
In some occasions, the mice used in the murine model were pre-colonised by 
another S. aureus ST8 strain (SA_MOU), which blocked further colonisation by 
USA300 LAC JE2 and prevented the third experimental serial passage to be 
performed. Genome investigations revealed that both strains are closely related 
 190 
with high rate of similarity when aligned against each other. However, SNPs 
analysis showed that SA_MOU nasopharyngeal adaptation is likely to have 
occurred through distinct mechanisms compared with USA300 LAC JE2, since 
only two identical sequence variants were identified in both SA_MOU and C14_7 
(USA300 LAC JE2 clone from the third serial nasopharyngeal passage). 
However, the SA_MOU could represent a strain that has been subjected to a very 
long evolutionary timescale of selection relative to the inoculated USA300 LAC 
JE2, making comparison of limited value.  The S. aureus competition observed in 
this study is in accordance with the competitive exclusion principle (Hardin, 
1960) which states that two species competing for similar resources cannot co-
exist in the same environment since one will always have advantage over the 
other, leading to extinction of the second competitor.  SA_MOU most likely 
prevented USA300 LAC JE2 invasion through these principles and its 
occupation of host ligands for colonization. 
 
It is possible that SA_MOU possess a better fitness than USA300 LAC JE2 due to 
improved metabolic responses against stress conditions in the nasopharynx. 
Future studies competing the SA_MOU strain with USA300 LAC JE2 and the 
evolved variants could provide insights regarding relative fitness for the 
nasopharynx.  Transcriptomics/metabolomics studies coupled with phenotypic 
assays would reinforce any difference in the cell metabolism between both 
strains. In addition to these investigations, future studies could simultaneously 
explore competitive exclusion due to limited host ligands. Inducing the 
colonisation with USA300 LAC JE2 first, followed by a challenging colonisation 
with SA_MOU would give highlight the nature of the competition between both 
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strains. If only USA300 LAC JE2 parent and evolved isolates are differentially 
present in the nasal wash after the nasopharynx is challenged with SA_MOU, it 
would support that early adhesion to the nasal epithelium is a critical factor in 
S. aureus carriage.  
 
 
In summary, this study showed that S. aureus DNA sequence variants selected 
during nasopharyngeal colonisation could indicate loci contributing to better 
fitness in this niche. The outcomes of this study raises questions on a broad 
range of components with potential role in S. aureus nasal carriage. The 
individual understanding of their relevance will serve as basis for future studies 
focused on prevention/elimination of S. aureus nasal colonisation, a high-risk 
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